project	submitter_id	figo_stage	synchronous_malignancy	days_to_diagnosis	created_datetime	figo_staging_edition_year	last_known_disease_status	tissue_or_organ_of_origin	age_at_diagnosis	primary_diagnosis	updated_datetime	prior_malignancy	year_of_diagnosis	state	prior_treatment	diagnosis_is_primary_disease	days_to_last_known_disease_status	method_of_diagnosis	days_to_recurrence	morphology	residual_disease	classification_of_tumor	diagnosis_id	icd_10_code	site_of_resection_or_biopsy	tumor_grade	progression_or_recurrence	ajcc_pathologic_t	ajcc_pathologic_n	ajcc_pathologic_m	laterality	tumor_of_origin	NA.	ajcc_pathologic_stage	ajcc_staging_system_edition	race	gender	ethnicity	vital_status	age_at_index	days_to_birth	year_of_birth	demographic_id	age_is_obfuscated	year_of_death	country_of_residence_at_enrollment	days_to_death	days_to_last_follow_up	follow_ups_disease_response	treatments_pharmaceutical_treatment_intent_type	treatments_pharmaceutical_treatment_id	treatments_pharmaceutical_treatment_type	treatments_pharmaceutical_therapeutic_agents	treatments_pharmaceutical_treatment_or_therapy	treatments_pharmaceutical_initial_disease_status	treatments_pharmaceutical_timepoint_category	treatments_pharmaceutical_treatment_outcome	treatments_pharmaceutical_days_to_treatment_end	treatments_pharmaceutical_clinical_trial_indicator	treatments_pharmaceutical_days_to_treatment_start	treatments_pharmaceutical_course_number	treatments_pharmaceutical_treatment_dose	treatments_pharmaceutical_number_of_fractions	treatments_pharmaceutical_treatment_anatomic_sites	treatments_pharmaceutical_treatment_dose_units	treatments_pharmaceutical_prescribed_dose_units	treatments_pharmaceutical_route_of_administration	treatments_pharmaceutical_number_of_cycles	treatments_pharmaceutical_prescribed_dose	treatments_pharmaceutical_residual_disease	treatments_radiation_treatment_intent_type	treatments_radiation_treatment_id	treatments_radiation_treatment_type	treatments_radiation_therapeutic_agents	treatments_radiation_treatment_or_therapy	treatments_radiation_initial_disease_status	treatments_radiation_timepoint_category	treatments_radiation_treatment_outcome	treatments_radiation_days_to_treatment_end	treatments_radiation_clinical_trial_indicator	treatments_radiation_days_to_treatment_start	treatments_radiation_course_number	treatments_radiation_treatment_dose	treatments_radiation_number_of_fractions	treatments_radiation_treatment_anatomic_sites	treatments_radiation_treatment_dose_units	treatments_radiation_prescribed_dose_units	treatments_radiation_route_of_administration	treatments_radiation_number_of_cycles	treatments_radiation_prescribed_dose	treatments_radiation_residual_disease	bcr_patient_barcode
TCGA-UCEC	TCGA-AJ-A3NC	Stage IA	No	0	NA	2009	NA	Endometrium	23353	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	53218018-d835-5878-a24c-d303aede851f	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	63	-23353	NA	af950860-01d9-57e3-a223-7ae401b8c798	FALSE	NA	United States	NA	1125	TF-Tumor Free	Adjuvant;NA	0bfff125-be0b-51b9-a1b6-c3be59e73898;3929fbc5-3698-4f31-be72-2fae9c3665d5	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	4f4c5eab-86cf-43cd-b726-59c79e667b4c	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AJ-A3NC
TCGA-UCEC	TCGA-KP-A3W0	Stage IB	No	0	NA	2009	NA	Endometrium	26378	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8441/3	R0	primary	27fb4d70-b5fe-515f-8dc1-b4d461322f31	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	not reported	female	not reported	Alive	72	-26378	NA	59388de5-fd85-5e5e-9f59-87345330429b	FALSE	NA	Canada	NA	404	TF-Tumor Free	Adjuvant;NA	267ad052-a47f-566c-b65b-bf25b5550753;c43cad50-ee14-4efb-bff9-abece4ce995e	Pharmaceutical Therapy, NOS	NA;Tamoxifen	yes;no	NA	NA;Prior to Diagnosis	Complete Response;NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	caa7f3b1-2775-45e1-99ce-95ebba8782ed	Radiation Therapy, NOS	NA	yes	NA	NA	Complete Response	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-KP-A3W0
TCGA-UCEC	TCGA-B5-A11N	Stage IA	No	0	NA	1988	NA	Endometrium	25442	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2007	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	d6158568-3774-5c50-aaa7-671bf85d5032	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	69	-25442	NA	ef38b762-6e65-5a5f-985e-ae40bec376aa	FALSE	NA	United States	NA	1876	TF-Tumor Free	NA;Adjuvant	a3cbd2ad-bfe1-4fe7-be9b-663d356748c1;b573c252-049a-5aa8-9ba9-258f89313a21	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	00600489-c086-443c-88b1-29acf98b6b68	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A11N
TCGA-UCEC	TCGA-BS-A0V7	Stage IB	No	0	NA	1988	NA	Endometrium	17810	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2006	released	No	TRUE	NA	Other	NA	8380/3	R0	primary	c33af881-6611-57b2-a417-aa419c4974d7	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	native hawaiian or other pacific islander	female	not hispanic or latino	Alive	48	-17810	NA	358c1776-769f-553f-9b5b-edaa92da5a9a	FALSE	NA	NA	NA	1934	TF-Tumor Free	Adjuvant;NA	615da570-874a-5d63-b27b-a5b5d7f92d9e;70478e0a-69c9-4e27-8710-23130658e9de	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	7426235d-e4bd-4fb3-84f6-4601382432d8	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BS-A0V7
TCGA-UCEC	TCGA-D1-A17Q	Stage IA	No	0	NA	2009	NA	Endometrium	20015	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	3f107814-8eeb-5e24-9e5a-5a9abc94546f	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	54	-20015	NA	105fd313-edc4-545d-b653-07fd87c0f017	FALSE	NA	NA	NA	54	TF-Tumor Free	NA;Adjuvant	5ac1b4c7-6551-463b-bbbe-82a38b2060b5;e38e41c4-7639-565f-b930-b00d395a01d6	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	f33ac362-a0c0-43f2-809f-3a6e5d5798f4	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A17Q
TCGA-UCEC	TCGA-BG-A0VT	Stage IIIA	No	0	NA	2009	NA	Endometrium	20602	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	3d11de4e-227e-54c3-a47f-a4bd36c33697	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	56	-20602	NA	e994a2fd-e48e-59d3-8f79-518983164bf1	FALSE	NA	NA	NA	1568	TF-Tumor Free	NA	5b7371be-16d0-4e0d-949c-0859ffa14657	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	d8d05731-5f5d-4711-a541-be9c6b4bbb49	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BG-A0VT
TCGA-UCEC	TCGA-AP-A0LG	Stage IA	No	0	NA	2009	NA	Endometrium	20047	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2002	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	6ce71ba2-cd75-57ee-af14-db1e0b405777	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	54	-20047	NA	dc97087e-e474-5a4a-ae55-9df2cd584547	FALSE	NA	NA	NA	2015	Unknown	NA;Adjuvant	726aade5-d3d1-4dc3-bbed-48e6e0c66abe;e2bf6274-dab7-475e-a561-b75b631b26a2	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	695886f4-309d-58ac-aefc-e2c3eb137fae	Radiation, Implants	NA	yes	NA	NA	NA	111	NA	83	1	2100	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-AP-A0LG
TCGA-UCEC	TCGA-AX-A060	Stage IC	No	0	NA	1988	NA	Endometrium	28472	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2007	released	No	TRUE	NA	Biopsy	NA	8380/3	R1	primary	f7ad81f2-cea4-5e5f-8da3-33ec4c74256b	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	american indian or alaska native	female	not hispanic or latino	Alive	77	-28472	NA	19a24b4b-1b54-5c06-ae56-8d3dde47aadd	FALSE	NA	NA	NA	1075	TF-Tumor Free	NA	95804d9f-0585-4562-b1ef-54c763c2afa3	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	8d747551-451b-5b61-8052-319604eba5dd	Radiation Therapy, NOS	NA	yes	NA	NA	NA	NA	NA	NA	1	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A060
TCGA-UCEC	TCGA-E6-A2P8	Stage IV	No	0	NA	2009	NA	Endometrium	19448	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8441/3	NA	primary	ac55b2e9-7e56-5d7f-acd8-d576ae60066c	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Dead	53	-19448	NA	a51a6a0a-d4c4-54ec-97a9-ce55baea0d0f	FALSE	NA	United States	72	72	WT-With Tumor	Adjuvant;NA	1ace1606-ee88-5554-8696-63819b2606aa;666653cc-dfaf-431d-a2c2-43c27b7e2ee8	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	f630a2a0-feb3-426a-b0e7-085ababf6ed1	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-E6-A2P8
TCGA-UCEC	TCGA-EO-A3AV	Stage IIIC1	No	0	NA	2009	NA	Endometrium	18713	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	b4428283-5286-527f-97ff-74c7988b7d01	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	not reported	female	not reported	Alive	51	-18713	NA	f558be12-2a1f-5506-b7a5-39ae58109415	FALSE	NA	Canada	NA	1069	TF-Tumor Free	NA	da24c471-aafd-46b5-b1bf-f9d072a1a2ad	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	c6b3a35f-f5c9-5c8e-8e97-baca09dd2367	Radiation, External Beam	NA	yes	NA	NA	Complete Response	267	NA	232	NA	4500	25	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-EO-A3AV
TCGA-UCEC	TCGA-AJ-A23M	Stage II	No	0	NA	2009	NA	Endometrium	22430	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	NA	NA	8441/3	NA	primary	d8cefeb1-6fae-59ae-ba9f-8421609c52e9	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Dead	61	-22430	NA	f103f7be-085d-52f8-a650-31b9e2c0bc56	FALSE	NA	United States	616	616	WT-With Tumor	NA	67e2553a-fdd9-4950-b7a7-dfffb64f3d45	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	90202d01-075f-4f4f-b3f4-7a888489c4e9;a161dcb0-d222-5abf-ba4e-669ad3d80968	Radiation, Internal;Radiation, External Beam	NA	yes	NA	NA	Stable Disease	243;215	NA	215;184	NA	NA	NA	Primary Tumor Field	NA	NA	NULL	NA	NA	NA	TCGA-AJ-A23M
TCGA-UCEC	TCGA-B5-A5OE	Stage IIIC2	No	0	NA	2009	NA	Endometrium	24905	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	NA	NA	8441/3	NA	primary	4c34818d-6290-52a5-a4d4-29ab9ec64c52	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not reported	Alive	68	-24905	NA	efdecf34-f346-53d8-9aab-eefc419d4463	FALSE	NA	United States	NA	1063	TF-Tumor Free	NA	55e5be27-f71c-4345-83b8-e30c9dec1152;81f17da7-69a8-43e1-860b-1094ae9d3a7c;a1de606d-210d-5d88-ab82-eff7e6b4ab75;ca2596a8-c081-4443-9e19-8190e7be5c41	Pharmaceutical Therapy, NOS	Tamoxifen;Ixabepilone;Carboplatin;Bevacizumab	unknown;yes	NA	Prior to Diagnosis;NA	NA;Treatment Ongoing	NA;196	NA;Yes	NA;100;69	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	47a341dd-6e2e-4a66-bbb4-f0f461248751	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A5OE
TCGA-UCEC	TCGA-D1-A1NW	Stage IVB	No	0	NA	2009	NA	Endometrium	26556	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8441/3	R0	primary	5d5d849c-052c-5063-ade9-20bd9e3e4943	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	72	-26556	NA	694e78fe-7a46-5958-8551-9345298fe4ba	FALSE	NA	United States	NA	22	TF-Tumor Free	Adjuvant;NA	683c480b-caa4-509d-9f18-23dbd20d4781;9360d2a5-c30f-4014-b161-97806f503c88	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	aef34fc3-982a-415e-81c8-3535a1630c39	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A1NW
TCGA-UCEC	TCGA-D1-A0ZU	Stage IB	No	0	NA	NA	NA	Endometrium	12458	Endometrioid adenocarcinoma, secretory variant	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8382/3	R0	primary	b4a356da-fe64-55c9-af8e-cfb83379916a	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	34	-12458	NA	ee1002c1-689a-5594-a725-effa8b8af1dc	FALSE	NA	NA	NA	872	TF-Tumor Free	NA	a0121bea-e6c4-4b0b-8849-ac18fc4f84ab	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	6e8af011-3c03-57b3-8a0b-40bdfc7655c3	Radiation, External Beam	NA	yes	NA	NA	NA	208	NA	173	1	5000	25	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-D1-A0ZU
TCGA-UCEC	TCGA-AP-A054	Stage IIIC1	No	0	NA	NA	NA	Endometrium	23404	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2004	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R1	primary	2b7347af-8dcf-51f7-a56d-c994d6a4fc35	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	64	-23404	NA	d6f05fb4-474c-5dc6-af92-61624f0f0d4c	FALSE	NA	NA	709	709	WT-With Tumor	NA	0b1dc951-0328-4faa-ad50-93864c81a868	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	b3635b37-977f-4693-9d7d-49bde381c5c2	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AP-A054
TCGA-UCEC	TCGA-BG-A0YV	Stage IIIA	No	0	NA	2009	NA	Endometrium	24567	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2010	released	No	TRUE	NA	Cytology	NA	8441/3	R0	primary	6e2eb9bb-87c9-5622-99ea-211fba71718e	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	67	-24567	NA	a725b8c8-1661-5ee3-8187-e4cb2286b6ed	FALSE	NA	NA	NA	382	TF-Tumor Free	NA;Adjuvant	0e25cea5-c28d-49c1-96cd-8376395a0ab7;1c1cda1f-b8d3-5f9b-9eb2-ef8ebed93596	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no;yes	NA	Prior to Diagnosis;NA	NA;Complete Response	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	ba113822-3011-4237-bc1c-8825ddb267e9	Radiation Therapy, NOS	NA	yes	NA	NA	Complete Response	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BG-A0YV
TCGA-UCEC	TCGA-AX-A0IW	Stage IIIA	No	0	NA	1988	NA	Endometrium	24488	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	0bbc5122-2673-5345-9e8f-9129e7abfd59	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	67	-24488	NA	c3177194-2df1-5361-a8c2-9a181bc27742	FALSE	NA	NA	NA	1149	TF-Tumor Free	NA	783474c2-5bb2-4c8e-a9b6-b5913fdfd0fa	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	feae2be2-3fc4-4622-81aa-c9756977ec1e	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A0IW
TCGA-UCEC	TCGA-AJ-A2QK	Stage IA	No	0	NA	2009	NA	Endometrium	23945	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	5266f863-323d-5f28-b48b-8f121693eebe	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	hispanic or latino	Alive	65	-23945	NA	8ab5b506-712f-54cc-95f5-082df9ea6660	FALSE	NA	United States	NA	643	WT-With Tumor	NA	4d4f9303-73a3-408a-9a6b-3d4cba4f0d66	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	ee6d2a2b-9030-5817-a44f-7a4abbfcdf01	Radiation, Internal	NA	yes	NA	NA	Complete Response	62	NA	48	NA	NA	NA	Primary Tumor Field	NA	NA	NULL	NA	NA	NA	TCGA-AJ-A2QK
TCGA-UCEC	TCGA-A5-A7WK	Stage IA	No	0	NA	2009	NA	Endometrium	26044	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2013	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	ec380795-f14e-5b6a-bf51-f17431ec8566	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	71	-26044	NA	24d1e0d9-dcac-5e22-be01-d00d6ccbf4ad	FALSE	NA	United States	NA	560	WT-With Tumor	NA	872f323a-bdc8-487f-9857-b1c8416527f4	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	86ed9a31-8647-44ea-b29f-8555951b9541	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-A5-A7WK
TCGA-UCEC	TCGA-B5-A11H	Stage IIIA	No	0	NA	1988	NA	Endometrium	24556	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2004	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	NA	primary	85535d33-70d5-53e0-b4f9-738a62b34432	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	67	-24556	NA	8c9e16d5-74cd-58a5-87ae-aa6dd8a31bff	FALSE	NA	United States	NA	2687	TF-Tumor Free	NA	7d6abe9b-5392-4799-bf8e-0c0fcd3f5e0d	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	db7956e4-0c70-4a10-b888-e8496282c58e	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A11H
TCGA-UCEC	TCGA-QF-A5YS	Stage II	No	0	NA	2009	NA	Endometrium	20841	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2012	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	7ef8e2f1-5575-5c40-9462-fbfc52077346	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	57	-20841	NA	07f2d324-0079-5388-a28a-e7b6a3c00f3d	FALSE	NA	United States	NA	689	TF-Tumor Free	NA	01ae239c-e4a8-42a6-b566-d6ce1bb43a6d	Pharmaceutical Therapy, NOS	Tamoxifen	unknown	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	67931494-ade1-4ab5-8a17-a536936cc018;e12441b5-1346-533a-b2d2-679afc1d2711	Radiation, Internal;Radiation, External Beam	NA	yes	NA	NA	Complete Response	227;212	NA	220;172	NA	1800;4500	3;25	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-QF-A5YS
TCGA-UCEC	TCGA-BS-A0TI	Stage IC	No	0	NA	1988	NA	Endometrium	23705	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2006	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	8c930394-3164-5af8-b62d-d93d088d0760	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	64	-23705	NA	031b9275-feab-5a98-ab1d-ea8def8bce56	FALSE	NA	NA	NA	1882	TF-Tumor Free	Adjuvant;NA	bafba2f7-f1e5-5613-b47d-316f08719439;bdd11f6b-0191-4707-8bf8-4adb19034f3a	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	5012768b-c1be-4a76-9ba3-cca33bbaa5aa	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BS-A0TI
TCGA-UCEC	TCGA-AJ-A2QN	Stage II	No	0	NA	2009	NA	Endometrium	21915	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	42bb44bc-d039-5d7d-9b18-e9d123743198	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	60	-21915	NA	715f8a44-a741-5bf0-977f-2d443c2c098d	FALSE	NA	United States	NA	1069	TF-Tumor Free	Adjuvant;NA	0e34cc70-9e6d-5096-8ef4-7033a91c848d;3be91995-1f8a-4eb1-a8ff-91415376abac	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	aeb78758-5aa0-461c-bcf4-c35310b2ac79	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AJ-A2QN
TCGA-UCEC	TCGA-BS-A0WQ	Stage IA	No	0	NA	1988	NA	Endometrium	20131	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2006	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	8c6d3454-af03-5c35-9e05-1102360a1563	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	asian	female	not hispanic or latino	Alive	55	-20131	NA	fbe59fad-77f1-5a5c-be08-9129ca24a265	FALSE	NA	NA	NA	2022	TF-Tumor Free	NA;Adjuvant	6576fdd9-5a39-47f2-a2df-f537bdf4fe7f;cb6ae894-4038-5502-9a71-501fa8b8bc77	Pharmaceutical Therapy, NOS	Tamoxifen;NA	yes;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	b2d6e878-9c1f-4472-b0df-78822c823b72	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BS-A0WQ
TCGA-UCEC	TCGA-EY-A1GT	Stage IIIA	No	0	NA	2009	NA	Endometrium	25151	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	c5270936-62ce-5d17-aea2-139f36582dbf	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	68	-25151	NA	82aaf7e3-9a30-5061-b417-624d521b0883	FALSE	NA	United States	NA	490	TF-Tumor Free	NA	fe93838d-3222-4b30-b499-7a5f19b5c3cc	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	6d87d11e-79d4-42d8-ac36-3f5029249566	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-EY-A1GT
TCGA-UCEC	TCGA-AP-A0LI	Stage IIIC2	No	0	NA	NA	NA	Endometrium	24573	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2003	released	No	TRUE	NA	Biopsy	NA	8441/3	R2	primary	6b3033f1-7849-5ed0-b1c1-abb61ba6d85b	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not reported	Alive	67	-24573	NA	1e9d614e-a709-5368-ad16-6a95d293e547	FALSE	NA	NA	NA	2972	TF-Tumor Free	NA	bfbb7296-ae2f-44dd-a89b-a941b4f27352	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	45dce2a1-41d9-5f94-8652-e9cb0b0c05eb	Radiation, External Beam	NA	yes	NA	NA	NA	147	NA	115	1	4500	25	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-AP-A0LI
TCGA-UCEC	TCGA-BS-A0UT	Stage IIB	No	0	NA	1988	NA	Endometrium	22775	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2005	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	c8e7cb30-8811-5468-920d-1c0643a8a7ed	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	asian	female	not hispanic or latino	Alive	62	-22775	NA	4483f9f3-4e11-52f5-bdd7-074f47cde40d	FALSE	NA	NA	NA	2212	TF-Tumor Free	NA;Adjuvant	322671eb-f8d5-4114-b4fa-9368fa527a9f;c84b6211-ff3a-5f74-a2c2-a3f49115c195	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	34b7211d-dcac-4d23-a09b-08878c9cdb75	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BS-A0UT
TCGA-UCEC	TCGA-AX-A3G6	Stage IA	No	0	NA	1988	NA	Endometrium	24681	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Surgical Resection	NA	8441/3	NA	primary	c9b92d64-fe19-550b-b12a-17efa6df460c	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	67	-24681	NA	4cf21d71-f8d6-515e-ab34-b6ce4a4126db	FALSE	NA	United States	NA	8	NA	Adjuvant;NA	91ddc979-9d46-5c1d-b995-49b4de1fbb37;e006a373-fd07-43c8-ab78-c65cfea84b81	Pharmaceutical Therapy, NOS	NA;Tamoxifen	unknown;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	585f905f-9577-4ed1-bf99-40bb15e6304e	Radiation Therapy, NOS	NA	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A3G6
TCGA-UCEC	TCGA-EY-A1GV	Stage IIIC1	No	0	NA	2009	NA	Endometrium	27581	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	0e70f82d-667f-5df8-a3d6-5dbbd3ab01e2	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	75	-27581	NA	f7a149e5-b25a-58e3-8ad4-4457ffb83a89	FALSE	NA	United States	NA	481	TF-Tumor Free	NA	93bf155c-e1d7-4bc0-9045-5e959be63ddb	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	ac3d49a9-9cbe-43ef-8ea6-7740ccb99127;b46d9d81-0276-5a48-8320-45c712937ffd	Radiation, External Beam	NA	yes	NA	NA	NA	166;175	NA	134;168	1	3960;900	23;5	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-EY-A1GV
TCGA-UCEC	TCGA-D1-A17B	Stage IB	No	0	NA	2009	NA	Endometrium	25504	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	adcf1940-b352-5c45-8993-318a66c3902e	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	69	-25504	NA	ecf70e7a-8b2e-57a7-82e6-a3ba6cf2ac80	FALSE	NA	NA	NA	213	TF-Tumor Free	NA;Adjuvant	01a90899-db8f-41d6-a8f5-3b9a4b746379;e5846de8-424b-5e80-ab3c-0a1e668c8f94	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	ce3e9ff6-fcce-44b7-adf7-1547c194628d	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A17B
TCGA-UCEC	TCGA-AX-A05U	Stage IB	No	0	NA	1988	NA	Endometrium	20533	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	8f4b5fbe-28bf-5a2d-b74e-970b40796eef	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	american indian or alaska native	female	not hispanic or latino	Alive	56	-20533	NA	f34a2659-0257-5109-8d37-63fd9d62af15	FALSE	NA	NA	NA	903	TF-Tumor Free	Adjuvant;NA	02b75a17-b9e5-53f9-913b-093874a7ec3b;25e36f05-b396-4bfb-99b9-6bd82c2c1a1e	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	abd644e8-69ec-44cf-9a02-1ee2e1a94a2a	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A05U
TCGA-UCEC	TCGA-AJ-A3I9	Stage II	No	0	NA	2009	NA	Endometrium	19139	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	f7872574-04be-5b1b-9731-c3f881015922	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	52	-19139	NA	426e16e6-d6a6-50ae-a3ae-748b39b15a60	FALSE	NA	United States	519	519	WT-With Tumor	NA	87a330a6-fcea-480b-b913-39bbe7175d83	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	d54609df-37f6-560c-aa3b-5d650d6f6dec	Radiation, Internal	NA	yes	NA	NA	Complete Response	141	NA	127	NA	2100	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-AJ-A3I9
TCGA-UCEC	TCGA-AX-A06H	Stage IIIA	No	0	NA	1988	NA	Endometrium	22270	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R1	primary	f8e76f0a-a24a-5a0b-8176-25c3681c2344	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	american indian or alaska native	female	not hispanic or latino	Alive	60	-22270	NA	d376f28e-2c9a-54ab-9426-adfa028674d4	FALSE	NA	United States	NA	833	WT-With Tumor	NA	c280d433-6d39-48e4-b033-10ff145c0420	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	51c87559-58fe-49c3-b8b3-dfcc9d06d775	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A06H
TCGA-UCEC	TCGA-D1-A177	Stage IB	No	0	NA	2009	NA	Endometrium	25602	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	2e0e272b-4997-507a-b791-0d1d28ed2cfd	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	70	-25602	NA	dd1d384b-f3e5-53cb-b3e1-cff1a4d84850	FALSE	NA	NA	NA	548	TF-Tumor Free	Adjuvant;NA	2a616b41-c6ca-4315-b346-ac4f50ba3bc1;75a4ea77-6fa7-470e-bd4c-11947bc8a3da	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant;NA	5b69be75-99d1-5c22-bb7f-f3f7fe51088a;bca3c249-2c60-4a14-9871-4df5919129bf	Radiation, Implants;Radiation, External Beam	NA	yes	NA;Recurrent Disease	NA	NA	71;548	NA	67;514	1	2100;500	3;25	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-D1-A177
TCGA-UCEC	TCGA-PG-A6IB	Stage IA	No	0	NA	2009	NA	Endometrium	24969	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2012	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	ea1ae058-a218-5194-81e9-51a1f83914d4	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	68	-24969	NA	86dca230-c669-54c6-b78d-74b1fa5a7b19	FALSE	NA	United States	NA	648	TF-Tumor Free	Adjuvant;NA	0bad11d8-8e1b-5320-864d-e636cebccba9;d11b8d90-6b8b-4126-ad32-214f15da835d	Pharmaceutical Therapy, NOS	NA;Tamoxifen	unknown;no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	7d3f07ef-b891-446c-b81d-6de92c98f914	Radiation Therapy, NOS	NA	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-PG-A6IB
TCGA-UCEC	TCGA-PG-A915	Stage IA	No	0	NA	2009	NA	Endometrium	22119	Serous surface papillary carcinoma	2025-10-24T10:03:58.643295-05:00	no	2013	released	No	TRUE	NA	Cytology	NA	8461/3	R0	primary	f3055bcf-c763-590e-869a-dfd58ff0b510	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	60	-22119	NA	27d1bde4-7227-5326-82a1-ce3dcf173f2d	FALSE	NA	United States	NA	249	Unknown	Adjuvant;NA	395b3137-55c4-5cba-9839-2c11f999844e;60e0ab0e-b7b2-4772-bd59-f57796a74bd5	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	f7b2991b-fcf0-4294-8a35-e643d94120e9	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-PG-A915
TCGA-UCEC	TCGA-B5-A3FC	Stage II	No	0	NA	1988	NA	Endometrium	19422	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2006	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	8f92a82c-7e5e-5769-ad9a-c8226ae6c174	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	53	-19422	NA	17832a39-9b9c-59f2-a313-ab23798e31fa	FALSE	NA	United States	NA	2185	NA	NA;Adjuvant	d67f659c-7242-4c49-afcc-802d7e70d570;f3176092-333e-52ee-8d52-6f340ed83f29	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	4288a837-b97e-40bf-8b2f-fb7193ac486a	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A3FC
TCGA-UCEC	TCGA-BG-A0VZ	Stage IIIA	No	0	NA	1988	NA	Endometrium	21414	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	c803212c-f333-587d-97fe-c2c670473010	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	58	-21414	NA	5671514e-c9d4-5f07-b12a-568226f20275	FALSE	NA	NA	NA	1601	TF-Tumor Free	NA	c20ec492-ba6c-4f57-b108-ee4c6b288c4c	Pharmaceutical Therapy, NOS	Tamoxifen	unknown	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	0b9c101f-bcbf-4831-9c5d-b2b7e91803ce	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BG-A0VZ
TCGA-UCEC	TCGA-B5-A3FD	Stage IA	No	0	NA	2009	NA	Endometrium	25813	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	NA	primary	7a2f53e6-61d9-50c5-b44e-1f576b14fbd5	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not reported	Dead	70	-25813	NA	e94319b4-e027-5ad2-aa86-d68b64ecca13	FALSE	NA	United States	1197	1197	NA	NA	55e478ed-358e-4659-9b7b-2d39e2a0edac	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	d4f23d57-049a-4177-8a6f-3d7a8922485c	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A3FD
TCGA-UCEC	TCGA-D1-A1O5	Stage IA	No	0	NA	2009	NA	Endometrium	22580	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	70b0e8e8-887f-58f8-9664-19fb14475c53	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	61	-22580	NA	5af7b769-4f26-5003-8b0c-835175118797	FALSE	NA	United States	NA	458	TF-Tumor Free	NA;Adjuvant	556d171b-d3af-4a96-ab14-184dcccc2738;de030ee2-e829-5b56-a962-2c5b08bec0ba	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	dc1b86da-6ffb-4c17-b3e4-8641ba3b80be	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A1O5
TCGA-UCEC	TCGA-D1-A175	Stage IC	No	0	NA	2009	NA	Endometrium	17802	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	5a78079f-1378-5ba1-be36-e3047a837778	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	48	-17802	NA	5adae4ab-9d4c-5380-ba44-2fc49810993d	FALSE	NA	NA	NA	202	TF-Tumor Free	NA	dc10b6df-74c9-4971-8336-e00626b929d4	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	504387e3-8483-54d6-930b-87ed3e89ac8b	Radiation, Implants	NA	yes	NA	NA	NA	56	NA	52	1	2100	3	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-D1-A175
TCGA-UCEC	TCGA-EC-A1QX	Stage IB	No	0	NA	2009	NA	Endometrium	26259	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	c06f4aec-8182-5dd8-a6c0-80cd29a1b683	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	71	-26259	NA	81b84182-932d-5e2e-9d97-0000ec2b42db	FALSE	NA	Ukraine	NA	224	TF-Tumor Free	NA	f5d92aa7-2bb6-43dc-a893-37bec8e376ce	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	7f9cfa80-e1c9-5b7b-af8a-df6c711f29af	Radiation, External Beam	NA	yes	NA	NA	NA	130	NA	100	1	3740	NA	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-EC-A1QX
TCGA-UCEC	TCGA-AX-A06L	Stage IB	No	0	NA	1988	NA	Endometrium	23294	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2006	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R1	primary	5ade4692-b9f4-5130-802d-4408788d54fe	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	63	-23294	NA	316d7ad8-9075-5bbb-b4b3-a38a05ae77c3	FALSE	NA	United States	NA	1845	TF-Tumor Free	NA;Adjuvant	06b2cd6b-f355-4d33-a2f7-83e6ef83f764;5cfbda68-70ae-50f0-9817-479a5ed5d894	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	2f2abaa9-df0c-4af9-ab2b-8b48168a6129	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A06L
TCGA-UCEC	TCGA-B5-A1MU	Stage IVB	No	0	NA	1988	NA	Endometrium	29027	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2006	released	No	TRUE	NA	Biopsy	NA	8441/3	NA	primary	13c28c27-513b-56ac-9f50-4a80d1dd06b2	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Dead	79	-29027	NA	202c205f-99be-54e1-b30f-7cc2d63ef130	FALSE	NA	United States	1548	1548	WT-With Tumor	NA	7435ea82-1532-4300-a205-f4dd2e82fd69	Pharmaceutical Therapy, NOS	Tamoxifen	yes	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	c28e466b-0893-4de5-96f5-8a605093d6ee	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A1MU
TCGA-UCEC	TCGA-D1-A15V	Stage IB	No	0	NA	1995	NA	Endometrium	24886	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8441/3	R0	primary	30f9ef49-9429-50d7-8a9d-1ba517fdc60a	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	68	-24886	NA	5e0b5d34-f9df-502e-94e6-7bfeeb92a539	FALSE	NA	NA	NA	1201	TF-Tumor Free	NA	9c209dca-8654-4c21-8721-bc13d4410b75	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	b3442fbd-0bc6-5afc-bbbe-e5ebbacba46d	Radiation, Implants	NA	yes	NA	NA	NA	172	NA	158	1	2100	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-D1-A15V
TCGA-UCEC	TCGA-EY-A212	Stage IIIC1	No	0	NA	2009	NA	Endometrium	30680	Papillary serous cystadenocarcinoma	2025-10-24T10:03:58.643295-05:00	yes	2010	released	No	TRUE	NA	Biopsy	NA	8460/3	R0	primary	f60eaf41-3996-5c10-80d0-d0d5e5ac5d9d	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	83	-30680	NA	2785b834-3a90-5c9b-81e7-57fe5805f684	FALSE	NA	United States	310	310	WT-With Tumor	NA;Adjuvant	05a1844c-fc59-4514-ba9f-7ae19f525039;2025919e-8fee-5a03-8d58-7d8101277621	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	0f14373f-07e2-4b9c-a7d2-762e5f32d22c	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-EY-A212
TCGA-UCEC	TCGA-BS-A0TJ	Stage IC	No	0	NA	1988	NA	Endometrium	21663	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2006	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	fd64c7b5-399a-538f-9858-421b3f51f8d7	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	asian	female	not hispanic or latino	Alive	59	-21663	NA	0cc93255-8851-55bd-a9eb-0619ad5f924b	FALSE	NA	NA	NA	2068	TF-Tumor Free	NA;Adjuvant	56534bff-3980-419b-962e-543e96c5046e;b71e842e-d954-4b91-b1dc-fdb84af9f532	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	a6902149-e5e1-5fa4-b2bf-ba353bdb5130	Radiation, Combination	NA	yes	NA	NA	NA	130	NA	77	1	6100	29	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-BS-A0TJ
TCGA-UCEC	TCGA-BG-A0MA	Stage IB	No	0	NA	1988	NA	Endometrium	22036	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	34eb0cae-e80a-5584-92dc-60f9673dac69	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	60	-22036	NA	5d06e636-7e27-5d5a-8bc0-dce45ba5fa01	FALSE	NA	NA	326	326	WT-With Tumor	Adjuvant;NA	0df877e1-4db1-558c-8841-3d961fc9c5f1;b967565c-04ff-4272-814f-12f52065c995	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	2be0b1cf-e754-4992-9e11-3eaefcf4f27b	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BG-A0MA
TCGA-UCEC	TCGA-AX-A1CP	Stage IA	No	0	NA	1988	NA	Endometrium	30737	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2008	released	No	TRUE	NA	NA	NA	8441/3	R1	primary	58a8b660-b3a8-53f3-822f-00a2ffdd5ee5	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	84	-30737	NA	5693261a-fc8a-5ba2-b87a-1fbb44a72372	FALSE	NA	NA	NA	1107	NA	NA;Adjuvant	4bf620ef-ea67-4063-872a-2046c1ee22b4;58439707-19bc-5397-bbb4-68af79ec6be2	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;yes	NA	Prior to Diagnosis;NA	NA;Not Reported	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	9d76ea4f-eb9d-42b8-8f91-3a1bd7f6f28c	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A1CP
TCGA-UCEC	TCGA-BG-A221	Stage IB	No	0	NA	2009	NA	Endometrium	30960	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	NA	primary	234059ae-74aa-52aa-9851-674d03cf8d59	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	84	-30960	NA	6a80fd66-a580-51bd-b9f9-c954eb173de6	FALSE	NA	United States	NA	55	TF-Tumor Free	NA;Adjuvant	2d1d8a18-29d6-43de-abab-a15af7423888;54302cd4-2071-5dda-a850-0217ad6ea790	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	77387d19-c28e-4159-ba20-2514c84ce802	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BG-A221
TCGA-UCEC	TCGA-AX-A1CI	Stage IB	No	0	NA	1988	NA	Endometrium	22582	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2004	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	d475ef4a-37c4-5638-88da-84f422483574	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	61	-22582	NA	0cbd2001-5067-5109-838d-3c053cfcfa55	FALSE	NA	NA	NA	2600	TF-Tumor Free	NA;Adjuvant	350328ca-46f0-4392-b43e-d654ebaacf83;a69ff0d7-1ba1-51d6-9d28-de1cf44521a9	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	b5d0e297-2770-4f5c-b08e-2d773625cd0a	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A1CI
TCGA-UCEC	TCGA-FI-A2CX	Stage IB	No	0	NA	1988	NA	Endometrium	30224	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2008	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	c9506856-ae38-5a48-ac59-1fe58579f840	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	82	-30224	NA	8bd8505e-e3b3-5167-adc2-d6abce781dc6	FALSE	NA	United States	NA	2031	TF-Tumor Free	NA;Adjuvant	002aee8c-9b15-404f-b0e8-c8df9800dcd0;759a432f-97b4-5b91-bc4a-b7feef85dfa0	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	e8a97d30-58ba-4c09-93e5-ede63f31a637	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-FI-A2CX
TCGA-UCEC	TCGA-EO-A3KX	Stage IA	No	0	NA	2009	NA	Endometrium	29260	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	413ae3c1-4e94-59f1-b639-f1c2a0b21c74	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	hispanic or latino	Alive	80	-29260	NA	4bed5f1e-e85b-5763-bb8b-ea0029cf902d	FALSE	NA	Canada	NA	1170	TF-Tumor Free	NA;Adjuvant	2cc3800d-6e17-427d-9a10-096eda0a8d63;63dc7488-6d91-4050-a1b2-5ad3acbaa2b2	Pharmaceutical Therapy, NOS	Tamoxifen;NA	unknown;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	a3f5b14c-0c42-59d0-8f57-64c6b0f72033	Radiation, Internal	NA	yes	NA	NA	NA	154	NA	NA	NA	NA	3	Primary Tumor Field	NA	NA	NULL	NA	NA	NA	TCGA-EO-A3KX
TCGA-UCEC	TCGA-AX-A3G3	Stage IIIA	No	0	NA	1988	NA	Endometrium	21308	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2009	released	No	TRUE	NA	Surgical Resection	NA	8441/3	NA	primary	ffc1671e-9b30-5a81-b25f-0e651261e367	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	58	-21308	NA	bfa17d93-143b-53bf-953e-b442f40b66da	FALSE	NA	United States	NA	42	NA	NA;Adjuvant	e6800f63-9e35-4cf2-a7e1-1e3e6cbe748b;f439094c-f8d9-583b-857a-dbe1c4f015c1	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;unknown	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	f357b87c-02cc-4c35-8de3-0542e669a1b3	Radiation Therapy, NOS	NA	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A3G3
TCGA-UCEC	TCGA-PG-A914	Stage IA	No	0	NA	2009	NA	Endometrium	26992	Serous surface papillary carcinoma	2025-10-24T10:03:58.643295-05:00	no	2013	released	No	TRUE	NA	Cytology	NA	8461/3	R0	primary	8e9682d1-d9d5-5299-8107-abc7b9e9c8b0	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	73	-26992	NA	16d35689-c5a4-50b8-b9ee-af408c742373	FALSE	NA	United States	NA	687	TF-Tumor Free	NA;Adjuvant	0873e2f6-eb5f-4a33-a413-a149c15f5e22;bc5b377f-e2a0-46fb-aaaf-4fd2a62dda45	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	f948624f-f941-5342-ba97-f1f3d18780c8	Radiation, External Beam	NA	yes	NA	NA	Complete Response	150	NA	133	NA	NA	NA	Primary Tumor Field	NA	NA	NULL	NA	NA	NA	TCGA-PG-A914
TCGA-UCEC	TCGA-EY-A1G7	Stage II	No	0	NA	1988	NA	Endometrium	31603	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2008	released	No	TRUE	NA	Surgical Resection	NA	8380/3	R0	primary	f85591b5-ba91-59d8-9e44-7a4af2e80e25	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	86	-31603	NA	d186577b-35c7-5ccd-9d88-b083e445362f	FALSE	NA	United States	189	189	WT-With Tumor	Adjuvant;NA	234e1f72-b2cb-49ee-86a4-1180d358e2c2;ebc3c079-768c-4859-8206-6afb3c3bec62	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Palliative	52864ae8-530f-537e-a9eb-04e7a720d395;d0da486d-04b6-4ebd-b261-5ad6a81c73a6	Radiation, External Beam;Radiation, Implants	NA	yes	NA	NA	NA	99;124	NA	99;102	1;2	500;1050	2;3	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-EY-A1G7
TCGA-UCEC	TCGA-AX-A06D	Stage IIIA	No	0	NA	1988	NA	Endometrium	30024	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2007	released	No	TRUE	NA	Biopsy	NA	8380/3	R1	primary	0eafcbcd-deec-577e-a9bb-31bfdb6a3b2b	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Dead	82	-30024	NA	0ba9baaa-8ead-50b7-a9e2-669532e9a138	FALSE	NA	United States	373	373	WT-With Tumor	NA	2b0fb9f4-b926-4c16-9cec-bc8847174fe3	Pharmaceutical Therapy, NOS	Tamoxifen	yes	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	8aefb993-65f9-458d-8f90-5fc9f342244c	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A06D
TCGA-UCEC	TCGA-B5-A11X	Stage IIIC2	No	0	NA	2009	NA	Endometrium	24217	Carcinoma, undifferentiated, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8020/3	NA	primary	350ce20b-915b-5926-8869-acbce9450a98	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not reported	Alive	66	-24217	NA	b77ca676-a31b-51be-bf22-fc4de05b5d1c	FALSE	NA	United States	NA	596	TF-Tumor Free	NA	67fa98b8-f725-4ed8-8f57-3ec1228cb0b2	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	8cc141b0-011f-4a07-a0a8-f1e89269fc53	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A11X
TCGA-UCEC	TCGA-EY-A2OP	Stage IA	No	0	NA	2009	NA	Endometrium	23090	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	798f6013-adc5-5d9f-b366-5d6749226b43	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	63	-23090	NA	1e0b3a28-6504-56ef-80e0-7c9db03689ee	FALSE	NA	United States	NA	944	TF-Tumor Free	NA;Adjuvant	4ad572ae-ca47-4413-8d79-8ab68bb6418c;ef0fc883-1043-5e72-9912-967f0b552c99	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	f0a63925-faa6-4f27-92a8-415f87cdc5a2	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-EY-A2OP
TCGA-UCEC	TCGA-EY-A214	Stage IIIC1	No	0	NA	2009	NA	Endometrium	24136	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	85dd8c26-31ae-5062-9499-e4bec29fab1f	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	66	-24136	NA	628a9231-6a6f-58ee-bb03-77194c4e2534	FALSE	NA	United States	NA	438	TF-Tumor Free	NA	37d799cc-a8aa-4a5a-830c-ddf69108962f	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	1e1fe118-9a3d-5d96-9855-2075379c7802	Radiation, External Beam	NA	yes	NA	NA	NA	210	NA	173	1	5040	28	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-EY-A214
TCGA-UCEC	TCGA-BG-A220	Stage IA	No	0	NA	2009	NA	Endometrium	25346	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	cbe109ac-6baf-5aed-92d5-45aa7db3e8fe	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	69	-25346	NA	fbd9da68-0278-5568-957d-94cbc2f6de8a	FALSE	NA	United States	NA	434	TF-Tumor Free	Adjuvant;NA	04c547cc-072b-57a6-b4d3-5d996fb47dfe;42a5a294-7294-470c-b9ae-87da26cccb65	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	de8aa307-9d3f-4e93-be77-a63bdacb9524	Radiation Therapy, NOS	NA	yes	NA	NA	Complete Response	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BG-A220
TCGA-UCEC	TCGA-EY-A1GW	Stage IVB	No	0	NA	2009	NA	Endometrium	26979	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	R1	primary	ceb2ecff-f419-559d-b576-ccdbedc6a805	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	hispanic or latino	Dead	73	-26979	NA	3bc93350-02f7-5561-97b2-11c92a32325d	FALSE	NA	United States	337	337	WT-With Tumor	NA	d6e18150-ea49-4302-ace9-717fdd60f525	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	92883f2b-ee20-4feb-8a98-fd8b5451483b	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-EY-A1GW
TCGA-UCEC	TCGA-BS-A0U8	Stage IIIC	No	0	NA	1988	NA	Endometrium	20402	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2004	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	463b376c-31c6-58bb-aacc-acdb4579f6bd	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	55	-20402	NA	124d1f29-524a-57e0-b4eb-6ed018678122	FALSE	NA	NA	NA	2963	TF-Tumor Free	NA	c6bb50bb-0263-4346-ad0c-d4d93d50f81c	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	607c343e-0703-5c87-9365-10cb01d8618b	Radiation, Combination	NA	yes	NA	NA	NA	86	NA	43	1	5740	29	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-BS-A0U8
TCGA-UCEC	TCGA-B5-A11M	Stage IA	No	0	NA	1988	NA	Endometrium	16063	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2007	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	NA	primary	c2e77d56-7025-5ab5-919e-43b706b07a50	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	43	-16063	NA	2c8ee06f-8361-510d-816f-c0e4550cdbd7	FALSE	NA	United States	NA	1362	TF-Tumor Free	Adjuvant;NA	3e4550eb-57c8-5930-870b-461edb575bdb;ebb07695-4218-4b57-8103-3827f86f0d5e	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	c0e80311-f873-4e11-9d23-8ca47f0d106e	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A11M
TCGA-UCEC	TCGA-AP-A053	Stage IA	No	0	NA	2009	NA	Endometrium	32872	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2004	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	2e148196-8012-5792-9d48-74c104ac12a8	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	89	-32872	NA	75602116-9f85-5987-8850-77008a821b05	TRUE	NA	NA	0	0	TF-Tumor Free	Adjuvant;NA	b1602d2d-15c9-4e75-9fa5-cfe008273bab;c0ad8743-6b0a-4515-a8db-11cbadd8f1d6	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;yes	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	f2c07f84-a8ab-57ee-bbc9-3c579efeb595	Radiation, Implants	NA	yes	NA	NA	NA	0	NA	0	1	2100	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-AP-A053
TCGA-UCEC	TCGA-BG-A18A	Stage IA	No	0	NA	2009	NA	Endometrium	27086	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	RX	primary	b97bcb90-bc6a-5bf9-8f36-37104b8ed2e3	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	74	-27086	NA	b2815b75-c7ba-5b55-bcdc-21aabbed3b28	FALSE	NA	NA	NA	426	TF-Tumor Free	NA;Adjuvant	2ad63b4a-2402-419b-b3c7-0855b84cccd7;3858cbca-1afb-5859-a4d7-9c10d0f02411	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	dc8428f8-d1fe-47cd-b8b5-0e648eedb73c	Radiation Therapy, NOS	NA	yes	NA	NA	Complete Response	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BG-A18A
TCGA-UCEC	TCGA-BG-A0MS	Stage IIIC1	No	0	NA	2009	NA	Endometrium	19547	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2009	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	439da3e5-75e8-5825-a748-010655b6fe25	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	53	-19547	NA	eb111509-466e-5511-a767-c881fb9375e6	FALSE	NA	NA	NA	1882	TF-Tumor Free	NA	a4ae5f48-92f7-4ca3-bd48-2c5bb4e49613	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	4fa9240b-9097-418e-9498-bcde57b607f3;9314546a-c286-59b2-970d-7b55c7672991	Radiation, Implants;Radiation, External Beam	NA	yes	NA	NA	NA	208;245	NA	201;209	1	1500;4500	3;25	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-BG-A0MS
TCGA-UCEC	TCGA-BS-A0UJ	Stage IA	No	0	NA	1988	NA	Endometrium	25149	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2004	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	5a2afee1-0ff8-5d8a-a236-b0e0659d1c5a	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	asian	female	not hispanic or latino	Alive	68	-25149	NA	dcfe6a13-0521-5b95-bb52-c2c413703643	FALSE	NA	NA	NA	2506	TF-Tumor Free	Adjuvant;NA	49f364b9-f520-5866-ac3d-bbca23797d11;da8658ea-6eb1-4d77-86ce-9643224c3559	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	fb646b6e-a321-4f63-a3d9-9c2bf354331e	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BS-A0UJ
TCGA-UCEC	TCGA-EY-A1G8	Stage IB	No	0	NA	1988	NA	Endometrium	30517	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Surgical Resection	NA	8380/3	R0	primary	09ebfe76-e226-502d-ab70-4d55a5b86d6a	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	83	-30517	NA	76d2f9cb-ddcb-59c4-9316-1df7c9f3062d	FALSE	NA	United States	456	456	TF-Tumor Free	Adjuvant;NA	ca239b3c-a104-5101-be77-1425fac0c419;d135cd9e-b362-439d-946f-71d6dcdecb3b	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	a8c17bd6-1eda-4807-b13e-e303d6e3508c	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-EY-A1G8
TCGA-UCEC	TCGA-BG-A0M8	Stage IA	No	0	NA	1988	NA	Endometrium	18308	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2008	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	abfe679c-a7cd-55a3-8b34-2a922121b9ee	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	50	-18308	NA	097a59d7-4cf0-51e6-b86b-bdf1052dd68b	FALSE	NA	NA	NA	2020	TF-Tumor Free	Adjuvant;NA	173d02c7-bcf6-5f10-b06a-9c846e38021b;77e309ae-66b3-46f3-b835-7066718e3e43	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	b5b36eba-8035-48b4-868a-246abf87ecf9	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BG-A0M8
TCGA-UCEC	TCGA-D1-A3JP	Stage IA	No	0	NA	2009	NA	Endometrium	22538	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	7f1cd09a-dbb3-551c-a67d-4f353409f807	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	61	-22538	NA	4c77a875-5eef-5480-b468-2ba87b6173ea	FALSE	NA	United States	NA	515	TF-Tumor Free	NA;Adjuvant	80bf7183-6427-4b8e-a2f1-e43323d88f9c;81dee702-5f57-5326-8857-fc80b738e1e9	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	33489123-fc57-43b2-8d2f-95f9c836bbaf	Radiation Therapy, NOS	NA	yes	NA	NA	Partial Response	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A3JP
TCGA-UCEC	TCGA-AP-A05D	Stage IIIC2	No	0	NA	NA	NA	Endometrium	24597	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2007	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	8e296ccc-66ee-5507-883a-618483a5d16b	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	67	-24597	NA	b9fe82c2-4fea-502e-9d7d-7bd0b98acde3	FALSE	NA	NA	NA	1758	TF-Tumor Free	NA	f2317b38-63e8-4ceb-8bdc-3350e90cba53	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	95e82cbe-e381-4f11-9392-b814401c207a;aaf0e00f-c511-5b67-bd52-a587e3ca359c	Radiation, External Beam	NA	yes	NA	NA	NA	139;134	NA	135;99	1	540;4500	3;25	Primary Tumor Field;Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-AP-A05D
TCGA-UCEC	TCGA-EY-A215	Stage IB	No	0	NA	2009	NA	Endometrium	22076	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	c0ab32b5-4c54-544a-9657-6efd97264221	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	60	-22076	NA	42256e3f-852f-5914-8b38-744378ef0cac	FALSE	NA	United States	NA	574	TF-Tumor Free	Adjuvant;NA	01289afb-132a-49dd-ab08-2729828d1ebd;576b76d6-0e4c-4c52-b422-3b9bec8d044e	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	ed0a5ef1-8e27-595b-b379-323f7ea2c86b	Radiation, Implants	NA	yes	NA	NA	NA	96	NA	83	1	2100	3	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-EY-A215
TCGA-UCEC	TCGA-D1-A2G5	Stage IB	No	0	NA	1995	NA	Endometrium	18322	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2007	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	c67e3e07-6dd1-5141-8c19-a1091989b5f2	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	50	-18322	NA	b2b94f43-6ae2-5741-a03e-9bd5b9d71433	FALSE	NA	United States	NA	1455	Unknown	Adjuvant;NA	1a5f6f8a-873c-56fe-968d-810328798059;e899193c-77ac-42b7-9347-2bea075d18aa	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	d7ea3b08-1cb4-413a-8b6b-bf14f7cbb575	Radiation Therapy, NOS	NA	yes	NA	NA	Complete Response	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A2G5
TCGA-UCEC	TCGA-2E-A9G8	Stage III	No	0	NA	2009	NA	Fundus uteri	NA	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2011	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	138c08ab-6469-5248-abf2-818fc309f839	C54.3	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	59	NA	NA	a0452fbc-d834-54b0-a7af-54217646f706	FALSE	NA	United States	NA	1249	TF-Tumor Free	NA	83dc8af0-593d-4abd-ba57-93cd0e0341ce	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	36798f07-eb13-4f78-a4b7-bc886c9ef620;b9ef309c-d76b-5d51-ac45-633e7da24e3f	Radiation, External Beam;Radiation, Internal	NA	yes	NA	NA	Complete Response;Stable Disease	457;122	NA	427;122	NA	5000;2200	25;4	Regional Site;Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-2E-A9G8
TCGA-UCEC	TCGA-AX-A1CR	Stage IIB	No	0	NA	1988	NA	Endometrium	25812	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8441/3	R1	primary	e394d111-8a67-537c-afde-898a8a049ea5	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	70	-25812	NA	e6a8c88e-d05a-5bd9-9167-6afdcb41699d	FALSE	NA	United States	NA	701	Unknown	NA	2be73081-72d3-4104-ad4e-3a70f0ec4ec6;2cc3681c-3f3a-4187-b980-b20370c4ff28	Pharmaceutical Therapy, NOS	Pegylated Liposomal Doxorubicin Hydrochloride;Tamoxifen	yes;not reported	NA	NA;Prior to Diagnosis	Unknown;NA	463;NA	No;NA	376;NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	85f42fa4-3282-4c34-a5cb-5a888dca35af	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A1CR
TCGA-UCEC	TCGA-D1-A0ZO	Stage IB	No	0	NA	NA	NA	Endometrium	27482	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	63e70dd2-1a97-5c6d-a4cd-e5fb9d25e179	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	75	-27482	NA	58b46677-323d-533b-980b-5a724af621af	FALSE	NA	NA	NA	602	TF-Tumor Free	Adjuvant;NA	86376fa5-b08c-5bba-b265-e6d30d562a90;f140f733-4e96-4c6d-bc1a-40505cde6d29	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	809da418-e901-4f47-afa4-77dbc9603b34	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A0ZO
TCGA-UCEC	TCGA-A5-A0GI	Stage IA	No	0	NA	1988	NA	Endometrium	23195	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2005	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	31803be2-1086-5476-b922-3506e5f2d6c0	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	63	-23195	NA	542d2c0f-96a1-52fb-89c7-b31e2e9cd8b9	FALSE	NA	NA	NA	2682	TF-Tumor Free	Adjuvant;NA	85ab9997-ee12-4781-9105-fc2c20583c68;afaaf099-19df-4fcb-a30d-6f8d16e5c041	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	0ac03464-cc57-51b5-a427-3e0e8b6ae472	Radiation, Implants	NA	yes	NA	NA	NA	92	NA	78	1	2100	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-A5-A0GI
TCGA-UCEC	TCGA-AX-A2HF	Stage IB	No	0	NA	1988	NA	Endometrium	24689	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2010	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	24d572af-0dda-57d1-ba9d-9cb686340d6b	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	67	-24689	NA	558de49a-8e14-51dd-8df2-fca36ddbcf3d	FALSE	NA	United States	NA	848	WT-With Tumor	NA	ec5dc227-1652-4767-8aca-f0c279bfcb6a	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	c287c649-8af9-52d6-907d-483fbd5bbdb2	Radiation, Implants	NA	yes	NA	NA	NA	NA	NA	35	1	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A2HF
TCGA-UCEC	TCGA-AX-A2H8	Stage IB	No	0	NA	1988	NA	Endometrium	23448	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2006	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	f34ddcc1-6f19-596f-ac77-2fdf5ddf1507	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	64	-23448	NA	abe07506-82c6-5605-8235-f6792943c654	FALSE	NA	United States	NA	1861	TF-Tumor Free	NA;Adjuvant	3803086b-2415-46b0-80c0-18057d43c07b;babebc46-c07f-4a7a-b68b-1741b2817f17	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	a405c0db-a0a9-5eb9-a91d-da06b48951d4	Radiation Therapy, NOS	NA	yes	NA	NA	NA	NA	NA	NA	1	NA	NA	Primary Tumor Field	NA	NA	NULL	NA	NA	NA	TCGA-AX-A2H8
TCGA-UCEC	TCGA-FI-A2D5	Stage IVB	Yes	0	NA	2009	NA	Endometrium	20666	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	c3f99001-ee1d-5f72-b8f7-416690803ed2	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	56	-20666	NA	e289b51f-d0b4-53a0-b413-30c24ce2f776	FALSE	NA	United States	421	421	WT-With Tumor	NA	5f7053d2-7b9d-4102-8c38-0b5bc8c8f227	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	04c3a52f-064d-5e78-9d54-dbcacd9140c7	Radiation, External Beam	NA	yes	Progressive Disease	NA	NA	363	NA	283	1	60	30	Locoregional Site	cGy	NA	NULL	NA	NA	NA	TCGA-FI-A2D5
TCGA-UCEC	TCGA-D1-A102	Stage IB	No	0	NA	NA	NA	Endometrium	17991	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	RX	primary	8392456e-f5ba-5589-8e27-985d34a4d90b	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	49	-17991	NA	24d81207-6d0e-56d6-9cff-9d05306baef1	FALSE	NA	NA	NA	135	TF-Tumor Free	NA;Adjuvant	37a55050-5f13-4f16-a2d4-a83686aaf9e2;3d8bf7b7-1423-5bb3-ae68-af654337e0b9	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	e92810d0-51e4-4faf-8e0d-9f8fe23586a9	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A102
TCGA-UCEC	TCGA-AX-A1C5	Stage IIIC	No	0	NA	1988	NA	Endometrium	17383	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R2	primary	523b2dd3-21d7-51f5-840a-98c0c584d53b	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	47	-17383	NA	94140e88-a9fa-5519-947c-1960dd16a2cd	FALSE	NA	NA	NA	1001	WT-With Tumor	NA	0288ce79-6202-4155-abf8-8a4b32511287	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	7c8a22d1-d380-5319-9440-b69bdc7d9fa5	Radiation, Implants	NA	yes	NA	NA	NA	291	NA	237	1	NA	NA	Primary Tumor Field	NA	NA	NULL	NA	NA	NA	TCGA-AX-A1C5
TCGA-UCEC	TCGA-A5-A0GX	Stage IA	No	0	NA	NA	NA	Endometrium	19625	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2005	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	cb8a0d82-3cce-5564-b5ab-04b7cec178c1	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	53	-19625	NA	129632b7-438f-510e-9eab-1d43fc365cc0	FALSE	NA	NA	NA	2088	NA	NA;Adjuvant	3973b8f1-1f29-4774-8aed-1633c8cc7a04;dbfef68d-0e3e-47e7-ab28-b1eb2324205b	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	7f31b194-84d2-520a-ad5c-e5a6ace5ab8b	Radiation, External Beam	NA	yes	NA	NA	NA	213	NA	167	1	5580	31	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-A5-A0GX
TCGA-UCEC	TCGA-AP-A051	Stage IA	No	0	NA	2009	NA	Endometrium	25269	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2003	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	04b7b6ca-6e8a-5702-b1e2-0bdd145d546c	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	69	-25269	NA	ce7f54a2-f817-5fdc-8f8e-56e5ea202cc7	FALSE	NA	NA	NA	3948	TF-Tumor Free	NA;Adjuvant	2f6b5533-aae7-44d0-8f6b-d2188586ebcd;c893b7f0-c63f-4d51-a81e-7774a5b7baba	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	dcefc2e5-fa75-54a4-b60f-34b5b44f0ee1	Radiation, External Beam	NA	yes	NA	NA	NA	117	NA	80	1	5040	28	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-AP-A051
TCGA-UCEC	TCGA-AJ-A3OL	Stage IIIA	No	0	NA	2009	NA	Endometrium	20115	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	5b300041-47a8-558a-8468-6db414bd9ff9	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	55	-20115	NA	5c564e9c-9baa-58fe-8dce-62768d9cc0dd	FALSE	NA	United States	449	449	WT-With Tumor	NA	3929017c-3a63-4786-8f73-34d7cb6f017b	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	9d346ed3-135c-48a0-a92a-48f90e9f1572	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AJ-A3OL
TCGA-UCEC	TCGA-AX-A2HD	Stage IIIA	No	0	NA	1988	NA	Endometrium	25499	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	R1	primary	c3080851-f81c-5b94-b205-562399603585	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	69	-25499	NA	0cbf6c30-6909-56ac-9390-67b1bba5eaac	FALSE	NA	United States	NA	1414	WT-With Tumor	NA;Adjuvant	2e6f0300-22ae-4beb-8582-81e57528a7f0;61f8a04d-cded-5f19-aa28-ea114d0f140d	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	38c3477d-6529-4cdd-a619-6e31584672ac	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A2HD
TCGA-UCEC	TCGA-B5-A3F9	Stage IB	No	0	NA	1988	NA	Endometrium	20523	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2003	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	75d7b4cd-1568-54e7-b463-0d5313354c90	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not reported	Alive	56	-20523	NA	50c45796-e968-564d-9c4b-165c22625230	FALSE	NA	United States	NA	4155	NA	NA;Adjuvant	4343053b-629a-444a-82d7-a8d5b71d52aa;56621181-87be-5d42-bdb2-fcfc5e0c6101	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	dfb919cb-8477-408d-8080-db763da5200c	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A3F9
TCGA-UCEC	TCGA-AX-A2H2	Stage IIA	No	0	NA	1988	NA	Endometrium	31524	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	9c2e8300-e809-535d-a98f-3380cc8b409a	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Dead	86	-31524	NA	f245ea87-05fb-51a2-b9fd-288a61e2424c	FALSE	NA	United States	145	145	TF-Tumor Free	Adjuvant;NA	1aa150f8-865a-5e73-a0cb-61fd3cafaeec;29b905cd-6dfd-44fb-a25e-b802023d77cf	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	d2fb9eed-333d-4e3f-b5a6-443378ffb8ab	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A2H2
TCGA-UCEC	TCGA-AX-A1C7	Stage IB	No	0	NA	1988	NA	Endometrium	28198	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	1ecfef7e-3108-57a3-a81c-4fa7f00ce512	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	77	-28198	NA	3814abc2-97c0-50d9-9f26-8ef2db2993f8	FALSE	NA	NA	NA	1054	Unknown	NA	ce91ddec-4e27-4137-8410-6d91c0a2a12a	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	6aded0ae-8e89-44e3-a18f-9d9bbb01e411	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A1C7
TCGA-UCEC	TCGA-EY-A1GL	Stage II	No	0	NA	2009	NA	Endometrium	18761	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	12d48312-efdd-529e-abdf-822efda92984	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	51	-18761	NA	51e0a502-6a75-5175-89d6-43421041fff7	FALSE	NA	United States	NA	1014	TF-Tumor Free	NA;Adjuvant	b981a684-1ceb-487d-8c26-de57807c55a0;d18d6645-3044-4199-8a9c-7bfc34c57d29	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	051c99ed-f477-415f-9ac8-60d052bbfcab	Radiation, External Beam	NA	yes	NA	NA	NA	98	NA	62	1	4500	25	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-EY-A1GL
TCGA-UCEC	TCGA-BG-A0YU	Stage IA	No	0	NA	2009	NA	Endometrium	13644	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Pap Smear	NA	8380/3	RX	primary	fb3780be-6dfa-56b2-981a-762ea0de6733	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	37	-13644	NA	33a85b3a-5efc-559a-958b-e7cc12adaff4	FALSE	NA	NA	NA	451	TF-Tumor Free	NA;Adjuvant	69d75118-a65b-4901-8903-d2e97cebfe2e;b1082cf6-f173-5473-8cbf-f4b7931b6341	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	e80e269a-3fa3-4972-b250-ac78ddf065a0	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BG-A0YU
TCGA-UCEC	TCGA-AP-A3K1	Stage IVB	No	0	NA	2009	NA	Endometrium	20594	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Cytology	NA	8441/3	RX	primary	d168edea-fbee-5c65-b2e7-ad373b611c87	C54.1	Endometrium	High Grade	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	56	-20594	NA	26763d38-c1a0-5f96-bad2-1a24c1c5555b	FALSE	NA	United States	666	666	WT-With Tumor	NA	6a24479f-440d-4218-89b5-24f0ed6de3c8	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	067ae848-61d1-423f-bf44-42d3e2ca95fc	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AP-A3K1
TCGA-UCEC	TCGA-B5-A11W	Stage IB	No	0	NA	2009	NA	Endometrium	22365	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	86b131a8-df1c-5e14-b809-1f0ff6bd3306	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	61	-22365	NA	5a99a5f6-68c6-5de3-97e6-d1990afc1648	FALSE	NA	United States	NA	593	TF-Tumor Free	NA;Adjuvant	4ea20c67-a8b8-4670-bb1c-7cde557626d1;65c05b21-f4d0-4655-8d14-1dc7beb71f12	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	b0f777ba-d81d-502e-bc54-1018f82cfc98	Radiation, Implants	NA	yes	NA	NA	NA	91	NA	77	1	500	5	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-B5-A11W
TCGA-UCEC	TCGA-A5-A2K5	Stage IA	No	0	NA	2009	NA	Endometrium	28057	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	2a714244-9f8e-5acd-b228-19563cf28716	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	76	-28057	NA	90e1163b-6080-5f74-b548-83420da90baf	FALSE	NA	United States	NA	752	TF-Tumor Free	NA;Adjuvant	0f33bba6-0d43-4687-868e-c7682e8328cc;24d915c6-a998-4d2f-a558-3e087208a847	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	db2b6dff-7eba-530d-8b9f-5d5db50d1ff3	Radiation, External Beam	NA	yes	NA	NA	NA	129	NA	87	1	5040	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-A5-A2K5
TCGA-UCEC	TCGA-BG-A0MH	Stage IC	No	0	NA	1988	NA	Endometrium	22475	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2007	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	1c708c57-cbf9-589f-85c1-c9979ed11899	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	61	-22475	NA	b42bdb93-a0ce-5f19-9aba-f7c50bdd8f5e	FALSE	NA	NA	NA	1930	TF-Tumor Free	NA;Adjuvant	27978bb4-6b12-4639-970d-fb24e3ec7dc4;56ecd1cf-b4e6-458e-a298-1060393d313e	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	f7509265-bfe3-5212-ab86-ea1e3f36b03b	Radiation, External Beam	NA	yes	NA	NA	Complete Response	133	NA	96	NA	4500	NA	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-BG-A0MH
TCGA-UCEC	TCGA-BG-A2AD	Stage IIIB	No	0	NA	2009	NA	Endometrium	23064	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	NA	primary	4ae53ec5-18e1-548f-bc61-82359ef2e1f8	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	63	-23064	NA	89d21b25-7c06-5b8c-b35c-4ae66fd0aa6d	FALSE	NA	United States	NA	609	NA	Adjuvant;NA	8c0ef4a5-2f57-5167-b4fb-6c811871c8ad;fda1fe25-dc27-4eef-b7d6-eb1429d9d143	Pharmaceutical Therapy, NOS	NA;Tamoxifen	yes;not reported	NA	NA;Prior to Diagnosis	Complete Response;NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	0f270d3f-bc49-487f-877f-413979d8d367	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BG-A2AD
TCGA-UCEC	TCGA-AP-A1E1	Stage IA	No	0	NA	2009	NA	Endometrium	27072	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	9797428f-80a0-5e9e-a2a2-83a4610630c9	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	74	-27072	NA	b9d31f87-628e-584a-b7ad-d7a6d69e6f91	FALSE	NA	NA	NA	1395	TF-Tumor Free	Adjuvant;NA	2fbb8ff6-5b57-5765-87b7-703703ff0c3f;4d402720-d8e0-4bd6-8c35-eaa0713c4933	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	de4dcbe9-84d9-4c07-b19d-ca53eee295cc	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AP-A1E1
TCGA-UCEC	TCGA-EY-A1GR	Stage IA	No	0	NA	2009	NA	Endometrium	24784	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	47653fc8-6a4d-5033-aa3d-abf73d9340a4	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	67	-24784	NA	eb77bd79-bd4a-5ef4-a359-c918b069e1a3	FALSE	NA	United States	NA	536	TF-Tumor Free	Adjuvant;NA	3c2a2349-2808-5e89-92d7-101c61829ba2;ee433c27-a179-40f6-a17f-6a7b04c5a7b7	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	e52b766a-e558-4d0f-be3d-36c770414b7c	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-EY-A1GR
TCGA-UCEC	TCGA-A5-A0G2	Stage IIIB	No	0	NA	NA	NA	Endometrium	20953	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	1997	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	e6730fe7-a340-5923-b5aa-9f29e1b840e5	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	asian	female	not hispanic or latino	Alive	57	-20953	NA	9d0e2902-bcba-53ff-bd4b-7c5d4e29e3ac	FALSE	NA	NA	NA	4549	NA	Adjuvant;NA	228e7f4f-b7ca-491f-9b3d-841232604a3d;4cccc78e-473a-4aa9-bc1b-47c3dcc29254	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	f807d385-a797-5faa-ab2f-89396c895cba	Radiation, External Beam	NA	yes	NA	NA	NA	84	NA	29	1	6000	39	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-A5-A0G2
TCGA-UCEC	TCGA-BK-A139	Stage IB	No	0	NA	NA	NA	Endometrium	27077	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	fff68755-ed35-52d0-9a4f-86a4b19bc82e	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	74	-27077	NA	283a931a-a653-50c4-992a-c69e21c6af1c	FALSE	NA	NA	943	943	WT-With Tumor	NA;Adjuvant	39a02462-bd19-4a10-ae4b-7c729e2975ee;6c775c6a-d5bf-5bd8-8b8c-3a27635d6c8e;a71cd70f-0a36-4e26-83d4-af8f13a7948e	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA;Recurrent Disease	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant;NA	05a53ccd-0837-4b64-9cd9-fad08d447cff;fe881572-668f-42a1-a8f9-92419f4f7694	Radiation Therapy, NOS	NA	no	NA;Recurrent Disease	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BK-A139
TCGA-UCEC	TCGA-E6-A2P9	Stage IA	No	0	NA	2009	NA	Endometrium	24088	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8380/3	RX	primary	659e3007-fec4-561b-a424-41c0e035dc24	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	65	-24088	NA	f4b4d94a-2b7d-53bd-8d10-811b893eed5d	FALSE	NA	United States	NA	1386	Unknown	Adjuvant;NA	2f8921e8-3faa-460c-be9f-00d3cc8ab9a6;92227fe5-535f-46fb-b7b0-c7c29e6cca52	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;unknown	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	5c509bb2-9e60-5357-b17b-4706277ea7e5	Radiation, Internal	NA	yes	NA	NA	Complete Response	72	NA	58	NA	3000	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-E6-A2P9
TCGA-UCEC	TCGA-EO-A3AY	Stage IB	No	0	NA	2009	NA	Endometrium	21291	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	063e134c-a2d4-54d2-ab38-c1a92c528dc1	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	not reported	female	not reported	Alive	58	-21291	NA	6fd6df70-ae97-57fd-97f6-997004450695	FALSE	NA	Canada	NA	1163	NA	Adjuvant;NA	ab0cdeb3-034c-5006-afe9-3964d0eda6f7;bc64c1d5-e1e2-463a-83be-d80993ad03b6;fc7592ea-d696-436b-8ef0-f49c2a11675a	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;unknown	NA;Recurrent Disease	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant;NA	4013c813-db42-4a21-a1f5-722d54718643;b60dc929-9b44-4af5-a386-b69aadade7fc	Radiation Therapy, NOS	NA	no;unknown	NA;Recurrent Disease	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-EO-A3AY
TCGA-UCEC	TCGA-B5-A11Z	Stage IA	No	0	NA	2009	NA	Endometrium	22505	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	d6c19cf3-0ae9-5911-ae67-1e2664af27a8	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	61	-22505	NA	e62a79ee-848d-50f1-a4e5-e32f4eb1605b	FALSE	NA	United States	NA	528	TF-Tumor Free	NA;Adjuvant	3d126c26-f4ba-4e4a-a38a-5fa996344462;5f3f631b-6729-5489-a9ab-cfaa34c91631	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	80d2134e-b987-4c9b-aece-94f28d227533	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A11Z
TCGA-UCEC	TCGA-BG-A3EW	Stage III	No	0	NA	2009	NA	Endometrium	22705	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	e43255c0-7939-5711-9902-2c989fe7a847	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	62	-22705	NA	d1af4708-62fe-5624-9a61-f1542621ba4b	FALSE	NA	United States	NA	344	TF-Tumor Free	Adjuvant;NA	a350ed80-dea3-43fe-b2f7-5843b8125d9c;bdc52be8-8b86-4ef8-b79f-fe47dbaf62e1	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	5a52d132-8e17-587a-adba-b3fa180144f6;b5a38e79-159b-422b-aee1-117b7090df58	Radiation, External Beam;Radiation, Internal	NA	yes	NA	NA	Complete Response	85;94	NA	49;87	NA	NA;1000	25;2	Primary Tumor Field	NA;cGy	NA	NULL	NA	NA	NA	TCGA-BG-A3EW
TCGA-UCEC	TCGA-AX-A3G9	Stage IIIC	No	0	NA	1988	NA	Endometrium	23361	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Surgical Resection	NA	8380/3	R1	primary	40bdafb9-bf8b-55fd-8ef5-1560d7588e65	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	63	-23361	NA	3085459e-dcc9-5589-b8de-cd5e8529769b	FALSE	NA	United States	NA	558	NA	NA	eec942c4-9e62-4a03-aa19-0b038b4cf621	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	97e1cb75-6659-5045-b7fe-ceef7634f7ea	Radiation Therapy, NOS	NA	yes	NA	NA	NA	NA	NA	NA	1	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A3G9
TCGA-UCEC	TCGA-B5-A0K6	Stage IA	No	0	NA	2009	NA	Endometrium	21515	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	NA	primary	6dbbb44b-9cf8-556a-8d00-bb62669b4dc2	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	58	-21515	NA	f2d6d9b4-f88a-5830-a5d4-499a571ee71f	FALSE	NA	United States	NA	1953	TF-Tumor Free	NA;Adjuvant	447c331e-0052-4e9b-8a90-0d0e89cf7f2f;503605e8-109f-5b95-880b-f8ef58552673	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	b81158ca-ed9c-4960-aed3-83662ab143b7	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A0K6
TCGA-UCEC	TCGA-BG-A0W2	Stage IA	No	0	NA	1988	NA	Endometrium	20998	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2007	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	RX	primary	2e957e13-19ba-579d-a39a-d6a1fa3d990f	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	57	-20998	NA	215f190d-5fd9-57db-9461-d00abcfae4e0	FALSE	NA	NA	NA	1721	TF-Tumor Free	Adjuvant;NA	378ea897-c35f-53f3-8fda-3de9b9394435;df503f4a-ec95-4875-a407-f7bb14fdfeb9	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	f24f5a75-c0ef-4447-8e13-dd2518df2bcc	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BG-A0W2
TCGA-UCEC	TCGA-BG-A186	Stage IIIA	No	0	NA	2009	NA	Endometrium	22370	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	RX	primary	fcee2d50-0927-56be-85d4-78b119adb2bb	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	61	-22370	NA	6a5cc3fe-7b5a-5d21-ae88-14f40340a5ca	FALSE	NA	NA	NA	419	TF-Tumor Free	Adjuvant;NA	2c10ea7f-da05-57fc-a377-0336e6869672;b5b48369-9ed0-431f-b6e3-93dfc6fbaea8	Pharmaceutical Therapy, NOS	NA;Tamoxifen	yes;no	NA	NA;Prior to Diagnosis	Complete Response;NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	a3c3d522-17da-4dd2-8bb9-52c350da2d90	Radiation Therapy, NOS	NA	yes	NA	NA	Complete Response	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BG-A186
TCGA-UCEC	TCGA-EC-A24G	Stage II	No	0	NA	2009	NA	Endometrium	20857	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	647de959-f4f7-552e-b46f-a335e3ee30d7	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	57	-20857	NA	93b52e42-bee1-5a84-973a-5dec59c6e5ed	FALSE	NA	Ukraine	NA	511	TF-Tumor Free	NA	ac596ddd-0d94-451b-a664-0ce92c370aa4	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	002afe07-a1a0-5d19-babf-29c713364fa6	Radiation, External Beam	NA	yes	NA	NA	NA	107	NA	76	1	4000	20	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-EC-A24G
TCGA-UCEC	TCGA-EY-A1GC	Stage IB	No	0	NA	2009	NA	Endometrium	22656	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Surgical Resection	NA	8380/3	R0	primary	703cdc4e-e025-5a91-aaf0-de0ac7d672d3	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	62	-22656	NA	7dd5c05e-762f-5589-8195-2e1094cbb70d	FALSE	NA	United States	NA	1647	TF-Tumor Free	Adjuvant;NA	381dfebc-8325-5e88-b190-1ac9d2d9166e;9cbde894-a2a9-426b-9d23-e213cd173ab2	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	96bc856e-74d3-4dcf-af91-305731ddee83	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-EY-A1GC
TCGA-UCEC	TCGA-B5-A0JU	Stage IB	Not Reported	0	NA	1988	NA	Endometrium	21159	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	not reported	2007	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	49971867-9281-589f-86d7-068279f8956c	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not reported	Alive	57	-21159	NA	152431b8-e214-5341-b373-68135dc22afb	FALSE	NA	NA	NA	1802	NA	NA;Adjuvant	4bd6bd1a-c866-42d6-9da2-62e67280dc77;fd84a4f0-a0dc-5c60-bcf0-e634d7bad2b4	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	cc7d0e6a-3db3-4822-90bf-2a0efe90a64b	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A0JU
TCGA-UCEC	TCGA-AX-A063	Stage IB	No	0	NA	1988	NA	Endometrium	23045	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2004	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	6f64640a-0b8c-5b5d-a19e-60719689e0aa	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	63	-23045	NA	a79cde1d-b7cb-5f8f-9bfd-be728e18f270	FALSE	NA	NA	NA	2417	NA	NA;Adjuvant	460a722a-e4e4-44f6-a0c8-211ba84c2dc2;c53da578-a68f-5ca8-9f73-1f1615f427e2	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	649189cb-1527-4220-96da-2bb6b2dd1e57	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A063
TCGA-UCEC	TCGA-BG-A0RY	Stage IB	No	0	NA	2009	NA	Endometrium	24952	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	e7bfe550-1300-5fb3-8005-266f08b0bb5a	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	68	-24952	NA	5130114a-f1c7-5f3d-ae99-e5202537213c	FALSE	NA	NA	NA	469	TF-Tumor Free	Adjuvant;NA	cc9535db-b08f-5d96-875b-c6ae3c40b80b;fbd391c8-4ea9-46ff-82a6-f81b13f02396	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	6a0138d2-2ca2-496c-99c0-934008c03ef5	Radiation Therapy, NOS	NA	yes	NA	NA	Complete Response	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BG-A0RY
TCGA-UCEC	TCGA-BS-A0UF	Stage IB	No	0	NA	1988	NA	Endometrium	23771	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2004	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	d22949cf-b9d3-5687-bf79-50ff6d30d208	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	asian	female	not hispanic or latino	Alive	65	-23771	NA	6e7bc132-cc3f-5675-b3bf-252c8a970841	FALSE	NA	NA	NA	2611	TF-Tumor Free	Adjuvant;NA	02704251-e595-565e-8de7-3aed721a87c0;ac9201ae-63c6-4100-947f-d7c627a7236d	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	0cd5eccf-2598-47a2-9c45-f463e1a63386	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BS-A0UF
TCGA-UCEC	TCGA-EY-A2ON	Stage IVB	No	0	NA	2009	NA	Endometrium	22624	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8441/3	R2	primary	c98972bf-f5fa-5a9e-9e88-1125fc8fb704	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Dead	61	-22624	NA	0f0b8383-5c08-5e28-93eb-571ce71c030e	FALSE	NA	United States	610	610	WT-With Tumor	NA	0a16cb00-e028-4227-9a1e-be351e33a493	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	6952e7c2-cc15-4bc5-b351-47acc4aace28	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-EY-A2ON
TCGA-UCEC	TCGA-B5-A1MW	Stage IA	No	0	NA	2009	NA	Endometrium	20183	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	ccc0b1d6-bd6c-541a-bdd1-8c304132dc99	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	55	-20183	NA	cb02881c-ab1f-5acf-ac66-56e28fae03c7	FALSE	NA	United States	NA	447	TF-Tumor Free	NA;Adjuvant	5b354a85-5a5c-413f-a6bc-3e04e17588d2;718c3824-cd2d-4bd2-a169-b9f877625f9a	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	4a1f4fbb-1ca4-50f7-84ec-4ef35f6c15ea;de76a7da-72d5-4679-95bd-f3db4229bcac	Radiation, Radioisotope;Radiation, External Beam	NA	yes	Recurrent Disease	NA	NA	401;381	NA	388;349	1	3000;4500	5;33	Locoregional Site;Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-B5-A1MW
TCGA-UCEC	TCGA-D1-A16O	Stage IB	No	0	NA	2009	NA	Endometrium	16114	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	ee91774f-4d7a-537f-89de-fb5655fa7819	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	44	-16114	NA	992e1ed5-04f1-53ff-9084-e6594408070b	FALSE	NA	NA	NA	1023	TF-Tumor Free	Adjuvant;NA	a2438fdc-5246-5b10-8e25-58542cb1c948;d5ca900f-3736-4461-a8ed-e452cc9c2dc3	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	bf377283-4317-4cef-a9c8-29fbae0fedfc	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A16O
TCGA-UCEC	TCGA-KP-A3W4	Stage IIIA	No	0	NA	2009	NA	Endometrium	23200	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	a64b797a-6739-5be1-a4a8-9ee44b7570a5	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	63	-23200	NA	a8449130-b9ad-5bf1-94ef-5855cf4613e5	FALSE	NA	Canada	554	554	WT-With Tumor	Adjuvant;NA	ed102a95-c140-572c-8132-cc949b135ae8;f1af8635-8507-466f-a8a3-cba32e869666	Pharmaceutical Therapy, NOS	NA;Tamoxifen	yes;no	NA	NA;Prior to Diagnosis	Partial Response;NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	3d102133-7adc-42da-8f4b-2302871ceb77	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-KP-A3W4
TCGA-UCEC	TCGA-AJ-A3NG	Stage II	No	0	NA	2009	NA	Endometrium	30351	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	0f62a787-347f-5b47-b491-0d3bd876229e	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	83	-30351	NA	2c8a958c-50b3-5c17-ad90-42e58160c400	FALSE	NA	United States	NA	475	TF-Tumor Free	NA;Adjuvant	902b08c1-e9f7-46fc-a955-da88a282d11a;aceb385a-f999-413f-9596-e02dd85329df	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	1d73f60c-5dd4-5d8c-a79d-9ec14b486e78;ef09d400-5e66-4ccd-b866-6ff42ff4716d	Radiation, External Beam;Radiation, Internal	NA	yes	NA	NA	Complete Response	146;177	NA	111;148	NA	4500;1500	25;3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-AJ-A3NG
TCGA-UCEC	TCGA-B5-A0JY	Stage IIIC1	No	0	NA	1988	NA	Endometrium	18475	Carcinoma, undifferentiated, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8020/3	NA	primary	2a69024b-1be6-586d-9895-f3cdc6062d14	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	50	-18475	NA	afd12a04-a61b-56c0-b7fc-bd90db975abb	FALSE	NA	United States	NA	2107	TF-Tumor Free	NA	961f08ae-c34b-40ac-a3e0-eb0906f977b4	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	aad0a85d-7d98-4a6b-ab25-69df5efe6177	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A0JY
TCGA-UCEC	TCGA-AX-A06F	Stage IVA	No	0	NA	1988	NA	Endometrium	21624	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2006	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	14a2847c-5fdd-5988-aa1f-84e3028a4d9a	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	59	-21624	NA	071110ba-b63c-5157-8a7a-12db64b4c1fd	FALSE	NA	NA	NA	1748	TF-Tumor Free	NA	43683cb9-f807-4bcf-a752-e0170f428576	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	fe86c01c-d8c9-499a-8773-2a33089269c6	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A06F
TCGA-UCEC	TCGA-BS-A0V6	Stage IB	No	0	NA	1988	NA	Endometrium	20369	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2006	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	f9e16061-74b2-560a-844c-561de6ed91ab	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	asian	female	not hispanic or latino	Alive	55	-20369	NA	118bb2cb-a544-5ce7-9eba-f989bd4f48f0	FALSE	NA	NA	NA	2725	TF-Tumor Free	Adjuvant;NA	a29ed7c9-472f-5e82-aa48-b3ce4b8057bd;a3a24f0a-f7af-4276-81b4-1bd9eb467e0b	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	4ca582a2-ca3e-4bca-bc0d-b651ff2cb7cf	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BS-A0V6
TCGA-UCEC	TCGA-AX-A2HA	Stage IB	No	0	NA	1988	NA	Endometrium	13142	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2005	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	daae28ec-ef21-5f4d-9d8f-201866caca25	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	35	-13142	NA	dbd03450-1805-5569-9589-3d0455324e64	FALSE	NA	United States	NA	2475	TF-Tumor Free	NA;Adjuvant	38971a4d-92c0-4b90-9c78-a637c023c9a2;9fc2141a-cb1f-52c6-a705-83396cfe0c7b	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	1da94afb-ea9f-4b68-b1ac-c25aed984080	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A2HA
TCGA-UCEC	TCGA-B5-A11F	Stage IA	No	0	NA	1988	NA	Endometrium	20171	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	1995	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	c1904f6f-f484-5afb-85e3-f1c6eace9af7	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	55	-20171	NA	de77fb9d-02b5-5d16-994a-46fa5a3e323b	FALSE	NA	United States	NA	5651	TF-Tumor Free	NA	65165115-3661-4cce-b1de-ba3f04da5e27	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	0e128094-cd09-58df-ae15-7738a966ef59	Radiation, External Beam	NA	yes	Recurrent Disease	NA	NA	1661	NA	1625	1	5400	27	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-B5-A11F
TCGA-UCEC	TCGA-B5-A121	Stage IIIA	No	0	NA	2009	NA	Endometrium	21018	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	c8c3a343-0666-5f03-866f-bdfe11bb12ed	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	57	-21018	NA	519905a6-d464-5f72-bbe1-83bc661c1821	FALSE	NA	United States	NA	504	TF-Tumor Free	NA;Adjuvant	83670501-f34b-4565-8c07-c0a4bd161bce;e5ecd91a-23f3-4778-8716-48d777f06154	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	9628bbe7-f630-591b-b8d4-a05ad6f7eddd	Radiation, External Beam	NA	yes	NA	NA	NA	102	NA	54	1	4500	25	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-B5-A121
TCGA-UCEC	TCGA-D1-A1NZ	Stage IA	No	0	NA	2009	NA	Endometrium	22027	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	58aae1bc-5d1c-5cc3-b192-dd6b10ecf0ac	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	60	-22027	NA	4a83af41-f0dd-5db8-a0bf-609e86d91d4a	FALSE	NA	United States	NA	548	TF-Tumor Free	Adjuvant;NA	413c8fad-cff8-5dc0-a9f6-f79a7b5e1c27;42730a3a-056a-4507-b18f-2d3b577ca927	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	83dbde84-f9b5-47a6-9335-27b75b69f4a9	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A1NZ
TCGA-UCEC	TCGA-EY-A1GS	Stage IVB	No	0	NA	2009	NA	Endometrium	26012	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Surgical Resection	NA	8441/3	R2	primary	884471a7-e889-56f7-a090-97fcb66320df	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Dead	71	-26012	NA	d4070e0f-bae1-5bbc-920e-4c67a15f4736	FALSE	NA	United States	670	670	WT-With Tumor	NA	6a340157-4c9b-4c74-bbc6-8f6e5e1aad85	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	83961e65-0510-47da-87a5-23876625237c	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-EY-A1GS
TCGA-UCEC	TCGA-AP-A05P	Stage IA	No	0	NA	NA	NA	Endometrium	20017	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	638ceddb-6bcf-511d-a998-b487df53824f	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	asian	female	not hispanic or latino	Alive	54	-20017	NA	34b18611-fa05-568a-8e4c-358e8525c1ef	FALSE	NA	NA	NA	636	TF-Tumor Free	Adjuvant;NA	c8b1c095-7106-5184-b148-62f9893d35b1;dfb15596-7cdb-406c-9c29-8d8dad87c270	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	e0966b82-4f21-4b78-a001-67ea51963430	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AP-A05P
TCGA-UCEC	TCGA-AP-A0L9	Stage IA	No	0	NA	NA	NA	Endometrium	26185	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2001	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	e04d0c32-8452-5a7c-b2f2-449dd19152c6	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	71	-26185	NA	05c600f7-24d5-5768-9a0b-9c03dc374335	FALSE	NA	NA	NA	3815	TF-Tumor Free	Adjuvant;NA	4efab499-95b4-51eb-9c79-96e89696e61f;cb638ca5-20d8-4834-8b1d-c995dd26ac4d	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	441f85ee-3c69-458e-9063-d8b644452ef4	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AP-A0L9
TCGA-UCEC	TCGA-A5-A0G3	Stage IIIC2	No	0	NA	NA	NA	Endometrium	22421	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2007	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	4acaf19b-207d-54a9-942c-57da493776cb	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not reported	Alive	61	-22421	NA	1919a3a7-a04e-5f06-bbe2-d190bee937e0	FALSE	NA	NA	NA	1428	WT-With Tumor	NA	c2bdddb1-6790-49f6-8798-3147c338fe29	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA;Adjuvant	4bc2594a-2844-41f5-b815-6d5d089e7538;811a0e22-845e-4c6c-be57-9583936cae41;c73162f8-a544-5db3-9016-966af22d8bd8;fe129f34-a681-4c26-9971-1362114c508d	Radiation, Stereotactic/Gamma Knife/SRS;Radiation, External Beam;Radiation, Implants	NA	yes	Progressive Disease;NA	NA	NA	1079;97;132;1163	NA	1079;60;112;1163	1;2;3	7900;4860;1500;6900	1;27;3;NA	Distant Site;Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-A5-A0G3
TCGA-UCEC	TCGA-FI-A2EX	Stage IIIA	No	0	NA	1988	NA	Endometrium	21489	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2005	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8441/3	R0	primary	a4feb6ed-8fc3-5bcb-bd28-bedc292581a5	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	58	-21489	NA	62496790-a6d7-551d-98e3-2cccd01e73d2	FALSE	NA	United States	NA	284	WT-With Tumor	NA	bc19ed84-e720-41b0-96b1-2bae977123c4	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	95d2829d-294a-4c33-ad30-80b837dcff6b	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-FI-A2EX
TCGA-UCEC	TCGA-D1-A3JQ	Stage IIIC	No	0	NA	2009	NA	Endometrium	22297	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	65a1716c-81fe-5861-8c2e-3b5efd86410a	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	61	-22297	NA	95fd1298-1173-577a-ad75-1755f2ea7291	FALSE	NA	United States	NA	526	TF-Tumor Free	NA	be8d7cc5-3949-4a1f-b88b-2db4738fbb6e	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	ae83943f-8697-5029-adb3-d384e8911b45	Radiation, External Beam	NA	yes	NA	NA	Complete Response	237	NA	200	NA	5040	28	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-D1-A3JQ
TCGA-UCEC	TCGA-AP-A1DR	Stage IIIC1	No	0	NA	2009	NA	Endometrium	21904	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	7958c319-6c8a-5ba4-99d0-4133f679682f	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not reported	Alive	59	-21904	NA	af4a58b5-00b5-54cb-9916-1f23f97edda9	FALSE	NA	NA	NA	1495	TF-Tumor Free	NA	e3c5f594-5e68-49b2-bcd5-5260b249d7f8	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	7d3bee46-6a25-5eae-be92-a210085b7b0a	Radiation, External Beam	NA	yes	NA	NA	NA	151	NA	112	1	5040	28	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-AP-A1DR
TCGA-UCEC	TCGA-A5-A7WJ	Stage IA	No	0	NA	2009	NA	Endometrium	23723	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2012	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	b66be01d-91aa-5e6d-91a2-76c1c5729a52	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	64	-23723	NA	9251d9f1-be21-5e38-9822-eede8d5cc51c	FALSE	NA	United States	NA	341	TF-Tumor Free	NA;Adjuvant	07fdf56b-9539-4eae-8d00-965e0cccaffe;cca169e6-85f5-5896-a2b2-1a7fa4f8b2ae	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	4de9193c-4112-491d-bc46-4cbff63b13ed	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-A5-A7WJ
TCGA-UCEC	TCGA-PG-A5BC	Stage II	No	0	NA	2009	NA	Endometrium	26436	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2012	released	No	TRUE	NA	Biopsy	NA	8441/3	NA	primary	c2f153c2-baf7-5c96-90bb-fc25436f0e97	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	72	-26436	NA	0feea406-ba2e-5a9f-b989-213d6a3964aa	FALSE	NA	United States	NA	707	TF-Tumor Free	Adjuvant;NA	0efbfe60-a787-5529-a05d-3399466a47a1;ae3b0587-75b6-4375-9d2b-0d8c18aabc7c	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	ec4abba4-9145-4bf7-bf27-e4f82da4e1b5	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-PG-A5BC
TCGA-UCEC	TCGA-A5-A2K3	Stage IA	No	0	NA	2009	NA	Endometrium	24907	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2007	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	18dc7277-755f-57f0-adad-d98b47ecb6d1	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	68	-24907	NA	018043c6-bd82-5183-8d98-7b422d6d321c	FALSE	NA	United States	NA	2012	TF-Tumor Free	NA	8a778a4a-987c-474f-971a-799e32dd0f40	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	ef4aa419-db46-4a1a-947e-038edbb632bf	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-A5-A2K3
TCGA-UCEC	TCGA-A5-A0GU	Stage IA	No	0	NA	NA	NA	Endometrium	21192	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	ac66ac8a-c4c4-5b6b-8b90-daf06b5f6af7	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	58	-21192	NA	33d6af45-80b9-546f-a040-7441d66a34d7	FALSE	NA	NA	NA	860	TF-Tumor Free	Adjuvant;NA	a8734643-9e1d-5435-8295-b23b0ece4ff1;b3cb5083-b4f7-4668-838f-f64dbcbbc9cf	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	aea11477-06fd-4a39-b145-d542507eb1d7	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-A5-A0GU
TCGA-UCEC	TCGA-B5-A0JS	Stage IA	No	0	NA	1988	NA	Endometrium	19995	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2007	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	3046aeb0-f512-5573-88e3-35b4dd8c25bd	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	54	-19995	NA	9a587a49-7e43-57b6-9599-0dfd29696ad7	FALSE	NA	United States	NA	2627	TF-Tumor Free	Adjuvant;NA	96cf4c75-104b-516c-be24-5c709faaa2cc;b6ffb67a-e251-4bc5-b92e-3f2311dc39ae	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	0a4ac920-0ab5-4ef4-8028-e414792cb831	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A0JS
TCGA-UCEC	TCGA-DF-A2L0	Stage IIIC	No	NA	NA	NA	NA	Endometrium	NA	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	NA	released	No	TRUE	NA	Biopsy	NA	8380/3	RX	primary	40f97b80-edac-5aea-ac69-928d372f2a80	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	not reported	female	not reported	Dead	60	-22200	NA	e7e96bee-ac74-59ef-bb8f-80dcfcd1df95	FALSE	NA	Canada	788	788	WT-With Tumor	NA	85e5f605-62d8-4d98-a7c3-0384cfba5a38;adcff6ba-d01b-450e-8a21-8c1ad5842493	Pharmaceutical Therapy, NOS	Clinical Trial;Tamoxifen	yes;no	NA	NA;Prior to Diagnosis	NA	607;NA	Yes;NA	565;NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	ca5efbea-4f5d-57b2-9571-57100bd95bc2	Radiation, External Beam	NA	yes	NA	NA	NA	263	NA	228	NA	4500	25	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-DF-A2L0
TCGA-UCEC	TCGA-D1-A17C	Stage IA	No	0	NA	2009	NA	Endometrium	28571	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	c37a7f86-46a7-5a73-b85e-db7612e0f0e4	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	78	-28571	NA	7510a9b9-dfb5-55c4-98c3-cfbd60e2d6a9	FALSE	NA	NA	NA	30	TF-Tumor Free	Adjuvant;NA	2bf2e225-b089-5162-a321-f27fa348557f;65faab28-7313-4201-9c0c-924a3304e96f	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	1a7eef1a-c2c0-4ccd-9725-636d632fb24e	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A17C
TCGA-UCEC	TCGA-A5-A0GG	Stage IA	No	0	NA	2009	NA	Endometrium	27809	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2003	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	1e3e2d09-526a-5154-a63e-32946e37e91b	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	76	-27809	NA	ffaff7f1-1d96-5720-9231-587e03833f53	FALSE	NA	NA	NA	3762	TF-Tumor Free	NA;Adjuvant	3ae8450b-56ef-44d9-834b-874d549426a1;fc7e9f4e-d612-4d75-88c2-0ddc61145efc	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	80b36487-b93d-5818-b76c-37a327462440	Radiation, Implants	NA	yes	NA	NA	NA	163	NA	149	1	2100	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-A5-A0GG
TCGA-UCEC	TCGA-H5-A2HR	Stage IB	No	0	NA	1988	NA	Endometrium	25986	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2006	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	6fc44a29-6ceb-53af-90e4-ae25365a33e0	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	71	-25986	NA	489ef6fd-7a84-59ac-966e-51af8f004b77	FALSE	NA	United States	NA	53	TF-Tumor Free	NA;Adjuvant	4bf949a5-bcea-402a-a8eb-fc760b1f6965;f499d198-0fcd-5570-8409-f9d0707c2205	Pharmaceutical Therapy, NOS	Tamoxifen;NA	unknown	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	265a1d1d-6aca-4a11-94e1-518fda234546	Radiation Therapy, NOS	NA	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-H5-A2HR
TCGA-UCEC	TCGA-AX-A06B	Stage IIA	No	0	NA	1988	NA	Endometrium	26348	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2005	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	181824f3-502b-50d8-a5a6-1308d7c7fed1	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	72	-26348	NA	26a37a66-829e-5cad-b2d4-c18ad2b5d28f	FALSE	NA	United States	NA	2058	TF-Tumor Free	NA;Adjuvant	320b5f76-2601-44ab-93e0-05060742aa5c;4bf7d712-8a69-48ba-bb76-e91c6f0a0286	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	2c0edc5d-dd45-5c1f-b9e1-854580e3588c	Radiation, Implants	NA	yes	NA	NA	NA	NA	NA	NA	1	NA	NA	Primary Tumor Field	NA	NA	NULL	NA	NA	NA	TCGA-AX-A06B
TCGA-UCEC	TCGA-EY-A1GP	Stage IA	No	0	NA	2009	NA	Endometrium	20011	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	9d18e30f-2e1e-511a-8941-81743f8b9cf7	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	54	-20011	NA	ce96d3e6-6f9d-54ec-8173-e7af52159c07	FALSE	NA	United States	NA	573	TF-Tumor Free	NA;Adjuvant	2528f74d-be7d-4060-b2e2-c1c4f6299c6c;2ac31c35-3472-5389-818d-f067f899b839	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	b03a5913-c02e-4682-a7de-f856c0cf1efd	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-EY-A1GP
TCGA-UCEC	TCGA-AP-A1E4	Stage IB	No	0	NA	2009	NA	Endometrium	19814	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	f9ba839c-3e1d-5954-8333-9dc646667389	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	54	-19814	NA	82bb1cb6-76bd-50d7-9942-d28b2ec7d3d6	FALSE	NA	NA	NA	1555	WT-With Tumor	NA	f2dabed9-e3bc-4f72-b097-f73050ddd1ff	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	f31bafdc-f2a9-5f90-adb3-f5ac66931044	Radiation, Implants	NA	yes	NA	NA	NA	124	NA	96	1	1800	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-AP-A1E4
TCGA-UCEC	TCGA-D1-A174	Stage IA	No	0	NA	2009	NA	Endometrium	18702	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	6d77a903-7e29-5b60-85e1-c20fcf1a0760	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	51	-18702	NA	6cb2b392-7f9d-56ff-951f-50fa1961540e	FALSE	NA	NA	NA	594	TF-Tumor Free	NA;Adjuvant	3afed0c7-887a-4e98-ad46-6459aed82b6d;81282ea8-cdd9-4e2a-9191-7712504a254d	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	1e006a92-c7dd-5a99-aa84-e7bee88b91f6	Radiation, Implants	NA	yes	NA	NA	NA	55	NA	49	1	2100	3	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-D1-A174
TCGA-UCEC	TCGA-DF-A2KV	Stage IB	No	0	NA	NA	NA	Endometrium	20160	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	NA	released	No	TRUE	NA	Cytology	NA	8380/3	RX	primary	1a85d10b-785d-5992-9efa-17360d4f462a	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	not reported	female	not reported	Alive	55	-20160	NA	65351b19-481f-5a72-9867-f1b3c0fad92d	FALSE	NA	Canada	NA	2717	Unknown	Adjuvant;NA	02be3f87-9cd1-581f-80c7-78100f58abf4;48648459-f64c-4c6e-8a70-eabe95d9947c	Pharmaceutical Therapy, NOS	NA;Tamoxifen	unknown	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	a420b646-4dec-495b-b7e1-dcb3a0fcabc0	Radiation Therapy, NOS	NA	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-DF-A2KV
TCGA-UCEC	TCGA-AX-A3G1	Stage IC	No	0	NA	1988	NA	Endometrium	31037	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Surgical Resection	NA	8380/3	NA	primary	96f53917-5907-5e68-b0b1-aee826e436dc	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	84	-31037	NA	1991506f-07bc-5bae-9fb7-10ef9fb7c2e4	FALSE	NA	United States	624	624	NA	NA;Adjuvant	05721283-f9c4-4145-938f-6056144c0191;c2cf532f-34f5-5000-8181-a48f52295b59	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	a4ca7ebf-92b2-4aad-9a2c-2fc99d421e7d	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A3G1
TCGA-UCEC	TCGA-DF-A2KS	Stage IB	No	NA	NA	NA	NA	Endometrium	NA	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	NA	released	No	TRUE	NA	Biopsy	NA	8380/3	RX	primary	ab2d1531-0ac6-5197-9585-ee8cd6beb3b6	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	not reported	female	not reported	Alive	69	-25313	NA	e6364172-46ac-520d-af07-f1d3d5bedeb9	FALSE	NA	Canada	NA	3318	TF-Tumor Free	NA;Adjuvant	179f0223-5aeb-4d92-beef-a5f9f560ddd9;813e5536-f878-4422-b817-92791b50399b;aebf3460-af3e-40b6-99c1-afa24def797b	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	Initial Diagnosis;NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	0001aaaa-b7ff-4b67-8d06-92b9473e2f9c;d861a452-0839-4be6-805b-cbd98d17612b;e69b49da-4c68-5663-bc0e-a86af502a5ef	Radiation, Internal;Radiation Therapy, NOS;Radiation, External Beam	NA	yes;no	NA;Initial Diagnosis	NA	Complete Response;NA	64;NA;118	NA	50;NA;104	NA	3000;NA	3;NA	Primary Tumor Field;NULL;Regional Site	cGy;NA	NA	NULL	NA	NA	NA	TCGA-DF-A2KS
TCGA-UCEC	TCGA-A5-A1OJ	Stage IA	No	0	NA	2009	NA	Endometrium	11635	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	f0133f94-0d43-5f2d-9cb6-85f8dd31a950	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	asian	female	not hispanic or latino	Alive	31	-11635	NA	e5720da2-a49b-5fb5-abcc-a6160a9f1e5b	FALSE	NA	United States	NA	1006	TF-Tumor Free	NA;Adjuvant	b921fb3a-1ee5-4e1b-b051-835c9c7f2304;f2737e46-f6d1-5acd-a707-0daed1edd884	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	f857f0e1-3e6d-42d5-bfa4-747c60e2967a	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-A5-A1OJ
TCGA-UCEC	TCGA-AX-A062	Stage IB	No	0	NA	1988	NA	Endometrium	19643	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2005	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	19b9b525-2fae-5676-b5d0-dde681d32629	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	53	-19643	NA	afb64fd6-7906-5bd8-87a9-03b43fb69900	FALSE	NA	NA	NA	1399	TF-Tumor Free	Adjuvant;NA	dfbd7fb2-ab5b-5a4e-b9be-dcb03e361957;ea91424f-3c3d-4d0c-8edf-8622f09f35f9	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	bb856c07-248e-4181-8cbe-1f830c21dd7d	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A062
TCGA-UCEC	TCGA-D1-A1O7	Stage IA	No	0	NA	2009	NA	Endometrium	22037	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	2e4c434e-b8e7-5db1-ac83-907d844bcf30	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	60	-22037	NA	cb0d8efa-9f52-5939-9cb2-bc1759bf7fdf	FALSE	NA	United States	NA	32	TF-Tumor Free	Adjuvant;NA	235fafd2-6cc7-5be6-a1be-e11fd76f1a84;5a85c037-0cea-44ed-b613-0e17524cd22d	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	8dada04b-efc0-4641-9232-03d510809013	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A1O7
TCGA-UCEC	TCGA-AX-A3FX	Stage IIB	No	0	NA	1988	NA	Endometrium	25260	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Surgical Resection	NA	8380/3	NA	primary	a1c3f997-b0ef-589d-8be2-28d44d1e2a26	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	69	-25260	NA	42ecb87e-7e52-5296-aa28-bafa3f80d30a	FALSE	NA	United States	1333	1333	NA	NA	29ff3c61-9a2e-4d21-99c5-3e692b9e1678;3e1ed538-380a-4875-96ca-d908463e7673;4da06578-2911-4de7-984d-505a808005ae;57bd2fb1-d948-4b21-a74a-d9069748d059;a5143486-d57d-4bdb-86e5-e51f9bbc8412;c14178c7-2c26-5cc4-8279-a98e9aa27017	Pharmaceutical Therapy, NOS	Bevacizumab;Tamoxifen;Pegylated Liposomal Doxorubicin Hydrochloride;Carboplatin;Paclitaxel	yes;not reported	NA	NA;Prior to Diagnosis	NA	NA;1336	No;NA	939;NA;1255	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	b988ecfd-6f8f-47f9-814e-f2bde08f513c	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A3FX
TCGA-UCEC	TCGA-D1-A15W	Stage IIIC	No	0	NA	1995	NA	Endometrium	21545	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	RX	primary	54ec6618-ae60-5df8-9a0e-32da9a95aeb4	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	58	-21545	NA	5e8f2da5-7f61-5140-9364-25325bf20cad	FALSE	NA	NA	NA	915	TF-Tumor Free	NA	f59e5d46-bba4-47f1-bb9d-fd31f4cb56bb	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	2f308331-acae-412f-a31e-e980c2107581;6ea57f75-1f3e-5422-b62a-ba1a9e573765	Radiation, Implants;Radiation, External Beam	NA	yes	NA	NA	NA	241;232	NA	239;198	2;1	1000;4500	2;25	Primary Tumor Field;Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-D1-A15W
TCGA-UCEC	TCGA-FI-A2EU	Stage IA	No	0	NA	1988	NA	Endometrium	24837	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2003	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	57b6e82a-baa3-5a30-90e5-787f6f2b905e	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	not reported	female	not hispanic or latino	Alive	68	-24837	NA	ae46540d-b520-585f-941d-5492c9ae03bb	FALSE	NA	United States	NA	2941	TF-Tumor Free	NA	2bc41308-5b24-4bb2-aee4-dc519ef0dc03	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	01e2813e-5604-4538-9a73-9b25f56a2721	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-FI-A2EU
TCGA-UCEC	TCGA-D1-A0ZP	Stage IVA	No	0	NA	NA	NA	Endometrium	21581	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Surgical Resection	NA	8441/3	RX	primary	a50ec4a3-5106-583e-a55c-bd33dfc9c68e	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	59	-21581	NA	0ecef8f0-f148-5b31-8f6d-ea0e4f2440da	FALSE	NA	NA	NA	911	TF-Tumor Free	NA	a8fb8f80-02d2-4778-bbb4-c0aeef0e9871	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	f1b231a6-bbdb-5a33-8a1a-4e9fc0585b84	Radiation, External Beam	NA	yes	Recurrent Disease	NA	NA	757	NA	725	1	5000	25	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-D1-A0ZP
TCGA-UCEC	TCGA-DI-A1NO	Stage IIIA	No	0	NA	2009	NA	Endometrium	24996	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	RX	primary	ab76fd83-0688-509b-a2f7-164e59ade853	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Dead	68	-24996	NA	c538c930-b7ad-54d7-a79e-15aa04e38237	FALSE	NA	United States	285	285	WT-With Tumor	NA;Adjuvant	069e8451-e6f5-4473-9eb2-e415d8c03617;fd99f745-6d70-5394-a9c0-be334264d4ff	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	211e1763-7c8a-4984-b500-d192e959020b	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-DI-A1NO
TCGA-UCEC	TCGA-BK-A0C9	Stage IB	No	0	NA	NA	NA	Endometrium	20876	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	69aaab7d-9b61-55a8-b617-f1ed370f06c3	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	57	-20876	NA	dbc9ef72-8377-52a7-b0cc-6a29c0c1c174	FALSE	NA	NA	NA	1092	TF-Tumor Free	NA;Adjuvant	31be3b4f-c9a8-4ebb-90a5-624d51e2947c;fbf028c5-5bd5-503a-8f53-a097d431b239	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	648f73d7-5f5d-4608-8d71-b4f2c7cf69dd	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BK-A0C9
TCGA-UCEC	TCGA-AP-A1DK	Stage IA	No	0	NA	2009	NA	Endometrium	19509	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2006	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	8d4d021a-930e-59f9-a84e-62cca254ea07	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	53	-19509	NA	2f3cfe29-af4d-5dcd-84a6-304a3717051a	FALSE	NA	NA	NA	2767	TF-Tumor Free	NA;Adjuvant	1802b433-4921-4ef4-a280-43bcca0b7a68;bb96c962-ecde-4d2b-a7f8-7579b974a962	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	3f4425e9-8e50-5558-9a49-80680266ae7e	Radiation, Implants	NA	yes	NA	NA	NA	120	NA	92	1	1800	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-AP-A1DK
TCGA-UCEC	TCGA-A5-A1OK	Stage IIIA	Yes	0	NA	2009	NA	Endometrium	23179	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	e73b3dc2-47fc-5c48-8b85-fa0416bad555	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	63	-23179	NA	b346824d-c961-5a69-978a-f04452f8b1f0	FALSE	NA	United States	NA	917	TF-Tumor Free	NA	d19c2943-c69e-4676-ba1d-807a36dfd036	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	59b1d10b-6e11-599b-b664-f48e0bf1bc14	Radiation, Implants	NA	yes	NA	NA	NA	196	NA	182	1	2100	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-A5-A1OK
TCGA-UCEC	TCGA-D1-A17A	Stage IIA	No	0	NA	2009	NA	Endometrium	21560	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	65afd97d-49f3-57ce-aef3-e0393aa0b85d	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	59	-21560	NA	34a4b0c0-cafa-5ade-9250-9a33891abdf0	FALSE	NA	NA	NA	48	TF-Tumor Free	Adjuvant;NA	9522a52c-1ca1-5b97-b212-33b0b26519fe;d23a9a59-c342-4f2e-b505-375b402f6112	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	773d5359-e16c-4a84-ba52-b0451525aa9a	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A17A
TCGA-UCEC	TCGA-PG-A916	Stage I	No	0	NA	2009	NA	Endometrium	25617	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2013	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	09927097-08c2-5dde-b4c6-4e05005aca23	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	70	-25617	NA	1b1c4e7b-2386-52da-929c-fc293a8cbad3	FALSE	NA	United States	NA	522	TF-Tumor Free	NA;Adjuvant	00537779-2fef-47e4-a919-e4958d26b6aa;f2410677-ed5a-5ee7-8abf-9cdebe514bdb	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	bbc06d2f-50fb-40ce-bb90-c886ded573a4	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-PG-A916
TCGA-UCEC	TCGA-AJ-A5DW	Stage IA	No	0	NA	2009	NA	Endometrium	20711	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2012	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	0f80c564-ea46-5654-a562-53c10686392d	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	56	-20711	NA	e0c51d2e-2739-5a27-ad54-25d14c00f90a	FALSE	NA	United States	NA	390	TF-Tumor Free	NA;Adjuvant	c58ed51d-5908-4545-a837-202df087afb9;d2bfeef2-549f-5886-ad2a-5761a5d1f908	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no;unknown	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	0f57e2be-8717-499d-9c74-41e64706ada0	Radiation Therapy, NOS	NA	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AJ-A5DW
TCGA-UCEC	TCGA-AX-A05Y	Stage IB	Not Reported	0	NA	1988	NA	Endometrium	20904	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	not reported	2004	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	a122877f-69ee-5e1e-975d-3ece1c4e4684	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	57	-20904	NA	d62cdfef-4a5d-51b3-90a0-369c60216423	FALSE	NA	NA	NA	2684	TF-Tumor Free	Adjuvant;NA	722a709c-684a-5209-9163-28a3e8b6d946;c784acce-b98c-4b04-a98d-3c22e42d1431	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	d80743c9-789e-4404-8c94-a67b922eaec9	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A05Y
TCGA-UCEC	TCGA-E6-A1LX	Stage IB	No	0	NA	1988	NA	Endometrium	14731	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2006	released	No	TRUE	NA	Surgical Resection	NA	8380/3	R0	primary	99c53e20-d513-55c3-bacf-ec514441fea5	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	40	-14731	NA	9c57e3d8-61cf-58c5-a4ff-386c7d91c6d4	FALSE	NA	United States	NA	711	TF-Tumor Free	Adjuvant;NA	4ff06222-f844-48a4-97cb-2495fbd53671;af36cfa8-d10a-4d0d-ad3f-b2c33a1c929e	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	ebf951ca-aefc-568b-9f87-6d13e7cda3e5	Radiation, Implants	NA	yes	NA	NA	NA	49	NA	35	1	2100	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-E6-A1LX
TCGA-UCEC	TCGA-D1-A168	Stage IB	No	0	NA	1995	NA	Endometrium	24586	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	a6f898ce-d3bf-5b6a-bf29-7a86fb211048	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	67	-24586	NA	877d24ed-dd52-5247-95aa-d023b682a6dd	FALSE	NA	NA	NA	1098	TF-Tumor Free	Adjuvant;NA	33544e3a-97e6-409c-aa97-37ebfc788116;8d0d2513-4138-4917-8155-15c8ee4fe266	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	21bac08b-e29c-5198-ae5c-4eea3bb311b6	Radiation, Implants	NA	yes	NA	NA	NA	48	NA	41	1	2100	3	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-D1-A168
TCGA-UCEC	TCGA-D1-A1O0	Stage IA	No	0	NA	2009	NA	Endometrium	28162	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	f4d89a7e-b70c-5e08-9a4b-b87165d3122a	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	77	-28162	NA	d4ecc93c-481d-5d2e-a1be-cadcc9a73cb8	FALSE	NA	United States	NA	63	TF-Tumor Free	NA;Adjuvant	61edbbd0-6aa1-4675-a06d-a87e29449f1b;83988d55-554c-54bc-b133-4faa168d9592	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	551bd82d-e470-48f1-b529-27f66a478be5	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A1O0
TCGA-UCEC	TCGA-AJ-A3NF	Stage IIIC	No	0	NA	2009	NA	Endometrium	22210	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8441/3	R0	primary	369db65e-496b-506f-a46f-f41fc34ef5f8	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	60	-22210	NA	606473b1-aaf5-50b5-9b3f-fd2fe9945ded	FALSE	NA	United States	NA	645	TF-Tumor Free	NA	25c548fd-e02c-4816-87af-b75ffcb2eea4	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	14770bb3-5de0-5295-ab7f-e37a3314024e;d25abf05-79c4-4850-94ce-4457ed02caa5	Radiation, External Beam;Radiation, Internal	NA	yes	NA	NA	Complete Response	193;222	NA	158;192	NA	4500;NA	NA	Primary Tumor Field	cGy;NA	NA	NULL	NA	NA	NA	TCGA-AJ-A3NF
TCGA-UCEC	TCGA-FI-A2CY	Stage IA	No	0	NA	1988	NA	Endometrium	22098	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	bf7ef25c-4fee-555f-a5ba-4f5029f881f0	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	60	-22098	NA	fe1253ff-6372-59d4-95d5-b7799dd58660	FALSE	NA	United States	NA	2080	TF-Tumor Free	NA	b46a4f16-5f38-4357-b21a-b515bec0c221	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	f13978db-354b-4b75-bf37-319b32a5e22b	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-FI-A2CY
TCGA-UCEC	TCGA-BG-A0VW	Stage IA	No	0	NA	2009	NA	Endometrium	28383	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	2c1907ca-c957-5798-9ce9-23fbcc276ab9	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	77	-28383	NA	540f6a1a-88ee-5303-8612-f84ac47bc183	FALSE	NA	NA	NA	1582	TF-Tumor Free	NA;Adjuvant	07c8560f-07ce-4e7e-95fb-f46425a37d91;e4c508a0-2edf-5f8b-974b-1652d00c1d88	Pharmaceutical Therapy, NOS	Tamoxifen;NA	unknown;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	9b3bd79c-94db-4942-90e9-80499adc7843	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BG-A0VW
TCGA-UCEC	TCGA-B5-A11S	Stage IA	No	0	NA	2009	NA	Endometrium	23085	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	NA	primary	10aae23f-e099-59e4-b255-22ec38998415	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	63	-23085	NA	d2b3ab8b-b070-588b-b574-8ee86e7eff94	FALSE	NA	United States	NA	2229	TF-Tumor Free	NA;Adjuvant	12e911c5-0dbd-4ff3-9a67-ec4579c747e4;24083fb0-14bf-5abf-bcbe-d0911ba93b0f	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	4b0ced42-1f4e-49b7-a6ec-4a4869fd5559	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A11S
TCGA-UCEC	TCGA-BG-A0MT	Stage IA	No	0	NA	2009	NA	Endometrium	23574	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	c00a7e30-e559-5fe1-afb0-4c86b798c6f3	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	64	-23574	NA	4d444b66-2a61-5097-8234-82701fa74420	FALSE	NA	NA	NA	644	TF-Tumor Free	Adjuvant;NA	01012744-f996-5de6-92e4-8b7a2748ae4e;0f7a3261-a4c0-4388-883d-585dae5a6d5b	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	9c939f0c-31ba-421f-a074-223e1ad216d5	Radiation Therapy, NOS	NA	yes	NA	NA	Partial Response	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BG-A0MT
TCGA-UCEC	TCGA-AX-A1CN	Stage IIB	No	0	NA	1988	NA	Endometrium	19860	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	05e7f7c9-ee29-5096-97c2-f5f08b948f5f	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	54	-19860	NA	5f17d402-31f5-519a-8045-d4092aead279	FALSE	NA	NA	NA	1143	WT-With Tumor	NA	b38cb132-7d59-4a09-a9d6-d9c8cd8717f8	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA;Adjuvant	f65b715f-59b0-4bcd-b2d9-c5cfd313e993;ff0adede-d697-563d-b250-3b60006fddbc	Radiation, Internal;Radiation, Combination	NA	yes	NA	NA	Unknown;NA	NA	NA	NA	NA;1	NA	NA	Locoregional Site;Primary Tumor Field	NA	NA	NULL	NA	NA	NA	TCGA-AX-A1CN
TCGA-UCEC	TCGA-D1-A17U	Stage IIIC2	No	0	NA	2009	NA	Endometrium	19544	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	0e51088d-0e30-5949-82fe-36db6f57ac16	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	53	-19544	NA	eada4ab5-d648-5c4f-9f46-ea31cebd6457	FALSE	NA	NA	NA	697	TF-Tumor Free	NA	b41067a8-75f0-4a27-a73f-697429557764	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	df41d07b-14db-5a29-bfa5-c1eaa22cb4aa	Radiation, External Beam	NA	yes	NA	NA	NA	137	NA	101	1	5500	25	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-D1-A17U
TCGA-UCEC	TCGA-AJ-A3OJ	Stage II	No	0	NA	2009	NA	Endometrium	19826	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	5588105e-6eed-5a1e-89c4-3a05d2f11428	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	54	-19826	NA	2d640521-fd23-5176-bb37-d5e66cbca59a	FALSE	NA	United States	NA	467	TF-Tumor Free	NA	3f872e42-6800-40d7-8b89-e738f7a1049e	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	09a45c05-f663-5293-8e4f-066f0455b87c;d9958272-6816-4308-ab33-062f80a57e98	Radiation, External Beam;Radiation, Internal	NA	yes	NA	NA	Complete Response	263;286	NA	233;274	NA	NA;1500	NA;3	Primary Tumor Field;Regional Site	NA;cGy	NA	NULL	NA	NA	NA	TCGA-AJ-A3OJ
TCGA-UCEC	TCGA-B5-A0K0	Stage IA	No	0	NA	1988	NA	Endometrium	17810	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	NA	primary	0e1b6dbb-ed50-5171-9dc6-383802394d94	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	48	-17810	NA	c4dacc00-24ae-5643-ba9f-f81668f7fc01	FALSE	NA	United States	NA	1478	TF-Tumor Free	NA;Adjuvant	5b2175ee-eb73-4922-8a5b-898dd9ed9d54;a4192721-05db-5d1a-8ae2-248c038bb76b	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	3ddb9428-a112-49b7-b076-13a936fd3ad5	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A0K0
TCGA-UCEC	TCGA-EY-A210	Stage IIIC2	No	0	NA	2009	NA	Endometrium	30095	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	166ebb1b-3acb-5af6-b800-00d5930c720c	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	82	-30095	NA	63c1a62a-724b-537a-ae88-6845143841c9	FALSE	NA	United States	NA	383	TF-Tumor Free	Adjuvant;NA	04ef0a9b-f05f-570b-a62c-8c689c93eda4;1873d6c6-a7de-41ea-b775-555454b5f15b	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	3175c6f7-6680-4a8f-9a41-201be425e5a2	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-EY-A210
TCGA-UCEC	TCGA-EO-A22R	Stage IB	No	0	NA	2009	NA	Endometrium	20604	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	262813f0-6ba0-5775-a7e9-cb37b50f78a1	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	not reported	female	not reported	Alive	56	-20604	NA	1c25671b-2d5d-5bb4-b022-6c8571ccc85f	FALSE	NA	Canada	NA	1878	TF-Tumor Free	NA;Adjuvant	13f4ede7-c3de-479c-9d9f-543a8436fe53;49c6c803-d169-44e8-b8b2-55bfd201b5d4	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	2f65a41f-081b-58b1-927c-29cb81517c29	Radiation, External Beam	NA	yes	NA	NA	NA	112	NA	76	NA	45	25	Primary Tumor Field	Gy	NA	NULL	NA	NA	NA	TCGA-EO-A22R
TCGA-UCEC	TCGA-D1-A0ZQ	Stage IB	No	0	NA	NA	NA	Endometrium	32872	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	25abd952-109e-5bdf-95e0-cac38a8354c0	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	89	-32872	NA	94dfa136-8422-58f4-a7c3-0856703cb127	TRUE	NA	NA	NA	0	TF-Tumor Free	NA;Adjuvant	9c7664c8-a057-4a58-8ccb-9b8ce3f30d14;b2eda5ce-233a-53a7-9b16-0e87b8918ed3	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	36c64f77-fd09-4039-9eed-84f2eb6b8eea	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A0ZQ
TCGA-UCEC	TCGA-B5-A3FB	Stage IB	No	0	NA	1988	NA	Endometrium	26779	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2006	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	a6abf562-401d-58f2-9205-ef490b917966	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not reported	Alive	73	-26779	NA	9f7d00ec-c32d-54a4-b535-29f67966f7b6	FALSE	NA	United States	NA	2844	NA	Adjuvant;NA	597ee7fc-bf02-5e62-9081-33f15bc255fa;bc43593b-7353-4eb8-a322-e594eed7aebd	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	566dec80-0350-4e79-8402-0a7ca85671ea	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A3FB
TCGA-UCEC	TCGA-AP-A0LD	Stage IB	No	0	NA	NA	NA	Endometrium	23216	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2002	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	66cf797e-30dd-5bbf-9874-1af349475018	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	63	-23216	NA	89dd9b5b-71a2-599c-b86a-9631ef174de5	FALSE	NA	NA	NA	3589	TF-Tumor Free	Adjuvant;NA	c15cc612-f1f6-4734-a767-96a1427421cc;f96401e4-e2ab-4327-ae59-d9c2c99d5f96	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	edeaddd9-bddb-507f-9589-3733e7be4968	Radiation, External Beam	NA	yes	NA	NA	NA	138	NA	101	1	5040	28	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-AP-A0LD
TCGA-UCEC	TCGA-EY-A549	Stage IA	No	0	NA	NA	NA	Corpus uteri	28570	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2012	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	5c7588e5-e56e-597d-8aa3-3822164e4464	C54.9	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	78	-28570	NA	48c62578-8e2e-5d1a-a37a-f971a6d5b7f2	FALSE	NA	United States	NA	605	NA	NA;Adjuvant	4cfadbaa-0457-432f-a316-54b0926f7f5b;4fc52262-6372-49ca-9cd6-231693f23acd	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	f6fe67bd-fdcd-50af-b5f7-66f286c11193	Radiation, Internal	NA	yes	NA	NA	Complete Response	212	NA	198	NA	2100	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-EY-A549
TCGA-UCEC	TCGA-D1-A176	Stage IB	No	0	NA	2009	NA	Endometrium	24521	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	e673f6da-029d-577f-a452-0853e53851b4	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	67	-24521	NA	93c550da-55b4-5bf1-be9c-bbc05ba86643	FALSE	NA	NA	NA	917	TF-Tumor Free	Adjuvant;NA	09de01e2-8c9c-5ffa-814c-be7c2f7fc5e2;6a701cd0-d5a8-474e-b86f-be6a9c576077	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	5050b1e3-d76a-40bf-a0eb-7e0dab344414	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A176
TCGA-UCEC	TCGA-AJ-A23O	Stage IB	No	0	NA	2009	NA	Endometrium	25433	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	e017d64b-fd53-5fa0-8344-3a17671f49aa	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	69	-25433	NA	b0f4f234-03f6-5629-b12d-ec4154d1c2b5	FALSE	NA	United States	312	312	NA	Adjuvant;NA	70502229-873b-5d58-bc64-a2e57732f9d1;ba84e513-4fa3-4f5e-8c6b-ea340d2d3826	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	c34db4af-6e35-440e-8735-d49ccd9893e9	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AJ-A23O
TCGA-UCEC	TCGA-A5-A0G1	Stage IA	No	0	NA	NA	NA	Endometrium	24477	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	1996	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	f504f44e-78b2-5166-bdd0-c3af786879ef	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	67	-24477	NA	8520fd69-3ed2-5152-961f-02319d643e56	FALSE	NA	NA	3251	3251	TF-Tumor Free	Adjuvant;NA	1b83bcbf-3495-4cde-975e-07d6b02c871d;24372beb-d8f6-408e-961a-0d50c5fe60c7	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	80033256-0bb7-53b5-a5d8-3a946ca42d16	Radiation, External Beam	NA	yes	NA	NA	NA	112	NA	72	1	5040	28	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-A5-A0G1
TCGA-UCEC	TCGA-B5-A0JT	Stage IIIA	No	0	NA	1988	NA	Endometrium	23041	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2007	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	1f791e55-9d7d-5124-93cb-f158cbaf8e8e	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	63	-23041	NA	d5d00d70-77b9-5443-bd30-112211cf1f36	FALSE	NA	United States	NA	1682	NA	NA	317d032e-9c4a-47c4-a185-25384007b830	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	443a737f-0834-4abd-8f68-c24a6cb1f48b	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A0JT
TCGA-UCEC	TCGA-FI-A3PV	Stage IA	No	0	NA	2009	NA	Endometrium	24898	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2003	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8441/3	R0	primary	fef8958c-b1db-5946-91a8-30531aa6f1b3	C54.1	Endometrium	High Grade	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Dead	68	-24898	NA	587919ff-fbe2-59f6-8ffe-fe75b6f4f3a7	FALSE	NA	United States	1249	1249	WT-With Tumor	Adjuvant;NA	22470e63-4901-58a1-bd91-d730bfb65ada;c67bcda8-5692-4f03-b97e-a54c49fd5a3d	Pharmaceutical Therapy, NOS	NA;Tamoxifen	unknown;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	5777d3f0-1c8e-4cad-a255-9a1d817132aa	Radiation Therapy, NOS	NA	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-FI-A3PV
TCGA-UCEC	TCGA-A5-A0R6	Stage IIIC1	No	0	NA	2009	NA	Endometrium	23449	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	34a9e020-9e90-5fd4-beca-55bb8f8e18bd	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	hispanic or latino	Alive	64	-23449	NA	ed7b2087-cf0f-5360-be88-97a509a5dcbf	FALSE	NA	NA	NA	1153	TF-Tumor Free	NA	5e956b67-a699-4b21-a638-e1649dcab97e;c74d97e3-8096-4db1-9586-242d482c30eb	Pharmaceutical Therapy, NOS	NA;Tamoxifen	unknown;no	Initial Diagnosis;NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant;NA	790f4370-75ac-582d-a918-aa5048071600;88b85972-0725-4283-8018-d68f8dca701c	Radiation, Implants;Radiation Therapy, NOS	NA	yes;unknown	NA;Initial Diagnosis	NA	NA	330;NA	NA	309;NA	1;NA	1500;NA	3;NA	Primary Tumor Field;NULL	cGy;NA	NA	NULL	NA	NA	NA	TCGA-A5-A0R6
TCGA-UCEC	TCGA-D1-A16B	Stage IC	No	0	NA	1995	NA	Endometrium	23450	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	8fc243ef-6ae1-505d-9afb-c0e9901a5020	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	64	-23450	NA	75adb354-65dc-56e8-a9bb-d01ff7b9ec15	FALSE	NA	NA	NA	1106	TF-Tumor Free	Adjuvant;NA	ac7adcc2-9cb6-51c6-ac77-bd02d4346d48;d34b69ff-c9ad-493a-9df9-5c83d19e933a	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	74f7791a-de29-4202-ab5d-afd07586f5c5	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A16B
TCGA-UCEC	TCGA-D1-A103	Stage IB	No	0	NA	NA	NA	Endometrium	31841	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	9667b64a-e27e-5ad8-8da6-b356444005ba	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	87	-31841	NA	d93c3f44-61a7-53ce-9bd8-a934eb81d151	FALSE	NA	NA	NA	669	TF-Tumor Free	Adjuvant;NA	1ec1ddde-d7ec-581b-9c2b-532e10d6cb8f;7c64df99-638e-4bde-a32e-d464778464b3	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	c28dcda9-8f91-48f5-86c6-1baefdd2ab0c	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A103
TCGA-UCEC	TCGA-BS-A0VI	Stage IIB	No	0	NA	1988	NA	Endometrium	21198	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2006	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	a960398d-abc0-599d-9f97-3f67d347ca15	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	58	-21198	NA	7a1bcab4-1dc6-5dff-bebc-6d77458d082e	FALSE	NA	NA	NA	2646	TF-Tumor Free	Adjuvant;NA	2fce146a-389a-5380-b325-fff653bc5446;d7bef90a-9b2e-4055-9fc7-0d1758d144a3	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	62855f3a-6e2c-4712-bbc8-c5fadd752f04	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BS-A0VI
TCGA-UCEC	TCGA-EY-A4KR	Stage IIIC1	No	0	NA	NA	NA	Endometrium	20669	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2012	released	No	TRUE	NA	Biopsy	NA	8441/3	RX	primary	3fc4011a-b780-5270-a1ad-0025e6e2de3f	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Dead	56	-20669	NA	9c5f20e2-32ce-5806-9d65-97b768df3265	FALSE	NA	United States	346	346	WT-With Tumor	NA	83660ee5-81d2-4070-80ec-b8268ff0a2da	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	36113050-3b74-479f-8b41-bf340466c25f;4f1943dc-bbbe-5d61-9b6d-93a9e5ce3594	Radiation, External Beam	NA	yes	NA	NA	Progressive Disease	278;117	NA	238;112	NA	4860;720	27;4	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-EY-A4KR
TCGA-UCEC	TCGA-B5-A0K2	Stage IIIA	No	0	NA	1988	NA	Endometrium	20080	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	3b479bf2-eb91-5790-bda7-bf6c64a89476	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	54	-20080	NA	8edb6f51-93e3-5ff9-88f6-e970cb486bb6	FALSE	NA	United States	NA	2209	TF-Tumor Free	NA	eec27494-5315-4bf4-9d9c-f526ac18a88e	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	b3c2fb69-877c-4f12-b3eb-d87fb019c94b	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A0K2
TCGA-UCEC	TCGA-BK-A56F	Stage IB	No	0	NA	2009	NA	Endometrium	27523	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2012	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	8121aad3-2741-5b93-a575-16463d2f87f1	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	75	-27523	NA	eb35520c-df45-5f2c-a0c9-e8edc9832a81	FALSE	NA	United States	NA	401	TF-Tumor Free	Adjuvant;NA	62410de4-7364-4ecd-a36a-79f54020d60f;7a98bdfd-045b-44d1-bcb5-2ec2bf38caf2	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	e8ca6047-6cfd-5ff0-9bb0-29364dff36a7	Radiation, Internal	NA	yes	NA	NA	Complete Response	140	NA	126	NA	3500	5	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-BK-A56F
TCGA-UCEC	TCGA-BG-A0M3	Stage IB	No	0	NA	1988	NA	Endometrium	27183	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	1df0ea26-2081-5b79-a3dc-bbed3d057699	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	74	-27183	NA	fc98d37b-3159-5080-92f4-829f488879b6	FALSE	NA	NA	NA	1071	TF-Tumor Free	Adjuvant;NA	442f88db-9331-46bd-85a1-0bc061ac11a2;b4a5b9e5-85a5-4f62-8575-7a55bda92beb	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	8da9a0a6-d51c-513f-8ad2-4828fa6efb5e	Radiation, Implants	NA	yes	NA	NA	NA	87	NA	80	1	2100	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-BG-A0M3
TCGA-UCEC	TCGA-B5-A11V	Stage IA	No	0	NA	2009	NA	Endometrium	23630	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	09b79b21-54c9-57a2-a6bc-fb02f236f79a	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not reported	Alive	64	-23630	NA	a0d7577a-1868-535e-b229-e0ea205cd267	FALSE	NA	United States	NA	595	TF-Tumor Free	Adjuvant;NA	45d01c6b-7ac8-58e1-b687-b2d440fac32b;8e80d325-05c8-4b46-b7eb-d5ead44b2775	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	31412736-8075-4cbb-a7a5-65b9ac41e128	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A11V
TCGA-UCEC	TCGA-FI-A2EW	Stage IIB	No	0	NA	1988	NA	Endometrium	26267	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2005	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	be321182-f652-5312-9819-ffd9509fa760	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not reported	Alive	71	-26267	NA	6576c375-63ee-5f39-8eba-d41859b9dc27	FALSE	NA	United States	NA	1795	WT-With Tumor	NA	77d6552e-cd60-4481-a914-3a8472aae407	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	083b9a5b-c1c8-417f-b08d-dce73cdc2688	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-FI-A2EW
TCGA-UCEC	TCGA-BS-A0TD	Stage IB	No	0	NA	1988	NA	Corpus uteri	23950	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2005	released	No	TRUE	NA	Surgical Resection	NA	8380/3	R0	primary	a3b06160-0aca-5799-91fe-d4b9b8999908	C54.9	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	asian	female	not hispanic or latino	Alive	65	-23950	NA	29722ebf-3505-5430-ab99-d9f747ae451e	FALSE	NA	NA	NA	2379	TF-Tumor Free	NA;Adjuvant	90d8786a-63f6-4441-9787-e1300e5d114e;c70e675a-5824-505d-9e3f-9058682a71b3	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	f995da38-012a-4104-ade1-e623e6ea5a7e	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BS-A0TD
TCGA-UCEC	TCGA-AX-A2HH	Stage IA	No	0	NA	1988	NA	Endometrium	21924	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	R1	primary	f32ae4a0-f573-5a9b-b3dc-97ac5ff847e5	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	60	-21924	NA	5155c521-35ee-5ea9-be34-9912fa0d736b	FALSE	NA	United States	NA	540	WT-With Tumor	NA;Adjuvant	306e9643-c8a3-464a-8768-a8f1c5d14e4d;b7522251-1f1c-5103-ac45-92e2008a62a9	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	882f8fe1-9985-451a-a872-a3605f135115	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A2HH
TCGA-UCEC	TCGA-B5-A5OD	Stage IIIC	No	0	NA	2009	NA	Endometrium	24775	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	NA	NA	8441/3	NA	primary	396a29cc-f50f-56bd-85ee-8fbb80e73e3c	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not reported	Alive	67	-24775	NA	8a10febd-d599-50a1-a42c-6dee0e428a6a	FALSE	NA	United States	NA	1038	TF-Tumor Free	NA	8e307e6d-c30c-4ffd-a840-f9c86ee48c68	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	89c32f7a-7690-546f-b303-d1a69c53ad64	Radiation, External Beam	NA	yes	NA	NA	NA	161	NA	133	NA	4500	NA	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-B5-A5OD
TCGA-UCEC	TCGA-BG-A0MC	Stage IA	No	0	NA	1988	NA	Endometrium	27136	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Surgical Resection	NA	8380/3	R0	primary	6489843e-939f-5f39-badf-ccab378a3ad6	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	74	-27136	NA	42b3c01b-def5-5cb2-be54-586665f83089	FALSE	NA	NA	NA	1263	TF-Tumor Free	Adjuvant;NA	6d91b950-ac08-5e7e-95f1-27820d5c7083;e18e032e-7392-4645-9d7f-79b1d45b00e1	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	3d37c5e3-2f23-427f-b596-9c021f2af53f	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BG-A0MC
TCGA-UCEC	TCGA-D1-A3DG	Stage IVB	No	0	NA	2009	NA	Endometrium	29771	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Excisional Biopsy	NA	8380/3	R0	primary	0f8d3a22-1d15-53f5-980b-63ebe2380b58	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	81	-29771	NA	4e318d3b-5faf-5302-b744-2aaf8d6fb33b	FALSE	NA	United States	130	130	Unknown	NA;Adjuvant	85580ec7-7056-4f71-9c38-cbdf7eb69955;b17f86ce-7b1c-5122-9bbb-c8055aba484e	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	099e7b17-9829-4cbc-9763-b6152e79faf1	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A3DG
TCGA-UCEC	TCGA-B5-A0K3	Stage IA	No	0	NA	2009	NA	Endometrium	22664	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	cccb49d5-f5a6-516f-aa16-e4095ee4c579	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not reported	Dead	62	-22664	NA	8827821d-7097-5450-b0fb-239fd48ffac4	FALSE	NA	United States	830	830	WT-With Tumor	NA	2f1cee4d-a413-4bbd-b6df-9df52debc976	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	9f775ca6-4123-4db2-ae53-bd7033d2cca1	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A0K3
TCGA-UCEC	TCGA-EY-A1GO	Stage IIIC1	No	0	NA	2009	NA	Endometrium	23853	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Surgical Resection	NA	8380/3	R0	primary	75a373fb-25bb-52a0-b7c5-a59f7de4a641	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	65	-23853	NA	bffaa34a-37f1-5822-ab31-7d17a1aca9e4	FALSE	NA	United States	NA	586	WT-With Tumor	NA	fd61bd40-a28e-4012-a32f-cf2a985dac36	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	09edf792-7a33-4311-bbda-6251f43ff835;0a16c6e7-7620-4b0b-8199-8a89f818033b;1bf9e4d5-faeb-5ff7-8742-47defac8fd1c	Radiation, External Beam	NA	yes	NA	NA	NA	150;159;154	NA	109;157;152	1	3960;540	NA;3	Primary Tumor Field;Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-EY-A1GO
TCGA-UCEC	TCGA-EO-A3L0	Stage IA	No	0	NA	2009	NA	Endometrium	28003	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	08eb6f0f-476b-5808-81b4-ccfa2541d5bd	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	76	-28003	NA	12fbd795-9cb8-5b5b-9c91-533a3df57bfc	FALSE	NA	Canada	NA	1554	TF-Tumor Free	NA;Adjuvant	532fc5c8-f2ec-4020-a671-6dabcf7f099c;c8e2b320-f3b4-4f12-abab-ac7431a639ed	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	fccef7e2-d697-541a-91fc-4807fca8bf5e	Radiation, Internal	NA	yes	NA	NA	NA	206	NA	202	NA	21	NA	Primary Tumor Field	Gy	NA	NULL	NA	NA	NA	TCGA-EO-A3L0
TCGA-UCEC	TCGA-D1-A16D	Stage IC	No	0	NA	1995	NA	Endometrium	17933	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	RX	primary	f7f506c6-1101-55e6-b065-dd8d8b34b67c	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	49	-17933	NA	202ea12b-b0a4-5b04-be06-d9780a653387	FALSE	NA	NA	NA	1141	TF-Tumor Free	NA	abf01aa5-0ae9-4549-9fd8-e1ffc734b37c	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	f54eb415-176d-555a-b62f-b00ccdd0d020	Radiation, Implants	NA	yes	NA	NA	NA	104	NA	96	1	2100	3	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-D1-A16D
TCGA-UCEC	TCGA-AJ-A3EJ	Stage IIIC2	No	0	NA	2009	NA	Endometrium	27317	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	72e5ad38-31a5-51bb-9c1e-f7ed34b91622	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	74	-27317	NA	651551b6-fc50-57b2-9072-7cb246435efc	FALSE	NA	United States	50	50	WT-With Tumor	Adjuvant;NA	8674bbae-61f4-5e98-a29c-ce0ef3e9f93f;902d44b9-c91c-4cc9-9368-a273c21bd318	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	4fc9b051-0eec-484e-8ae1-576d944bc8d6	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AJ-A3EJ
TCGA-UCEC	TCGA-EO-A22T	Stage II	No	0	NA	2009	NA	Endometrium	20608	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	ac541daa-1255-51ea-add1-8b6374d98e66	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	asian	female	not hispanic or latino	Alive	56	-20608	NA	255807e2-d413-5f0e-8244-0047a41ee5fe	FALSE	NA	Canada	NA	2035	TF-Tumor Free	Adjuvant;NA	841aa6c1-309c-41b4-9e16-7c3f995af9a6;dc843ffe-fde3-48d8-a6a8-85ce4ee7fbd4	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	fb692730-85bf-5ac6-ad3e-318b0eb96063	Radiation, External Beam	NA	yes	NA	NA	NA	102	NA	66	NA	4500	25	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-EO-A22T
TCGA-UCEC	TCGA-B5-A0K1	Stage IA	No	0	NA	1988	NA	Endometrium	25291	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	442389b3-5644-5d77-b051-326272c14d85	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	69	-25291	NA	3eb25b7a-aeb5-5adc-b873-2ff37b59675f	FALSE	NA	United States	NA	1110	TF-Tumor Free	NA;Adjuvant	5343cb59-139a-4d9e-88a8-173f03500f9a;7de3abe3-f926-51d2-a411-a8730af5d70c	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	96109e32-f0b0-4dd4-b50d-9453f6526818	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A0K1
TCGA-UCEC	TCGA-D1-A165	Stage IIIA	No	0	NA	1995	NA	Endometrium	23526	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	faceeab7-76af-541e-a04d-6cfdbfa8b23f	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	64	-23526	NA	23755925-6968-50a9-b660-040e517fa61c	FALSE	NA	NA	NA	20	TF-Tumor Free	NA;Adjuvant	1c9d5deb-575f-40d7-af92-0d9d5bfc4a1e;302c56de-3836-5d29-9e73-f4532f4af26d	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	578dc5f2-a8a1-43bc-be4e-c27c1d146282	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A165
TCGA-UCEC	TCGA-A5-A0GP	Stage IA	No	0	NA	NA	NA	Endometrium	21365	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2007	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	d22e87fc-a446-5e6f-8544-18705a43a8e7	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	asian	female	not hispanic or latino	Alive	58	-21365	NA	15dac957-20b9-50f8-8f86-a1d216f696d3	FALSE	NA	NA	NA	1416	TF-Tumor Free	Adjuvant;NA	2682baa7-0d1d-5ec3-94ba-6653052f3a15;ce238d3a-8cf6-4e71-ae5f-6f1d85500989	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	6a696ac8-591d-451f-995a-d311ad32ad61	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-A5-A0GP
TCGA-UCEC	TCGA-AP-A0LN	Stage IA	No	0	NA	NA	NA	Endometrium	20704	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2005	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	91604168-6c6c-50c3-bc78-d7ce70798015	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not reported	Alive	56	-20704	NA	92af23e2-41c0-5f21-ad67-cd16091385df	FALSE	NA	NA	NA	2510	TF-Tumor Free	NA;Adjuvant	4c9929fe-d58f-4e05-b236-27c6059dc908;a1d28366-9d31-5e08-9b5a-b862b2421b63	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	2ed76389-6ac4-4a1e-9473-8f95bc118f86	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AP-A0LN
TCGA-UCEC	TCGA-D1-A17M	Stage II	No	0	NA	2009	NA	Endometrium	20685	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	20b0d629-74ae-5329-b423-57586cbea3b1	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	56	-20685	NA	196b8cc4-bb1e-5790-9ba1-218e0a0309a2	FALSE	NA	NA	NA	311	TF-Tumor Free	Adjuvant;NA	70c9e091-f227-4d38-a8cb-7936597bb296;f55c6f2f-6d7b-4675-b9d4-1c26b6dd8f10	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	c76664c7-f9f7-5ddc-b6c1-509eac7499a1	Radiation, Implants	NA	yes	NA	NA	NA	90	NA	84	1	1989	3	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-D1-A17M
TCGA-UCEC	TCGA-B5-A11I	Stage IVB	No	0	NA	1988	NA	Endometrium	23857	Adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2005	released	No	TRUE	NA	Biopsy	NA	8140/3	NA	primary	0a88bce6-1fc7-5b47-b586-c3f60a39ed68	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not reported	Alive	65	-23857	NA	bbb417a3-02c2-56b4-b115-92346aa6216f	FALSE	NA	United States	NA	2303	TF-Tumor Free	NA	593ddd1d-6313-43a6-8b48-4c9c3213e2ae	Pharmaceutical Therapy, NOS	Tamoxifen	yes	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant;Palliative	1e269e8b-584c-5dbe-ad4d-2c5b8358bd59;a655a289-98bb-470c-9084-80f00b78da2b	Radiation, External Beam	NA	yes	NA	NA	NA	186;1993	NA	151;1967	1;2	4500	25;19	Primary Tumor Field;Distant Site	cGy	NA	NULL	NA	NA	NA	TCGA-B5-A11I
TCGA-UCEC	TCGA-BK-A13C	Stage IB	No	0	NA	NA	NA	Endometrium	17317	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	609011ba-d2fd-5a6c-a353-3959ab108622	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	47	-17317	NA	51289bbf-8cc2-5022-bfdd-b1377b17ce22	FALSE	NA	NA	NA	760	TF-Tumor Free	Adjuvant;NA	ae363043-0668-5e9f-82b7-125cf2d2d6cc;ddd3629c-b53a-446c-8679-e6bf57ad0ada	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	1c52221e-7739-4e52-8fb7-df541831c3e8	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BK-A13C
TCGA-UCEC	TCGA-BG-A0MQ	Stage IA	No	0	NA	1988	NA	Endometrium	26284	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	2435de46-4c58-55df-94eb-1e49bf074da5	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	71	-26284	NA	1cfbb428-8eb0-51c0-ab30-92967445c79e	FALSE	NA	NA	NA	1817	NA	Adjuvant;NA	85eb8154-5e49-5f0d-84fd-c80b6ee653b1;b0306134-394f-44be-9ff0-85d3b9b144fe	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	9a1e8833-1914-46fb-886e-b17b65ae3a7b	Radiation Therapy, NOS	NA	yes	NA	NA	Stable Disease	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BG-A0MQ
TCGA-UCEC	TCGA-KP-A3W3	Stage IB	No	0	NA	2009	NA	Endometrium	26310	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	5bb79aec-bb1a-5619-a006-0cf8edcb82f4	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	72	-26310	NA	2e5d8b2d-f3a4-5ebd-a612-2fd511f12455	FALSE	NA	Canada	NA	794	WT-With Tumor	NA;Adjuvant	a7ff2379-16fd-496f-9e3c-6a52167e3c05;f68f37cc-4f05-5ca2-b716-52f6a66f169a	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no;yes	NA	Prior to Diagnosis;NA	NA;Complete Response	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	3e16d62d-fabc-477f-a621-42200c37391c	Radiation Therapy, NOS	NA	yes	NA	NA	Complete Response	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-KP-A3W3
TCGA-UCEC	TCGA-AX-A05S	Stage IIIC	No	0	NA	1988	NA	Endometrium	29928	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	R2	primary	40d99eb2-715c-55b0-a86d-61e61cb4232d	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	81	-29928	NA	6fcf1e15-6b38-500f-9d76-b481914a30cb	FALSE	NA	United States	413	413	WT-With Tumor	NA	0f364078-33b0-4590-9600-6465c057d919	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	66071faf-6cc8-5867-9e12-8dac95934630	Radiation Therapy, NOS	NA	yes	NA	NA	NA	NA	NA	NA	1	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A05S
TCGA-UCEC	TCGA-B5-A0JZ	Stage IIIC1	No	0	NA	1988	NA	Endometrium	22106	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	NA	primary	8cc6e20a-f170-5433-bbca-2537c70c226f	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	60	-22106	NA	3fccce6d-e7af-5ff7-9246-31b7c387040d	FALSE	NA	United States	NA	2173	TF-Tumor Free	NA	e5f37ba8-62d4-4121-9ca0-de1215afc848	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA;Adjuvant	52942e59-628b-5748-a05a-4cbe3aea5d2b;a15a261e-5342-4dcb-9e02-3ef55ab38876	Radiation, External Beam	NA	yes	Recurrent Disease;NA	NA	NA	424;124	NA	390;76	2;1	4500;5400	25	Locoregional Site;Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-B5-A0JZ
TCGA-UCEC	TCGA-AJ-A3BD	Stage IIIC2	No	0	NA	2009	NA	Endometrium	20998	Papillary serous cystadenocarcinoma	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8460/3	R0	primary	a1b1c6cb-6499-5b68-a141-e465b688c84f	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	57	-20998	NA	8c2d24f1-cb1d-5b13-84a0-dcccefd1655c	FALSE	NA	United States	NA	1039	TF-Tumor Free	NA	e75033b6-233f-4825-92bc-f1557de2a2bc	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	0f11beca-c742-5020-8e34-25c01a756d48;a084ed9e-5525-49ff-9af5-d1d9916b26b6	Radiation, External Beam;Radiation, Internal	NA	yes	NA	NA	Complete Response	156;186	NA	118;168	NA	5040;NA	28;NA	Primary Tumor Field	cGy;NA	NA	NULL	NA	NA	NA	TCGA-AJ-A3BD
TCGA-UCEC	TCGA-EY-A1GM	Stage IIIA	No	0	NA	2009	NA	Endometrium	22010	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	77eb7ced-0eb8-5255-9645-643a4fed5f93	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not reported	Dead	60	-22010	NA	ab1d9537-bbcc-55e7-8d2b-f3582eced474	FALSE	NA	United States	995	995	WT-With Tumor	NA	47878de5-7c9d-4204-91d5-84c0d8b37267;6716e522-44dd-44d8-95f9-21d154dae232	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA;Recurrent Disease	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA;Adjuvant	36a0d334-835d-4e4a-8603-977774571316;d09fd283-6049-41d3-954b-dda8fa4cb902	Radiation Therapy, NOS	NA	no	Recurrent Disease;NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-EY-A1GM
TCGA-UCEC	TCGA-AX-A2IN	Stage IC	No	0	NA	1988	NA	Endometrium	23275	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2007	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	101ca4ed-726d-5b08-9e58-34d3a6cd9d81	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Dead	63	-23275	NA	3c71ccb1-7bdf-5b48-9bbf-b4dfe7809100	FALSE	NA	United States	947	947	NA	Adjuvant;NA	956c3431-53e9-46da-8b6d-f0d3295df9aa;c75cf0e5-eca5-4e6b-9f4e-d756f5e735f9	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	afb31d48-c65b-5ff7-8d73-ee08eb562d16	Radiation Therapy, NOS	NA	yes	NA	NA	NA	605	NA	288	NA	NA	NA	Distant Site	NA	NA	NULL	NA	NA	NA	TCGA-AX-A2IN
TCGA-UCEC	TCGA-A5-A0VP	Stage IA	No	0	NA	NA	NA	Endometrium	27335	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	956c0fb2-eb4d-52ce-9e44-b01eaab459fb	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	74	-27335	NA	ad5dab9e-da95-57a2-aee7-1d0708b16f05	FALSE	NA	NA	NA	1288	TF-Tumor Free	NA;Adjuvant	3c45b43b-f185-4a16-ae9e-1c63440efd86;540bd89e-956f-4d78-a972-eaa1c10ad3bb	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	a3666392-744d-5d18-800e-443e3171d222	Radiation, External Beam	NA	yes	NA	NA	NA	876	NA	840	1	4500	25	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-A5-A0VP
TCGA-UCEC	TCGA-EO-A2CG	Stage IA	No	0	NA	2009	NA	Endometrium	25279	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	8f4ffe4f-967f-5d0a-876b-1bc00c13b80d	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	asian	female	not hispanic or latino	Alive	69	-25279	NA	07c36ef4-9831-5e46-a1af-0458dd1703c6	FALSE	NA	Canada	NA	1564	TF-Tumor Free	NA	981f2468-27f5-42f7-a543-89cc3fda05dc	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	1488e994-e459-5daf-ba2e-e37bba5831c0	Radiation, External Beam	NA	yes	NA	NA	Complete Response	319	NA	285	NA	NA	25	Primary Tumor Field	NA	NA	NULL	NA	NA	NA	TCGA-EO-A2CG
TCGA-UCEC	TCGA-D1-A16N	Stage IIIA	No	0	NA	1995	NA	Endometrium	18787	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	5fd69136-43be-59b2-8e31-a625adbfba40	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	51	-18787	NA	f0036ae7-4205-5040-8e3e-a693f85e34ec	FALSE	NA	NA	NA	945	TF-Tumor Free	NA	5ba00217-f036-4456-ba2d-b1030ed78ec5	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	b957ae85-6a97-54ff-85af-bf337f8f225f	Radiation, Implants	NA	yes	NA	NA	NA	52	NA	46	1	2100	3	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-D1-A16N
TCGA-UCEC	TCGA-D1-A2G7	Stage IB	No	0	NA	1995	NA	Endometrium	23913	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2007	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	37e5cf6e-ef1e-500e-8588-bbba65048663	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	65	-23913	NA	7a1a5571-514e-589e-afbb-0c731011e50c	FALSE	NA	United States	1793	1793	Unknown	Adjuvant;NA	96f6d679-6203-54a2-9a1e-b4162d4516ac;9acc0fce-6df0-483e-aba0-b5af49e4f709	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	b9db1b16-70fd-4837-aea9-cfb1609c53df	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A2G7
TCGA-UCEC	TCGA-AX-A05Z	Stage IIIA	No	0	NA	1988	NA	Endometrium	13529	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2006	released	No	TRUE	NA	Biopsy	NA	8380/3	R1	primary	ac0b991f-ff86-5331-a54d-5a8367993517	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	not reported	female	hispanic or latino	Alive	37	-13529	NA	8a10a03b-4e16-529a-9ea8-d36aa532aad9	FALSE	NA	NA	NA	2175	TF-Tumor Free	NA	6e43df82-7344-4336-bb0e-305e7e3dbc61	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	5bc6561b-d703-4a30-89bd-191608ed33a8	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A05Z
TCGA-UCEC	TCGA-D1-A0ZV	Stage IB	No	0	NA	NA	NA	Endometrium	21374	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	54abed21-c1a1-55fb-95a4-1018adbd0293	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	58	-21374	NA	c172bc97-df3f-59ab-b64c-63529d29ba3d	FALSE	NA	NA	NA	728	TF-Tumor Free	NA;Adjuvant	68ff31f4-a35b-484e-8f23-4137780f328f;9847d6e2-f1f8-5c53-a200-8ea26e33ecf5	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	c2e4d906-d986-4a73-941c-59b344123484	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A0ZV
TCGA-UCEC	TCGA-EO-A1Y7	Stage IB	No	0	NA	2009	NA	Endometrium	24085	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	9120f880-1056-59e1-9717-b0e2a63d5702	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	not reported	female	not reported	Alive	65	-24085	NA	4197c40d-f4d9-5603-8712-f15525e88cf4	FALSE	NA	Canada	NA	1495	NA	NA	7d3a6183-b0ee-47b8-9206-295ed61053f5;9583cc77-a2f3-4769-bdd4-ff26030f435a	Pharmaceutical Therapy, NOS	Tamoxifen;NA	unknown;yes	NA;Progressive Disease	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	43e17df0-a242-5798-bda2-2e6444e243d4	Radiation Therapy, NOS	NA	yes	NA	NA	Progressive Disease	155	NA	117	NA	49	27	Primary Tumor Field	Gy	NA	NULL	NA	NA	NA	TCGA-EO-A1Y7
TCGA-UCEC	TCGA-AX-A1CE	Stage IB	No	0	NA	1988	NA	Endometrium	21969	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Surgical Resection	NA	8380/3	R0	primary	7460dd75-3445-5805-b2f8-d49dcdcca843	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	60	-21969	NA	5bdd67ed-7c28-56a7-84b4-89f703283c5c	FALSE	NA	NA	NA	1037	TF-Tumor Free	NA	cfbeb99d-64fc-4c05-bd95-4c55a220f2a7	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	25afc6f3-e19c-5de7-87c6-6cf7db53f79a	Radiation, Implants	NA	yes	NA	NA	NA	NA	NA	35	1	NA	NA	Primary Tumor Field	NA	NA	NULL	NA	NA	NA	TCGA-AX-A1CE
TCGA-UCEC	TCGA-B5-A11P	Stage IB	Not Reported	0	NA	1988	NA	Endometrium	32047	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	not reported	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	33bb6f27-9eb6-5d4f-a83f-e3c89193ad47	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	87	-32047	NA	55b042ff-89d8-5610-8f99-d3f469e6edd4	TRUE	NA	NA	NA	825	TF-Tumor Free	NA;Adjuvant	0122457e-8021-4de3-aadf-b8a1bab76b49;0ab65933-70af-536b-8007-a1b053b63419	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	b39efa2b-46da-43da-8934-3633bbfb832f	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A11P
TCGA-UCEC	TCGA-EY-A3QX	Stage IVB	No	0	NA	2009	NA	Endometrium	23663	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	848350aa-eb1a-54e2-9b71-f9584248ad9d	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	64	-23663	NA	02f9c51a-865f-5292-9165-f7d4c7de2cd1	FALSE	NA	United States	989	989	NA	NA	8b6195f0-b09d-42cb-9488-d9f3cb08270e;b9869d1e-7316-4c3e-a736-b12a0b71ea51	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;yes	NA;Recurrent Disease	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA;Adjuvant	2e541598-6fb2-4a59-b80f-a015a4548f6d;e909c808-96d6-493f-ae05-36ef4454eafe	Radiation Therapy, NOS	NA	no	Recurrent Disease;NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-EY-A3QX
TCGA-UCEC	TCGA-AX-A0J0	Stage IB	No	0	NA	1988	NA	Endometrium	17466	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2006	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	316a64b1-581c-573b-95c0-487c977868d8	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	47	-17466	NA	0740835f-f4ed-5dc5-8ff0-d9df87dbd640	FALSE	NA	NA	NA	1220	TF-Tumor Free	Adjuvant;NA	3b53d30b-df55-5124-bb8e-b2b07424b9df;496f6c2c-402a-4313-bc7e-b4100d8e9a40	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	f412bd9b-679a-435b-b958-d5376314748a	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A0J0
TCGA-UCEC	TCGA-FI-A3PX	Stage IIIC2	No	0	NA	2009	NA	Endometrium	21063	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8441/3	R0	primary	e041e648-069c-5ebb-a0a2-d4c311ae000d	C54.1	Endometrium	High Grade	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	57	-21063	NA	42272efd-0292-5bdf-b4cc-8a767f9dfc7f	FALSE	NA	United States	NA	2384	TF-Tumor Free	NA;Adjuvant	0d1a40b1-5668-4c8c-be6e-e8506f30d0d4;90a0fd69-2c28-5d6c-bf20-9ff6caa18cf1	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	be7de360-9cef-4d79-a887-08335817a93c	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-FI-A3PX
TCGA-UCEC	TCGA-DI-A1NN	Stage IIIC	No	0	NA	1988	NA	Endometrium	23026	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	3747482b-b1d6-5c36-9a94-1ab52a2ab851	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	63	-23026	NA	603ef2c1-6a1b-5889-926a-2cb5e9eaaba8	FALSE	NA	United States	NA	1076	WT-With Tumor	NA	f1f350a7-32d2-4127-9502-6fb61f9ba353	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	ae8883d7-b919-46dd-95a9-5bc2f4e3ad2c	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-DI-A1NN
TCGA-UCEC	TCGA-AJ-A3TW	Stage IB	No	0	NA	2009	NA	Endometrium	28559	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2012	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	2c526212-4581-593b-b288-6315a6fdab8f	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	78	-28559	NA	561d660f-959e-5ee1-8989-14eebe9c71a9	FALSE	NA	United States	NA	513	TF-Tumor Free	Adjuvant;NA	b642aaf8-dd56-434c-a93f-26ffe1b4f5f4;bd0b093b-c0f8-4c31-8e28-c7b554458330	Pharmaceutical Therapy, NOS	NA;Tamoxifen	unknown	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	23229ee4-af8d-5d34-8678-19aeb85322f8	Radiation, External Beam	NA	yes	NA	NA	Complete Response	143	NA	93	NA	5040	28	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-AJ-A3TW
TCGA-UCEC	TCGA-BG-A2AE	Stage IB	No	0	NA	2009	NA	Endometrium	21069	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8441/3	NA	primary	68451be9-1a15-568b-a1b9-2cc9f3b4009d	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	57	-21069	NA	8f20f1ea-97c6-5bcf-8305-b4b7451de028	FALSE	NA	United States	NA	721	TF-Tumor Free	NA	3ecdb80b-91ab-4b1b-9e92-5496e707cb8f	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	ce1d2823-37fe-5088-8103-677f5225b794	Radiation, External Beam	NA	yes	NA	NA	Complete Response	273	NA	230	NA	4500	NA	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-BG-A2AE
TCGA-UCEC	TCGA-KP-A3W1	Stage IA	No	0	NA	2009	NA	Endometrium	27902	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8441/3	R0	primary	08dc5ad6-6bd9-5771-b249-46fa848dc1e8	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	not reported	female	not reported	Alive	76	-27902	NA	877f9a19-9723-5331-bde9-2b6313f89de2	FALSE	NA	Canada	NA	288	TF-Tumor Free	NA;Adjuvant	88aba140-d725-4a62-96f9-4e15fb727f33;99fd35f6-5cc5-5425-baf3-1c742b048649	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no;yes	NA	Prior to Diagnosis;NA	NA;Complete Response	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	da9f7378-4648-470a-b194-6e58ef7d59d4	Radiation Therapy, NOS	NA	yes	NA	NA	Complete Response	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-KP-A3W1
TCGA-UCEC	TCGA-D1-A1O8	Stage IIIC	No	0	NA	2009	NA	Endometrium	25789	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	161cef11-d172-5366-9b02-fd2be1a2bb60	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	70	-25789	NA	2e3c3f4c-ceef-53e4-b6b8-a078693197c6	FALSE	NA	United States	120	120	TF-Tumor Free	Adjuvant;NA	17f36da0-2cc8-5370-a870-ad3811c808c7;f01ef606-bb9b-478e-9d69-51acfe96ebe9	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	71171f09-f938-4e3f-9341-715382ada73e	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A1O8
TCGA-UCEC	TCGA-D1-A16R	Stage IA	No	0	NA	2009	NA	Endometrium	14465	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	267a5524-e18d-51ad-a054-5e2ae97eb8c2	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	39	-14465	NA	f9768205-d7e5-5d5e-bf59-37e064d73669	FALSE	NA	NA	NA	21	TF-Tumor Free	Adjuvant;NA	354197a5-3d09-509d-ae82-ba787b2a26be;ade9fc53-0e0e-4173-9d5c-b5cd4e9c2eb1	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	b194dbc7-4eea-46fc-8277-a8d7ed045799	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A16R
TCGA-UCEC	TCGA-D1-A162	Stage IB	No	0	NA	1995	NA	Endometrium	25543	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	02aed327-1439-5bbf-b166-8638931a8e41	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	69	-25543	NA	a9871d31-b21f-58cf-99c9-c43961029a80	FALSE	NA	NA	NA	1145	TF-Tumor Free	Adjuvant;NA	3c3c641d-bca9-52cd-8ce6-a091443e8692;b8a2d0dc-1b58-4aa0-826e-c35008a58b99	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	88d00272-1fd7-427c-80fd-37fad74dcfec	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A162
TCGA-UCEC	TCGA-AX-A1CJ	Stage IC	No	0	NA	1988	NA	Endometrium	21655	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2006	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	9255f42f-4135-576d-a2eb-8e25a8a9263d	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	59	-21655	NA	dde39d8c-7e4a-5965-852b-cd6904b2e99e	FALSE	NA	NA	NA	2233	NA	Adjuvant;NA	5b990b38-acb4-4099-98d1-fdf09433bd86;ca1b547c-53f9-417f-9a35-f633ee548342	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	f2e18f7d-746c-54ee-ba50-e6d17e039c4b	Radiation, Implants	NA	yes	NA	NA	NA	110	NA	97	1	NA	3	Primary Tumor Field	NA	NA	NULL	NA	NA	NA	TCGA-AX-A1CJ
TCGA-UCEC	TCGA-DI-A2QY	Stage IIB	No	0	NA	1988	NA	Endometrium	23398	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2003	released	No	TRUE	NA	Pap Smear	NA	8441/3	RX	primary	16ba3979-eeba-5a99-a3e4-50daa96f30cd	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	64	-23398	NA	1bf3a85e-3bba-5f86-bdac-e4b82c02dbf6	FALSE	NA	United States	3349	3349	TF-Tumor Free	NA	3c266b87-3d1c-4c43-a125-577decc74cdf	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	80c89912-4642-58ff-9420-bcf75d9bb5a7	Radiation, External Beam	NA	yes	NA	NA	Complete Response	129	NA	88	NA	4500	25	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-DI-A2QY
TCGA-UCEC	TCGA-A5-A0GR	Stage IA	No	0	NA	NA	NA	Endometrium	25353	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	4a331b84-3e37-57fc-b8ba-74480f256522	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	69	-25353	NA	4507d83f-2738-5679-abb2-92367a2ac213	FALSE	NA	NA	NA	1120	TF-Tumor Free	Adjuvant;NA	302c22c2-e905-5abb-8d21-80b12d60607c;9d64c9e2-e3b3-49cc-b36b-8b02a97f2025	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;yes	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	360badc5-aafe-49cf-8c3f-a9910332a84c	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-A5-A0GR
TCGA-UCEC	TCGA-BK-A13B	Stage IB	No	0	NA	2009	NA	Endometrium	21493	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	6f7ffb2b-4f22-5c27-ab1c-9d85a9f94254	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	58	-21493	NA	92a5ea75-6ced-568e-928f-d1aef0646988	FALSE	NA	NA	NA	966	WT-With Tumor	NA;Adjuvant	183476c6-0d2d-4d9c-b97c-38bcc8bd4e24;4f6814a8-284c-4b30-8f0f-3de34cdfab3e;512ab871-f396-4a94-bf3e-17246b81433c	Pharmaceutical Therapy, NOS	NA;Tamoxifen	yes;no	Recurrent Disease;NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant;NA	14aba66d-c795-4d56-9a55-dcaa39eb851e;2b1a486b-d81a-5f2c-9f3a-8171782e237b;b4dd585a-37ce-4c09-b0f0-c36132896b0a	Radiation, External Beam;Radiation, Implants;Radiation Therapy, NOS	NA	yes;no	NA;Recurrent Disease	NA	NA	125;145;NA	NA	91;131;NA	1;2;NA	4500;1200;NA	25;2;NA	Primary Tumor Field;NULL	cGy;NA	NA	NULL	NA	NA	NA	TCGA-BK-A13B
TCGA-UCEC	TCGA-A5-A2K7	Stage II	No	0	NA	2009	NA	Endometrium	14980	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	9eb35cf2-e1d7-5a6c-abdd-5f04c5a7b1dd	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	not reported	female	hispanic or latino	Alive	41	-14980	NA	0dc5ba75-646a-5fac-be58-86ae178ea9a3	FALSE	NA	United States	NA	1063	TF-Tumor Free	NA	a004e2fc-65b8-4cae-806d-60ea070fcf4b	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	25d41f28-b73e-50dc-aa15-c234be932e6d	Radiation, Implants	NA	yes	NA	NA	NA	91	NA	75	1	2100	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-A5-A2K7
TCGA-UCEC	TCGA-A5-A0VO	Stage IB	No	0	NA	2009	NA	Endometrium	23547	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	2c7303ce-f4f8-5671-9283-42959b0788c2	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	64	-23547	NA	123d4916-d5a9-5a00-9e89-34b4acda61e5	FALSE	NA	NA	875	875	TF-Tumor Free	NA;Adjuvant	57102eb4-be8b-453c-bcf8-d4df284623c4;9cf4cd1d-a95f-4454-86fc-cf7df3d57156	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	1c203ba4-a944-5a35-8f30-275b1d3abe76	Radiation, External Beam	NA	yes	NA	NA	NA	128	NA	90	1	5040	28	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-A5-A0VO
TCGA-UCEC	TCGA-AJ-A4ZG	Stage IVB	No	0	NA	2009	NA	Endometrium	19492	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2012	released	No	TRUE	NA	Cytology	NA	8441/3	RX	primary	3cf4583c-1b81-5798-b7a9-b17dc0ab6862	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	53	-19492	NA	bb65e3c6-0979-5f98-a76c-dc2b773cc795	FALSE	NA	United States	NA	498	TF-Tumor Free	NA	278acd0f-7c44-4d3b-8a3b-f496727882e4	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	4fee8fba-8343-5a1d-8cdc-6b40cfc89551	Radiation, Internal	NA	yes	NA	NA	Complete Response	70	NA	51	NA	NA	NA	Primary Tumor Field	NA	NA	NULL	NA	NA	NA	TCGA-AJ-A4ZG
TCGA-UCEC	TCGA-B5-A11G	Stage IA	No	0	NA	1988	NA	Endometrium	25995	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2001	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	69dd2f41-a209-50cc-88a1-5baa38da839e	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not reported	Alive	71	-25995	NA	f42df73b-0462-5a66-b2da-39969fa1bcb0	FALSE	NA	United States	NA	3448	TF-Tumor Free	NA;Adjuvant	245d5102-c0d7-4776-8ef7-5f19e25124e7;3c9f4783-73f1-5b34-abbd-878387de2a34	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	4740708f-0b06-45dd-92c9-f2625ab674d9	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A11G
TCGA-UCEC	TCGA-4E-A92E	Stage I	No	0	NA	2009	NA	Endometrium	19818	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2013	released	No	TRUE	NA	Surgical Resection	NA	8380/3	R0	primary	2db9e566-967e-5b4b-8b14-9ecb2d7ee2ab	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	54	-19818	NA	0599478f-7f76-560c-a1c0-93972e0d41da	FALSE	NA	United States	NA	13	TF-Tumor Free	Adjuvant;NA	05b9fb1e-52f1-5acd-9b36-559e012d02de;0fa299bc-1a68-47d5-85a5-a6567cc04088	Pharmaceutical Therapy, NOS	NA;Tamoxifen	unknown;no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	bd566a73-dd2a-40fb-9b34-e361b37f922b	Radiation Therapy, NOS	NA	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-4E-A92E
TCGA-UCEC	TCGA-5B-A90C	Stage IA	No	0	NA	2009	NA	Endometrium	25518	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	db9169d0-b9bd-544f-990f-924e37e052ae	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	69	-25518	NA	554b34de-9690-5845-a36e-4302ca06a99b	FALSE	NA	United States	NA	1202	TF-Tumor Free	NA	df022e00-bbd5-41ea-bfd0-9885a477faea	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	d263a3e8-8229-540b-a6fa-44d003157433	Radiation, Internal	NA	yes	NA	NA	NA	82	NA	67	NA	6000	5	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-5B-A90C
TCGA-UCEC	TCGA-EY-A548	Stage IA	No	0	NA	NA	NA	Endometrium	30544	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2012	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	8f6aaac5-a59d-5d94-ba34-e90593e47aec	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	83	-30544	NA	2842e7d2-131b-560d-9b81-97d97647ff8a	FALSE	NA	United States	NA	430	NA	Adjuvant;NA	777d2841-457c-5ff1-8176-3de8bc70bc8e;cb6e2ac6-cd4e-4095-9a60-fe4742b9ae11	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	d55ff8c9-66c9-4fac-b7a1-4e42307d8c3f	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-EY-A548
TCGA-UCEC	TCGA-D1-A17S	Stage IA	No	0	NA	2009	NA	Endometrium	21794	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	9aac47c0-49ae-5dc3-963a-a75f57f52e1d	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	59	-21794	NA	b85bd397-ef0d-53ff-a97e-1078fd412234	FALSE	NA	NA	NA	739	TF-Tumor Free	Adjuvant;NA	491783be-d724-5305-bb44-aa53c2d2f7cd;b7095c89-048f-4b11-868b-0b7737dd4202	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	22162947-035f-4f0e-9d23-03f7cd5797f2	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A17S
TCGA-UCEC	TCGA-BK-A4ZD	Stage IA	No	0	NA	2009	NA	Endometrium	15536	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2012	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	52ef00ac-cc39-502a-9e36-18076721f0be	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	42	-15536	NA	932b5f34-279f-58a1-b7ea-5ac264c68f39	FALSE	NA	United States	NA	506	TF-Tumor Free	NA;Adjuvant	2ab395cc-b9ee-490d-a154-68a27f3a9673;8b8b5ac1-2427-574c-aad5-0051111ddbf0	Pharmaceutical Therapy, NOS	Tamoxifen;NA	unknown;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	61aa3463-a070-49ab-b0e9-f5a089fbe9b0	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BK-A4ZD
TCGA-UCEC	TCGA-AX-A0J1	Stage IB	No	0	NA	1988	NA	Endometrium	29501	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2005	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	d6b774d2-1612-538f-a4b2-ffa96238483a	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	80	-29501	NA	e75c880e-40b7-5369-8760-575774b83938	FALSE	NA	NA	NA	2354	TF-Tumor Free	NA;Adjuvant	082d3e72-0ebe-405c-be0e-d266d80c7c45;46084428-8366-5730-95d0-4857216622bb	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	44759799-1c89-4196-95da-9dd1b2abe8a5	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A0J1
TCGA-UCEC	TCGA-BG-A0MK	Stage IIB	No	0	NA	1995	NA	Endometrium	19034	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2006	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	d4f3ce8c-2851-5c83-b8ab-35ab88dbe5ed	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Dead	52	-19034	NA	a4b71057-d927-5959-83ac-9a5e77c626eb	FALSE	NA	United States	1317	1317	WT-With Tumor	NA;Adjuvant	3df6d160-ceab-450e-a93e-e0f453218a37;a15d8fdc-9bbf-44e8-aea7-04b5f1b586a8	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	a73bdb4d-be63-5b60-86b5-2ae334cd5c9c;ce6c1ed8-1bcb-460e-9bfa-48bb61e79c7b	Radiation, External Beam;Radiation, Internal	NA	yes	NA	NA	Complete Response	147;158	NA	108;153	NA	50;10	28;2	Primary Tumor Field	Gy	NA	NULL	NA	NA	NA	TCGA-BG-A0MK
TCGA-UCEC	TCGA-AP-A052	Stage IVB	No	0	NA	NA	NA	Endometrium	21721	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2004	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8441/3	R2	primary	38131fdb-27ab-55c1-96eb-d8d1577b4764	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not reported	Dead	59	-21721	NA	85eec076-18a5-5b0e-a276-1c95815c60c8	FALSE	NA	NA	669	669	WT-With Tumor	NA	33baa3a1-70d3-4445-acef-6c37d4e3ceb2	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	337f288d-f855-4c49-bd9f-00ae7af0c982	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AP-A052
TCGA-UCEC	TCGA-D1-A16F	Stage IB	No	0	NA	1995	NA	Endometrium	22242	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	f14db50e-6bd3-55e2-9bc0-0a71a28eae56	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	60	-22242	NA	6ce087d0-d4e5-5568-a73d-d12df1aba4d9	FALSE	NA	NA	NA	80	TF-Tumor Free	NA;Adjuvant	1718e6a5-4e3a-404c-be80-c02ff494bacc;37a24e06-4f5f-5676-8e4f-9c28fe0910f1	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	e45fe6d1-132b-48ee-8255-3a0880d42518	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A16F
TCGA-UCEC	TCGA-AX-A1CK	Stage IB	No	0	NA	1988	NA	Endometrium	21200	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2005	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	5c32ec46-1a26-57af-ae73-42b96cd3a53d	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	58	-21200	NA	64bf5f32-7f0d-5ea2-80c1-8fc679a3de3b	FALSE	NA	NA	NA	2441	WT-With Tumor	NA	45ffc9fc-edf9-48b8-b2a9-b5da33037706	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	30195921-ad1a-4dfb-92bc-1249e4c64b9a	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A1CK
TCGA-UCEC	TCGA-EO-A22Y	Stage IA	No	0	NA	2009	NA	Endometrium	25127	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	c6501557-57ac-5799-85ec-44e4c15ae22b	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	68	-25127	NA	5e0bfc08-50a0-56fd-b8fe-6dbdde64fd2e	FALSE	NA	Canada	NA	1567	TF-Tumor Free	NA;Adjuvant	96ece418-2a93-4453-a230-524ba6a42dac;a6166219-1509-4389-b007-451c087c23ec	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	f8b5bb6c-83ad-5344-827a-dc977d0cd9d7	Radiation, Internal	NA	yes	NA	NA	Complete Response	92	NA	NA	NA	NA	NA	Primary Tumor Field	NA	NA	NULL	NA	NA	NA	TCGA-EO-A22Y
TCGA-UCEC	TCGA-B5-A1MX	Stage IB	No	0	NA	2009	NA	Endometrium	17320	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Surgical Resection	NA	8380/3	NA	primary	2c4fc6a9-529d-59ce-8ea1-4e4dadf8380c	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	47	-17320	NA	9c2b69c8-d692-58c7-aa43-f7ed2aaa6dc7	FALSE	NA	United States	NA	1473	TF-Tumor Free	NA	a2bec06b-5beb-41de-b565-abfdde9c0a02	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	e8d186bb-8b17-5f60-95ef-9caced8d79f1	Radiation, External Beam	NA	yes	NA	NA	NA	80	NA	39	1	4500	42	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-B5-A1MX
TCGA-UCEC	TCGA-AX-A1CC	Stage IC	No	0	NA	1988	NA	Endometrium	23795	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	272ec012-fe88-5946-b590-5fd2f36587aa	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	65	-23795	NA	7c2e2f5f-ce78-504d-817b-73a479cd09f9	FALSE	NA	NA	NA	788	TF-Tumor Free	NA	c40b3e88-3d70-47f3-a70d-ee8747f40940	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	d3371c82-a014-4996-9f1c-4527d9cc7450	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A1CC
TCGA-UCEC	TCGA-AX-A3FV	Stage IIIA	No	0	NA	1988	NA	Endometrium	22752	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	29e797a7-4a65-573e-b3a7-8650ffca6ed2	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	62	-22752	NA	68eeb680-0c16-5cd2-ad66-077e1551696c	FALSE	NA	United States	NA	-6	NA	Adjuvant;NA	521523e4-353b-5e8d-bf02-62daef0086d1;f92e0af4-2eef-48f7-b530-f7b2dc23c839	Pharmaceutical Therapy, NOS	NA;Tamoxifen	unknown;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	1fc26848-1390-4a3a-994b-ba1634212b68	Radiation Therapy, NOS	NA	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A3FV
TCGA-UCEC	TCGA-D1-A3DA	Stage IIIC1	No	0	NA	2009	NA	Endometrium	28142	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Excisional Biopsy	NA	8380/3	R0	primary	bd1f03ea-4e86-5ba8-9410-e1280da9b765	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	77	-28142	NA	2b099a95-8a5f-51ce-ace7-57107a9affab	FALSE	NA	United States	NA	483	TF-Tumor Free	NA	516eb4c1-a29d-40c6-b9f3-0b9e796239c8	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	541bb09b-fed2-4aba-978c-b03c241b9829	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A3DA
TCGA-UCEC	TCGA-D1-A17L	Stage IA	No	0	NA	2009	NA	Endometrium	29899	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	e3ac8e2c-44a2-5714-87e5-36a3a6ad7198	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	81	-29899	NA	aa2b17e8-1a85-503a-b7ba-7847433aafaf	FALSE	NA	NA	NA	802	TF-Tumor Free	Adjuvant;NA	a36f788d-0a58-5518-9bff-1a14b262aec1;a9812928-be54-41b0-a7cd-7c0c22ae4201	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	ae04d3dd-4f17-4a97-8d23-4af259560156	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A17L
TCGA-UCEC	TCGA-BS-A0TA	Stage IVB	No	0	NA	1988	NA	Endometrium	21505	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2005	released	No	TRUE	NA	Fine Needle Aspiration	NA	8380/3	RX	primary	fae06394-6c46-5ec5-8f41-1b53fbb65203	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	native hawaiian or other pacific islander	female	hispanic or latino	Dead	58	-21505	NA	55d1f392-d699-5dd4-9831-47cdcdf35006	FALSE	NA	NA	740	740	WT-With Tumor	NA	c5847ed0-ea73-4101-b1fe-1eb3f64dcc2b	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA;Adjuvant;Palliative	1774d85b-eab0-434f-ba17-f95c7d579bb6;96a1cf9e-f2a6-47e7-bd00-8b4e113c5672;f85e4c69-fc08-5296-a038-1a34c2b7569c	Radiation, External Beam;Radiation, Combination	NA	yes	Recurrent Disease;NA	NA	NA	423;241;613	NA	407;189;599	2;1;3	3900;6100;3000	13;29;10	Distant Site;Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-BS-A0TA
TCGA-UCEC	TCGA-AX-A05T	Stage IB	No	0	NA	1988	NA	Endometrium	30137	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	9d060ff9-8e33-5477-b0d0-9bc80e8b207a	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	82	-30137	NA	52e346ab-59e4-5cfc-97c1-ea275e8769a6	FALSE	NA	United States	NA	1010	TF-Tumor Free	Adjuvant;NA	035425d3-a234-51cb-990e-cacf2f6d8a49;8d7f50d2-6ca2-4cbd-9a66-2ef4e21e50fc	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	838ff2ae-236f-42f6-ad36-63ad6676be20	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A05T
TCGA-UCEC	TCGA-AX-A0IU	Stage IIIC	No	0	NA	1988	NA	Endometrium	29063	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	cd91da4b-9f1c-590c-9b86-ae8be6b80640	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	79	-29063	NA	337f449f-972e-5bc5-a434-fe6dfca3d407	FALSE	NA	NA	NA	1087	NA	NA	957fc7d6-53b3-48d8-a6bb-28661c900bae	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	1ba464df-9abe-4abc-aa84-b798e1a6530d	Radiation Therapy, NOS	NA	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A0IU
TCGA-UCEC	TCGA-E6-A1M0	Stage IIIC	No	0	NA	2009	NA	Endometrium	20629	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Surgical Resection	NA	8380/3	R0	primary	2613f1af-c343-5333-bf51-3cc30b0e4996	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	56	-20629	NA	11bbbb3d-ec5c-5cb7-885c-50576834f378	FALSE	NA	United States	NA	1793	TF-Tumor Free	NA	cfcfbebc-f32c-45e9-b39b-72ea3ea90169	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	094eec5b-f600-44f1-97f7-a2d57c1a1103	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-E6-A1M0
TCGA-UCEC	TCGA-AX-A3G8	Stage IA	No	0	NA	1988	NA	Endometrium	27899	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	55334364-e942-507e-a788-e01c1651b279	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	76	-27899	NA	9f6ec603-0186-5e86-bd95-3ae3fe32682b	FALSE	NA	United States	NA	36	NA	NA;Adjuvant	9dd788fa-0c05-474f-b4ef-a143401454fb;a244c19e-ccc7-5b22-a17c-57c6f4d3c426	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;unknown	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	433a4c18-dc47-4087-9165-d34e9c9653d8	Radiation Therapy, NOS	NA	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A3G8
TCGA-UCEC	TCGA-BS-A0V4	Stage IB	No	0	NA	1988	NA	Endometrium	20777	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2006	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	NA	primary	a1b6fdf1-0714-573e-9903-953ce31f660f	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	56	-20777	NA	72351cbb-af0d-50ae-b476-edbb6706eadc	FALSE	NA	NA	NA	1810	TF-Tumor Free	NA;Adjuvant	7cd4ec9c-d96a-40f5-a292-269c236f3a2b;a6b6e318-d64f-5f22-bf53-bdb8033d0902	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	3b05e45a-dcd3-41a1-97c3-deb9edef531e	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BS-A0V4
TCGA-UCEC	TCGA-DF-A2KN	Stage IC	No	NA	NA	NA	NA	Endometrium	NA	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	NA	released	No	TRUE	NA	Surgical Resection	NA	8380/3	RX	primary	f0c22945-90d0-568d-a3ab-dfed57db05fc	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	not reported	female	not reported	Alive	NA	NA	NA	9e21e02c-b227-5e1f-8ed6-c145c7713145	FALSE	NA	Canada	NA	67	TF-Tumor Free	NA;Adjuvant	7b55c21b-f711-4002-9642-3cf37a4cf3d9;bd3d7d6a-606f-5bcc-83d2-9de0d36e2971	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;unknown	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	f05270db-9a7f-4509-b01e-227a2e40cad2	Radiation Therapy, NOS	NA	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-DF-A2KN
TCGA-UCEC	TCGA-QF-A5YT	Stage II	No	0	NA	2009	NA	Isthmus uteri	20981	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	a6a42e4d-add8-57a7-8b60-f9f1f890df34	C54.0	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	57	-20981	NA	7593a65f-93eb-5143-a5a6-8e4c144e0880	FALSE	NA	United States	NA	1215	TF-Tumor Free	NA	9dc98c3c-26c4-4f30-8be3-914906479f49	Pharmaceutical Therapy, NOS	Tamoxifen	unknown	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	0610ab27-0a85-5962-817c-8c854d4d564e;547e2fdf-4ad0-4108-85e5-8bffa53bf6ec	Radiation, External Beam;Radiation, Internal	NA	yes	NA	NA	Complete Response	204;221	NA	165;214	NA	50;11	28;2	Regional Site;Primary Tumor Field	Gy	NA	NULL	NA	NA	NA	TCGA-QF-A5YT
TCGA-UCEC	TCGA-B5-A0K8	Stage IB	No	0	NA	2009	NA	Endometrium	25992	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8441/3	NA	primary	47d73528-9f12-5d55-9afb-eb467c56f0bb	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	71	-25992	NA	a44ec5e7-b90f-5892-bdaa-19fe891d1b50	FALSE	NA	United States	NA	847	TF-Tumor Free	NA	1263d98d-d595-43ed-bfa7-e28177541225	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	ce3b112d-c975-4ece-866a-2404de50e038	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A0K8
TCGA-UCEC	TCGA-EO-A1Y8	Stage IA	No	0	NA	2009	NA	Endometrium	31971	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	4a9fc05f-f6e7-5a58-8645-d028796719a1	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	not reported	female	not reported	Alive	87	-31971	NA	79264be9-ce83-5574-b4de-74e520602570	TRUE	NA	Canada	NA	901	TF-Tumor Free	Adjuvant;NA	828ab711-9d7a-52de-99da-4314be36d2d8;f13c4c37-e3be-476d-b43a-4ee839468f61	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	ac204985-2409-4610-8978-97b2a569dac2	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-EO-A1Y8
TCGA-UCEC	TCGA-B5-A3FH	Stage IA	No	0	NA	2009	NA	Endometrium	27221	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	600b71c3-44e0-59ff-b7b7-997e8563788c	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not reported	Alive	74	-27221	NA	deb86788-08c6-59ba-9c5d-5637dd170b6e	FALSE	NA	United States	NA	841	TF-Tumor Free	NA;Adjuvant	41e1d8f9-1e6a-4a88-9676-b97e32d613b3;bf84eb09-d3e2-50f8-a63c-9292ae243dee	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	f2ff487c-f9e8-49e4-a58e-fcd94c350c74	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A3FH
TCGA-UCEC	TCGA-SJ-A6ZJ	Stage IB	No	0	NA	2009	NA	Endometrium	22597	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2012	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	aa82239a-6f37-5408-9bce-46d482a3c695	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	61	-22597	NA	921580f9-9167-5eb6-86ee-2c4f16954e7c	FALSE	NA	United States	NA	556	TF-Tumor Free	Adjuvant;NA	0778ec60-560a-49f9-9fff-2c593272391f;27e5510d-a7fa-4237-a46d-6b3967b83fef	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	cdf0c22b-fcc0-5ec8-8e54-02d949cd4822	Radiation, Internal	NA	yes	NA	NA	Complete Response	212	NA	205	NA	21	3	Primary Tumor Field	Gy	NA	NULL	NA	NA	NA	TCGA-SJ-A6ZJ
TCGA-UCEC	TCGA-A5-A0R8	Stage IB	No	0	NA	NA	NA	Endometrium	29777	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	ab21d7de-ea75-54ed-9d30-65a64b56122b	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	81	-29777	NA	ee2f47ac-33f2-5a9e-8205-33f5961263b8	FALSE	NA	NA	NA	596	TF-Tumor Free	Adjuvant;NA	674f54f3-b14d-4926-b4cf-37554aab81eb;86a473b2-fdfb-402c-a7b4-fdf4cca2c047	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	5271e7b4-b7b4-5dc1-ac6d-170f56e2d9d4	Radiation, Implants	NA	yes	NA	NA	NA	100	NA	86	1	2000	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-A5-A0R8
TCGA-UCEC	TCGA-A5-A0G9	Stage IB	No	0	NA	NA	NA	Endometrium	29122	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2004	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	9efcef0b-9ec0-570a-9836-92d8c0bb01e2	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	79	-29122	NA	22ddbd13-3b49-5a2d-a251-a5cbe4b96c39	FALSE	NA	NA	NA	2540	TF-Tumor Free	Adjuvant;NA	847742d4-328a-5ade-bbb9-b37c937bb5b7;956454c2-550e-43ea-90ab-fc0aa53e302a	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	79268ed8-c985-4db4-a7f6-55b01d7186f2	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-A5-A0G9
TCGA-UCEC	TCGA-A5-A1OH	Stage IIIA	No	0	NA	2009	NA	Endometrium	31451	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	bf3d0dd5-2dd5-5d34-b02c-d776a26745ec	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	86	-31451	NA	fa79ab3e-3e6a-53f8-8f85-fe4c34052427	FALSE	NA	United States	NA	1105	TF-Tumor Free	NA	f72500e2-16cd-49bf-a85f-6349cb32016a	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	3c9754da-2a89-52e4-bf33-cd1610f9c400	Radiation, Internal	NA	yes	NA	NA	Complete Response	265	NA	251	NA	2100	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-A5-A1OH
TCGA-UCEC	TCGA-A5-AB3J	Stage II	Yes	0	NA	2009	NA	Endometrium	19020	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2013	released	No	TRUE	NA	Other	NA	8380/3	R0	primary	81c22851-9367-5247-96b9-934f8a458523	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	52	-19020	NA	a4c89303-0bac-562f-bd1a-207d4fd60680	FALSE	NA	United States	NA	512	TF-Tumor Free	NA	d582f2b9-aafc-476d-bbdf-697c1c6b78c1	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	5cffb7dc-c095-5a07-a445-89bceb62fcf2	Radiation, Internal	NA	yes	NA	NA	Complete Response	98	NA	85	NA	2100	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-A5-AB3J
TCGA-UCEC	TCGA-FI-A2EY	Stage IIIA	No	0	NA	1988	NA	Endometrium	23042	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2006	released	No	TRUE	NA	Surgical Resection	NA	8441/3	R0	primary	b7a3cfff-2bf8-5264-a606-25b3a131db3d	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	63	-23042	NA	631fe89e-04fb-56a0-ab68-80e604dfdaac	FALSE	NA	United States	880	880	TF-Tumor Free	NA	edc9a587-90a2-4530-8aa7-aac1c0732663	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	8aec5e6c-6b27-40de-818a-da1a41c5d1b3	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-FI-A2EY
TCGA-UCEC	TCGA-A5-A0GW	Stage IA	No	0	NA	NA	NA	Endometrium	17092	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	6b3d9176-5493-57f8-b6b2-0326c5e54e8e	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	asian	female	not hispanic or latino	Alive	46	-17092	NA	4b3d4da8-f22d-5391-8b1f-3dc0a47b2dcb	FALSE	NA	NA	NA	706	TF-Tumor Free	NA;Adjuvant	9868fc77-0c0e-4038-a002-f7a00297a096;c73822b4-0d86-45cc-84a1-0c64bcfd4f23	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	bcfbb83b-3ec2-572b-8f1f-83df371c1c62	Radiation, Implants	NA	yes	NA	NA	NA	120	NA	106	1	1800	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-A5-A0GW
TCGA-UCEC	TCGA-BS-A0UA	Stage IB	No	0	NA	1988	NA	Endometrium	24872	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2004	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	2f04a3a1-b00b-5cfc-87b4-d4bd9b401c23	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	68	-24872	NA	344d426f-68fd-5ffe-8808-4716cab3c3c5	FALSE	NA	NA	NA	3495	TF-Tumor Free	NA;Adjuvant	00b4f097-8c81-4e86-88a4-faddb4eb5a63;422869ff-9c07-4f13-8e2c-9bcf05e487fe	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	223ec108-3a8d-593c-9628-338927ee526d	Radiation, External Beam	NA	yes	Recurrent Disease	NA	NA	NA	NA	NA	NA	NA	NA	Locoregional Site	NA	NA	NULL	NA	NA	NA	TCGA-BS-A0UA
TCGA-UCEC	TCGA-BK-A0CA	Stage IIIC	No	0	NA	NA	NA	Endometrium	22378	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Cytology	NA	8441/3	RX	primary	1b042946-cb3e-57aa-8321-29375cbfaf8c	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	61	-22378	NA	3b6442dc-a44c-5d6d-91f4-9aabb0781977	FALSE	NA	NA	NA	1064	NA	NA	06fabf58-4260-40ed-9c15-a62154d0c298	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	dbd4e0ca-f262-4194-b7b7-d5fcef86f385	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BK-A0CA
TCGA-UCEC	TCGA-D1-A163	Stage IIIC	No	0	NA	1995	NA	Endometrium	18604	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	76162bb9-f138-5dde-9b50-b697cd6328cb	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	50	-18604	NA	3706c952-17d0-5829-9624-26ed35ce61c6	FALSE	NA	NA	NA	991	TF-Tumor Free	NA	a7bc599e-69e0-484b-b34e-1eb287be1201	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant;NA	0b943dd2-fc3d-4c7c-bfb0-9791669b5c73;3607ab02-35fe-4996-a4f7-c903c3f2fd08;7281bfd0-c3df-5071-9c27-4df40e1b39cc;dc0f870d-1188-480c-a98d-ebde250a53f0	Radiation, External Beam;Radiation, Implants	NA	yes	NA;Recurrent Disease	NA	NA	106;281;110;327	NA	74;249;110;327	1;2	4500;500;1000	25;1	Regional Site;Locoregional Site	cGy	NA	NULL	NA	NA	NA	TCGA-D1-A163
TCGA-UCEC	TCGA-EY-A1H0	Stage IIIC2	No	0	NA	2009	NA	Endometrium	20937	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	850391fc-3536-5ce9-b8ad-2fc1b06b5eab	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	57	-20937	NA	0fe639d2-e36c-5dd9-bed0-8e11e1d36a61	FALSE	NA	United States	NA	588	WT-With Tumor	NA	aa6372e1-6373-4fa3-a46e-fb576b232a31	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	2fe1996a-4d6a-4311-aa84-d5a5049a0671;6106b9c8-845e-5722-aa46-0c0a637644a2;612e3cba-a283-49c1-b3b1-2d96fcd8eeef;9941f877-3e3b-416e-8afb-31b32e8dd6a3	Radiation, External Beam	NA	yes	NA	NA	NA	246;241;176	NA	244;202;174	1	540;4500	3;30;25	Regional Site;Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-EY-A1H0
TCGA-UCEC	TCGA-AP-A0LF	Stage IVB	No	0	NA	2009	NA	Endometrium	30027	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2002	released	No	TRUE	NA	Biopsy	NA	8380/3	R2	primary	e09759b2-7f3c-5e76-b034-8b15aebd184d	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	82	-30027	NA	157a0de8-9a60-547a-92df-8b04e55b9482	TRUE	NA	NA	NA	2845	Unknown	Adjuvant;NA	071b4f71-ac6c-510a-97c4-4fa5c83397a4;da96a8fe-58ac-45f6-acb2-0930a6e789f4	Pharmaceutical Therapy, NOS	NA;Tamoxifen	unknown;no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	566533ab-0fe1-48e4-b2dc-86860397fcf7	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AP-A0LF
TCGA-UCEC	TCGA-E6-A8L9	Stage IB	Yes	0	NA	2009	NA	Endometrium	22333	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2012	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	bee9e07c-de76-5588-8add-332436e717e2	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	61	-22333	NA	f0e29733-ab34-52ea-8d38-1c603eda8865	FALSE	NA	United States	NA	1013	TF-Tumor Free	NA	0d210126-dfe1-47d4-8b33-7ed728c39b72	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	cfdb0473-ab2f-5c6b-856f-3843aa400c27	Radiation, Internal	NA	yes	NA	NA	Complete Response	120	NA	106	NA	30	3	Regional Site	Gy	NA	NULL	NA	NA	NA	TCGA-E6-A8L9
TCGA-UCEC	TCGA-AJ-A3EK	Stage IA	No	0	NA	2009	NA	Endometrium	19609	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8441/3	NA	primary	7ae32546-37ad-563a-b07c-259612c7d3c2	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	hispanic or latino	Alive	53	-19609	NA	d53f1a50-e0f6-56cd-8d86-3f2c7fa50cd5	FALSE	NA	United States	NA	446	TF-Tumor Free	NA	f723b20d-51ba-4384-9958-b6439d1aed95	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	471a8465-9e03-5c43-ac81-aa90ee210f5e	Radiation, Internal	NA	yes	NA	NA	Complete Response	81	NA	84	NA	2100	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-AJ-A3EK
TCGA-UCEC	TCGA-AJ-A3NE	Stage IA	No	0	NA	2009	NA	Endometrium	16957	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	18780bc0-1bba-5cd3-8b89-1ad711411545	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	46	-16957	NA	7cd0bfbb-89d6-5f79-8bee-d7a676d2e60d	FALSE	NA	United States	NA	628	TF-Tumor Free	Adjuvant;NA	2e5afb49-8cc8-53c3-8444-1b285a628db9;e1b590fc-f1bd-4a97-8c63-a166dd0cde00	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	6923fe0c-b4d5-4fec-a5e4-f2b2a71bb083	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AJ-A3NE
TCGA-UCEC	TCGA-BG-A0M2	Stage IB	No	0	NA	2009	NA	Endometrium	22822	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	be22f33f-6622-5a48-842b-2176fd309799	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	62	-22822	NA	e46162a7-b38d-5473-ba17-81b4e62c5c17	FALSE	NA	NA	NA	637	TF-Tumor Free	NA;Adjuvant	0e178f30-86f5-4bcd-91ad-c9a0e5b486ee;a4677d4e-7200-4dfc-98dc-da1d6e6d6476	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	9fc5b4dd-f556-55a2-adb3-a32ab6ee1233	Radiation, Implants	NA	yes	NA	NA	NA	98	NA	84	1	2100	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-BG-A0M2
TCGA-UCEC	TCGA-EY-A1GF	Stage IA	No	0	NA	2009	NA	Endometrium	27450	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	da1d2ce6-d1fa-59e2-bfc0-cf6ab085c864	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	75	-27450	NA	0ecfa5bf-9458-5c6b-9ed8-3f37ef209fee	FALSE	NA	United States	NA	826	TF-Tumor Free	Adjuvant;NA	16dd6398-da72-5801-8dd2-007510d0c0f4;c92ca281-7290-4538-bc80-d0bf9be50100	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	571765ff-a2dd-480b-8c62-aca44fe580d0	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-EY-A1GF
TCGA-UCEC	TCGA-E6-A1LZ	Stage IA	No	0	NA	1988	NA	Endometrium	28054	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2007	released	No	TRUE	NA	Surgical Resection	NA	8441/3	R0	primary	1f0bef4b-abd9-5bee-a57b-7fc404c4eada	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	76	-28054	NA	f4785965-fb92-5876-80dc-48eba5d1a988	FALSE	NA	United States	NA	2406	TF-Tumor Free	NA	a6c6c243-037d-416b-a16e-6c7f30a5b14f	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	9d915d6b-aef4-59a9-bdc2-39c576c543bc	Radiation, Implants	NA	yes	NA	NA	NA	48	NA	34	1	2100	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-E6-A1LZ
TCGA-UCEC	TCGA-BS-A0UL	Stage IA	No	0	NA	1988	NA	Endometrium	19982	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2004	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	0209538e-826c-5cc3-92de-c19f17737c3f	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	native hawaiian or other pacific islander	female	not hispanic or latino	Alive	54	-19982	NA	c2e76a4c-ddb2-55de-baa7-c7067c1259f4	FALSE	NA	NA	NA	2481	TF-Tumor Free	Adjuvant;NA	77c46c07-7ce3-57e1-9ad5-c49955c8340f;7eded7df-c5c5-4428-8a79-8503e3808e46	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	e990d94e-b0a3-483d-90fc-25f06b0cb390	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BS-A0UL
TCGA-UCEC	TCGA-BG-A0M4	Stage IA	No	0	NA	1988	NA	Endometrium	22090	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	004d6366-8402-56fe-9858-7f1ba606f8af	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	60	-22090	NA	ab7c810e-febe-5caa-a6c2-35ad0f421909	FALSE	NA	NA	NA	2167	TF-Tumor Free	NA	edf0a392-b36b-4753-a007-44de1aae25ed	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	e4a89508-2ce3-4590-8df5-d0c1397cf91a	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BG-A0M4
TCGA-UCEC	TCGA-BS-A0U5	Stage IA	No	0	NA	1988	NA	Endometrium	27945	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2003	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	1500a430-392c-5459-bbb2-de07e77900cb	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	76	-27945	NA	ba99ed39-a94d-592d-ac4a-1ad8c93ba4d6	FALSE	NA	NA	NA	2935	TF-Tumor Free	NA;Adjuvant	29eaa030-100d-43f1-8f7e-dbd7226a3605;c8a1090d-555b-5b20-8083-3467e950f28d	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	0ac0c70b-ac66-4de6-b690-c4957e9554b5	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BS-A0U5
TCGA-UCEC	TCGA-A5-A0R7	Stage IA	No	0	NA	NA	NA	Endometrium	20250	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	527f39b6-f271-5c52-b8cb-5decddec860d	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	55	-20250	NA	65b14ddc-7ed2-577d-b70b-affa93ccebdd	FALSE	NA	NA	NA	535	TF-Tumor Free	Adjuvant;NA	5ab445cf-b9da-5100-9c92-916dcfdd43be;81c555a0-faa6-46d0-b059-9fe0db47cc00	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	c307b93d-2f52-4ac0-89a2-598436725eda	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-A5-A0R7
TCGA-UCEC	TCGA-AJ-A3OK	Stage IA	No	0	NA	2009	NA	Endometrium	26851	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	07254dcb-569e-5834-90ca-0fa36cd3db19	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	73	-26851	NA	44ebf565-e6c0-59c5-a3d6-7e355683c90a	FALSE	NA	United States	NA	485	Unknown	NA	7561ebe5-ddf7-4bac-bcfc-7fd48c89f90d	Pharmaceutical Therapy, NOS	Tamoxifen	unknown	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	d6d44d5d-f1f6-5a2e-bc44-823d5dfe6d98	Radiation, Internal	NA	yes	NA	NA	Complete Response	177	NA	158	NA	7000	NA	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-AJ-A3OK
TCGA-UCEC	TCGA-AX-A3G7	Stage IVB	No	0	NA	1988	NA	Endometrium	26187	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Laparotomy	NA	8441/3	NA	primary	12e86155-3dc3-5b54-841e-8d6078c4c32c	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	71	-26187	NA	ee9641f4-f36d-5742-be0c-130144f39240	FALSE	NA	United States	NA	9	NA	Adjuvant;NA	90e2a60c-42a3-578d-9176-ab514552434d;d458f15d-78cd-4785-a52d-13a5d791f402	Pharmaceutical Therapy, NOS	NA;Tamoxifen	unknown;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	191df8b0-ecee-4f51-8630-ddb8067151ab	Radiation Therapy, NOS	NA	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A3G7
TCGA-UCEC	TCGA-D1-A1NS	Stage IA	No	0	NA	2009	NA	Endometrium	19638	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	aab4e05f-3644-56c4-b7f7-af9d5e1b8adc	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	53	-19638	NA	9c7ebc91-28c8-5947-adb5-8a59ce7a93c4	FALSE	NA	United States	NA	43	TF-Tumor Free	Adjuvant;NA	10cd44cc-c7cc-5dff-b589-04115adc19a0;abe850bb-feab-4f09-b0a4-6a5e5d459b7a	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	9c5ce361-271e-41bf-bc96-a801efc517b9	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A1NS
TCGA-UCEC	TCGA-D1-A16J	Stage IIB	No	0	NA	1995	NA	Endometrium	22319	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	2f2c0c71-ca23-59b9-9d29-4677fde95ce5	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	61	-22319	NA	e5131de6-df58-5310-8f3f-9792154e2d41	FALSE	NA	NA	NA	910	TF-Tumor Free	NA	b63bab56-0dfc-427e-ba37-f3bbcc507203	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	7f670e55-3386-5dfb-95ba-8273d709d922	Radiation, Implants	NA	yes	NA	NA	NA	61	NA	53	1	2100	3	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-D1-A16J
TCGA-UCEC	TCGA-AP-A056	Stage II	No	0	NA	NA	NA	Endometrium	23707	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2004	released	No	TRUE	NA	Pap Smear	NA	8380/3	R0	primary	dca335c4-c79c-5c18-8bac-7e8070caebd4	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	64	-23707	NA	e8476897-909b-57ac-abe1-14a9f79e2a3a	FALSE	NA	NA	NA	2618	TF-Tumor Free	Adjuvant;NA	0a280f08-474c-4c08-8497-8abdb1cb14ca;26b13e29-8100-41eb-9d10-81a2e1724b9a	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	5c8b1d8c-39b7-5624-8cd9-93f44f9220bc	Radiation, External Beam	NA	yes	NA	NA	NA	126	NA	84	1	5040	28	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-AP-A056
TCGA-UCEC	TCGA-A5-A0GE	Stage IA	No	0	NA	NA	NA	Endometrium	14170	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2002	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	0fa4bc83-ddc7-5bf3-9d0f-dbe6998d1497	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	asian	female	not hispanic or latino	Alive	38	-14170	NA	909e5384-bc65-57da-a325-b3e37696288a	FALSE	NA	NA	NA	3205	TF-Tumor Free	NA;Adjuvant	02c7e9c1-230e-4f91-ac46-7d7b3c4f6e94;0976fc35-d907-4fdd-b4e2-ddaffca0e5cd	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	b1de703e-7e57-509d-bcd7-73fc90e95140	Radiation, Implants	NA	yes	NA	NA	NA	69	NA	55	1	2100	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-A5-A0GE
TCGA-UCEC	TCGA-BK-A26L	Stage IIIC1	No	0	NA	2009	NA	Endometrium	26002	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8441/3	RX	primary	d2b10490-3a90-5a92-bf52-ee5faaa52852	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	71	-26002	NA	cd6ec347-4caf-5ff7-a22e-34c0c62a99b3	FALSE	NA	United States	NA	734	TF-Tumor Free	NA	12c5fcca-500b-417b-bbcb-6705b9280736	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	a800f1f1-88f2-5f57-be1e-c504f5f2d832;e05f64b1-1f98-4016-8c37-e02018b61d5f	Radiation, External Beam;Radiation, Implants	NA	yes	NA	NA	NA	187;192	NA	151;186	1;2	4500;1200	25;2	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-BK-A26L
TCGA-UCEC	TCGA-EY-A1GD	Stage IA	No	0	NA	2009	NA	Endometrium	18638	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Surgical Resection	NA	8380/3	R0	primary	b6287040-362f-59f2-b7a3-a5fef7595c2f	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	51	-18638	NA	20432a64-7226-55a6-bc3f-2c6dd69a4572	FALSE	NA	United States	NA	1639	TF-Tumor Free	Adjuvant;NA	1370eb32-cec4-518f-bf6d-6686ab485217;75da1d3f-8171-4872-9317-639d8fd5e192	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	f4caec42-b69f-479c-9f0f-b6707980b048	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-EY-A1GD
TCGA-UCEC	TCGA-EO-A3KW	Stage IA	No	0	NA	2009	NA	Endometrium	26492	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	4d741fd5-b1bb-59fe-a569-74158159de1e	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	not reported	female	not reported	Alive	72	-26492	NA	2892198e-6c40-564b-b111-52a3797e9f8c	FALSE	NA	Canada	NA	497	TF-Tumor Free	NA	68a5147b-6ca5-47cd-86c4-e09f529e4069;96f3b3a7-a7ed-4cfe-a2fa-fb17b0b03748	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;yes	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	ef755f5e-2676-5747-b307-7eb36c72e6fb	Radiation Therapy, NOS	NA	yes	NA	NA	NA	NA	NA	NA	NA	NA	NA	Unknown	NA	NA	NULL	NA	NA	NA	TCGA-EO-A3KW
TCGA-UCEC	TCGA-FI-A2D0	Stage IA	No	0	NA	1988	NA	Endometrium	20393	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	2942c9b3-ec72-5212-9a2b-cffefc5e8d1d	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	55	-20393	NA	7fe5583a-aa8c-5ce8-896a-0397ead74a1a	FALSE	NA	United States	NA	1213	TF-Tumor Free	NA;Adjuvant	2a191a78-e7a5-4d8e-a93e-7935f5ff6064;ef840ec7-a121-5fdf-ac01-541c3728ec9a	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	ca4a84cf-c68a-46bd-91d6-8220149d4aad	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-FI-A2D0
TCGA-UCEC	TCGA-D1-A17T	Stage IA	No	0	NA	2009	NA	Endometrium	24652	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	972ab98a-5ddf-54b4-8cf5-dc9bc4ebfad9	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	67	-24652	NA	e2b366b5-54d4-52ab-9057-e2a3f7755781	FALSE	NA	NA	NA	71	TF-Tumor Free	Adjuvant;NA	862ff2bc-ac37-531b-b997-11f108a392c9;f136ce5a-f5d7-4ae8-9d35-bf1af281c0c1	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	f1d16f9c-43aa-4f33-9bbf-bdde80fb19fd	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A17T
TCGA-UCEC	TCGA-AP-A1E0	Stage IIIC2	No	0	NA	2009	NA	Endometrium	14653	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	bcaeab42-ac51-534a-8007-c4de65e6c3d8	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	40	-14653	NA	27868555-f3af-59fb-ba00-4da9c14176e1	FALSE	NA	NA	NA	1832	TF-Tumor Free	NA	cf574216-b83a-43b0-8a0e-67ac8e77dfc6	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	14bf5de0-d1bb-433a-9ffa-8048186e9055	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AP-A1E0
TCGA-UCEC	TCGA-AX-A3G4	Stage IIIC	No	0	NA	1988	NA	Endometrium	22099	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Surgical Resection	NA	8441/3	NA	primary	72611320-df20-5a36-8dde-6c5856557583	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	native hawaiian or other pacific islander	female	not hispanic or latino	Alive	60	-22099	NA	f3e4184b-0452-5930-98c5-ac8023f647f4	FALSE	NA	United States	NA	9	NA	Adjuvant;NA	1633b899-ede4-541a-978e-6ff2d595cb9f;f78ba9e7-03c4-4771-87a5-1e77ae3666e8	Pharmaceutical Therapy, NOS	NA;Tamoxifen	unknown;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	6e1ce947-bd64-414f-8f56-7f0e3a3090b4	Radiation Therapy, NOS	NA	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A3G4
TCGA-UCEC	TCGA-AJ-A2QM	Stage II	No	0	NA	2009	NA	Endometrium	24776	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2011	released	No	TRUE	NA	Biopsy	NA	8441/3	NA	primary	dde0f5b7-2211-5416-ac11-5766a2b0cf8d	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	67	-24776	NA	e636331b-e748-57b6-8d24-32106af64cdf	FALSE	NA	United States	NA	894	TF-Tumor Free	NA	c6d7010d-f4b7-42b2-afd5-6a32bf02866a	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	1e59e528-de63-431c-aa6e-38cffc232749;4df372b1-60ba-52b0-93b7-48970232bb46	Radiation, External Beam;Radiation, Internal	NA	yes	NA	NA	Complete Response	163;184	NA	128;172	NA	4500;1500	25;NA	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-AJ-A2QM
TCGA-UCEC	TCGA-D1-A160	Stage IB	No	0	NA	1995	NA	Endometrium	25673	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	3851b957-4645-5b14-9890-0123848bfb32	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	70	-25673	NA	0225e9ef-fd53-5fbb-8fe7-d11be0fd4d83	FALSE	NA	NA	NA	112	TF-Tumor Free	Adjuvant;NA	7d5bd713-96d1-5014-b55c-08eb26b1bae4;dce8c09c-5e98-4f43-a98c-04fe5caa8889	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	3f81cb45-466e-4fe4-8eb5-a662a610bfed	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A160
TCGA-UCEC	TCGA-D1-A16E	Stage IB	No	0	NA	1995	NA	Endometrium	26859	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	3a94f159-3a38-550d-86eb-65f6b65800a6	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	73	-26859	NA	ee615383-004f-552b-b4bb-3ec74433dfa9	FALSE	NA	NA	NA	1119	TF-Tumor Free	Adjuvant;NA	d832fbd1-f20c-5ded-8321-bc80a7b81d63;e191d602-4345-44b5-a460-66c804294dc9	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	7636812c-df7a-4ff3-a7cc-ad91372d271e	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A16E
TCGA-UCEC	TCGA-AP-A1DO	Stage IA	No	0	NA	2009	NA	Endometrium	22787	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2007	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	58d53b8b-44f2-50b9-8188-a1b3b9ba9a9a	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	62	-22787	NA	2e4bcad2-f344-56f7-888b-3fca2afe52df	FALSE	NA	NA	NA	952	TF-Tumor Free	Adjuvant;NA	e378758c-1a50-506a-bee0-2ce85c6c7aa7;e38d1b5a-e1f6-4eb6-b58a-1497911621ae	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	757baffc-cc7e-431f-a074-de5c771c343e	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AP-A1DO
TCGA-UCEC	TCGA-B5-A11Y	Stage IB	No	0	NA	2009	NA	Endometrium	21860	Endometrioid adenocarcinoma, secretory variant	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8382/3	NA	primary	f93b188b-6244-59fe-9580-e068f8f319dd	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	59	-21860	NA	0ac0360f-5df5-52b5-a219-49f145a7e2ba	FALSE	NA	United States	NA	560	TF-Tumor Free	Adjuvant;NA	beed18da-4b8e-51ce-af0a-eb8102903543;f9c4c640-6983-4a29-9229-5a8ccee606d5	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	333e8cf7-9608-4665-b39e-a41c87c45b4c	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A11Y
TCGA-UCEC	TCGA-BK-A6W4	Stage IA	No	0	NA	2009	NA	Endometrium	22766	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2013	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	796e258f-42f2-5fdb-8f39-750511699f03	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	62	-22766	NA	13527a4f-c30d-54d3-87c3-f2e6883445da	FALSE	NA	United States	NA	300	TF-Tumor Free	NA;Adjuvant	1364b4a7-4ef6-4660-a51e-a2acd6b2028e;71639eb8-6121-444d-830a-22aa82460cac	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	728d30c7-200c-50c1-85c6-d80f08642e0c	Radiation, Internal	NA	yes	NA	NA	Complete Response	119	NA	97	NA	3750	5	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-BK-A6W4
TCGA-UCEC	TCGA-AW-A1PO	Stage IIIA	No	0	NA	2009	NA	Endometrium	24225	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Surgical Resection	NA	8380/3	R0	primary	35cb1cd4-f910-5479-81cf-31d0e38e0ee2	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	66	-24225	NA	725602a2-1229-515a-b401-94a1ead148af	FALSE	NA	Russia	NA	17	TF-Tumor Free	NA;Adjuvant	99339fb4-fae8-4c33-98ea-75831f54471c;ef2d4b93-0146-59e3-b0bf-3a126334bd82	Pharmaceutical Therapy, NOS	Tamoxifen;NA	unknown;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	aeaf2753-79c7-4bf4-a681-e54e2c949f4b	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AW-A1PO
TCGA-UCEC	TCGA-EO-A3B1	Stage IB	No	0	NA	2009	NA	Endometrium	23162	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	fa7982cc-0b59-5be3-807e-b2dafcb02b85	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	not reported	female	not reported	Alive	63	-23162	NA	6f899329-75a0-56df-99c2-e4cc79c2a1c4	FALSE	NA	Canada	NA	820	TF-Tumor Free	NA	faa7b190-b836-4865-81b4-7c31f1fe1ea0	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	4ee400d4-e725-523a-bcbc-69b3cdb89b08	Radiation, External Beam	NA	yes	NA	NA	Complete Response	141	NA	105	NA	5	25	Primary Tumor Field	Gy	NA	NULL	NA	NA	NA	TCGA-EO-A3B1
TCGA-UCEC	TCGA-D1-A0ZN	Stage IA	No	0	NA	NA	NA	Endometrium	22026	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Surgical Resection	NA	8380/3	R0	primary	ca0a7de2-265c-56df-8221-83cdff52a52c	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	60	-22026	NA	820573ea-7bc9-59dd-aca0-e4e712597461	FALSE	NA	NA	NA	512	TF-Tumor Free	NA;Adjuvant	0c07b0c0-ccc7-45e0-be72-8782af5c7f1d;f4b1b787-9d52-4e73-ae70-ddddc2df285a	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	8126ce2b-b1e3-51db-a428-e1152951871c	Radiation, External Beam	NA	yes	Initial Diagnosis	NA	NA	497	NA	463	1	5000	850	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-D1-A0ZN
TCGA-UCEC	TCGA-SL-A6J9	Stage IB	No	0	NA	2009	NA	Endometrium	26701	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2013	released	No	TRUE	NA	Surgical Resection	NA	8380/3	RX	primary	41c082af-250a-57a1-bdf3-11be4f195d17	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	73	-26701	NA	3171801b-ead8-54fc-a7b9-481100dfe39d	FALSE	NA	United States	NA	2	NA	NA;Adjuvant	43c207f3-b23d-4e2b-802c-cf26177a3a84;dc003f42-69b7-5ac8-bdd4-931f31c0559f	Pharmaceutical Therapy, NOS	Tamoxifen;NA	unknown	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	5cdc9bd1-5ac3-4f9c-83fa-de1b891c1922	Radiation Therapy, NOS	NA	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-SL-A6J9
TCGA-UCEC	TCGA-B5-A1N2	Stage IIIC1	No	0	NA	2009	NA	Endometrium	25612	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8441/3	NA	primary	327134b5-089b-59d7-8f74-1504576e9298	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not reported	Dead	70	-25612	NA	da3707f8-f6ee-513d-b165-45858db4dcd1	FALSE	NA	United States	954	954	WT-With Tumor	NA	ab8ffabe-9974-4a71-a011-bf609e8eae16;d920d17d-76bd-403f-919c-44dda8165ed1	Pharmaceutical Therapy, NOS	NA;Tamoxifen	yes;not reported	Progressive Disease;NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA;Adjuvant	03f6087d-b6f3-4a10-964b-cbebc4accf4e;1df98583-271a-521f-b524-eff3f9bb7f06	Radiation Therapy, NOS;Radiation, External Beam	NA	yes	Progressive Disease;NA	NA	NA	NA;178	NA	NA;141	NA;1	NA;4500	NA;25	NULL;Regional Site	NA;cGy	NA	NULL	NA	NA	NA	TCGA-B5-A1N2
TCGA-UCEC	TCGA-D1-A16X	Stage IB	No	0	NA	2009	NA	Endometrium	19799	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	2adb3bfe-3072-512c-ae66-781ce266d5eb	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	54	-19799	NA	21211a7f-bfde-54df-8a7d-c139cb0922c9	FALSE	NA	NA	NA	111	TF-Tumor Free	Adjuvant;NA	25bc91ad-9658-5359-aa17-6e1072c35894;7eaa6800-3923-41c9-8bcc-ec091fc1f489	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	32b9539f-b888-4501-a88f-f8b8184fc494	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A16X
TCGA-UCEC	TCGA-A5-A0GJ	Stage IA	No	0	NA	NA	NA	Endometrium	16421	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2005	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	b6fb24ef-56f2-58fe-9500-478b07397a71	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	44	-16421	NA	bb77659e-237f-5a94-8538-2fb5d2a1797f	FALSE	NA	NA	NA	2000	TF-Tumor Free	NA	533fa221-56bb-42f7-8b5f-5d939ac47e51	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	d733473d-74fa-4fd7-81e6-5e6fa265ef34	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-A5-A0GJ
TCGA-UCEC	TCGA-B5-A0JX	Stage IB	No	0	NA	1988	NA	Endometrium	22834	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2007	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	a401e5ac-82c4-54b0-976e-fa86731953d1	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	62	-22834	NA	6014440f-b492-52dc-a262-f14f49e88341	FALSE	NA	United States	NA	1787	TF-Tumor Free	Adjuvant;NA	40ee69f8-a8b5-569e-882d-41a9614b7a93;832d036b-10b2-479f-8fef-15f64bd50065	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	41f0611c-9dc7-4c8a-8851-39597d0ac7e9	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A0JX
TCGA-UCEC	TCGA-AJ-A5DV	Stage IA	No	0	NA	2009	NA	Endometrium	23892	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2012	released	No	TRUE	NA	Biopsy	NA	8380/3	RX	primary	96dfad91-dccc-59e3-9879-0bfd79b07218	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	65	-23892	NA	f51e0306-5841-5740-83d5-43755b0b9f1e	FALSE	NA	United States	NA	679	TF-Tumor Free	NA;Adjuvant	94cf363d-604d-4d47-8a71-9608675299a2;a87dbe9b-af61-5eec-b2f4-f6d40bb908fa	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no;unknown	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	d195af05-9470-4b28-ac9e-64e71d964350	Radiation Therapy, NOS	NA	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AJ-A5DV
TCGA-UCEC	TCGA-D1-A17N	Stage IA	No	0	NA	2009	NA	Endometrium	17045	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	1973302c-ef19-59e0-b80f-4404565763c7	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	not reported	female	not hispanic or latino	Alive	46	-17045	NA	e00830e7-7afa-5262-95b1-9ec093cf6ff4	FALSE	NA	NA	NA	46	TF-Tumor Free	Adjuvant;NA	d733b7ec-b2b8-5b4b-92bd-92dee7f97bf0;e8c57c02-461d-470d-9b70-0a08c051227f	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	c103523f-78a7-4b65-9627-f721ac3844e0	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A17N
TCGA-UCEC	TCGA-B5-A1MS	Stage IC	Not Reported	0	NA	1988	NA	Endometrium	22068	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	not reported	2003	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8441/3	RX	primary	ff1c9ded-fbef-52e6-ba9d-e89ba8446649	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	60	-22068	NA	2f5073c6-d784-534d-8170-ca24a733d556	FALSE	NA	NA	3112	3112	WT-With Tumor	NA	ea2d826e-6597-400f-9435-b86aec3080bf	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Palliative	9e5b530f-ec1e-5c73-8e79-d35b98157eed;c4f0738d-9dd5-4c47-a68c-c893edf18cce	Radiation, External Beam	NA	yes	NA	NA	NA	2752;2802	NA	2718;2782	1	4500;3500	NA	Locoregional Site;Distant Site	cGy	NA	NULL	NA	NA	NA	TCGA-B5-A1MS
TCGA-UCEC	TCGA-BG-A0M6	Stage IIIC2	No	0	NA	1988	NA	Endometrium	26666	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2008	released	No	TRUE	NA	Surgical Resection	NA	8441/3	R0	primary	1d9b02ad-e4a7-5861-8f48-040a0b558207	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	73	-26666	NA	3e7266d1-dce3-556c-ab45-4ed485d16350	FALSE	NA	NA	671	671	TF-Tumor Free	NA	ceec0b58-9b33-4806-a693-580062bf773f	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	80930add-59eb-55a4-907e-75b402c24473;961cbf28-e534-4e83-949c-e17745fd59c2	Radiation, Implants;Radiation, External Beam	NA	yes	NA	NA	NA	241;227	NA	231;195	1	1800;4500	3;25	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-BG-A0M6
TCGA-UCEC	TCGA-BG-A0M7	Stage IIIC1	No	0	NA	1988	NA	Endometrium	22096	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	ca893451-6c23-52c1-86ed-65da0df32661	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	60	-22096	NA	a5a0d889-9d31-55c0-80a8-9c3eb31ed85d	FALSE	NA	NA	NA	1937	TF-Tumor Free	NA	84b59bbf-d781-4227-a068-621daf6a34f5	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	1d000dea-f4e2-5d05-9167-287fd41901f8;ae851166-391a-4397-a567-b83914543ec0	Radiation, Implants;Radiation, External Beam	NA	yes	NA	NA	NA	223;216	NA	218;182	1	1000;4500	2;25	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-BG-A0M7
TCGA-UCEC	TCGA-AJ-A2QO	Stage IB	No	0	NA	2009	NA	Endometrium	31222	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	7e286786-b8d5-50d7-9097-a9ef232702c7	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Dead	85	-31222	NA	150c9f58-1fa3-59d5-af58-ec8e150277bc	FALSE	NA	United States	1045	1045	TF-Tumor Free	NA;Adjuvant	5d89bbcd-52b9-4a47-a45a-338dcc038200;967034e4-bd02-5092-a7f2-609080272db0	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	7073df8c-7a6b-4438-a33c-6dd1e8489398	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AJ-A2QO
TCGA-UCEC	TCGA-EY-A2OQ	Stage IA	No	0	NA	2009	NA	Endometrium	22309	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	cfe4c1f5-1020-5c29-9267-81b5d63b9c55	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	61	-22309	NA	30f06462-90ed-5004-81de-422d8ce9b270	FALSE	NA	United States	NA	885	TF-Tumor Free	Adjuvant;NA	b24a85dc-4b3f-5b43-bded-f68333ec9758;d6c13098-d97a-45f7-b10b-8eacfb9b860f	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	5d1af7af-cf6d-460b-a3c8-7e5b1a79e3c9	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-EY-A2OQ
TCGA-UCEC	TCGA-BG-A0MU	Stage IIIA	No	0	NA	2009	NA	Endometrium	28621	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Surgical Resection	NA	8380/3	R0	primary	a87f99dd-5401-5644-83c3-bd101864d91b	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	78	-28621	NA	ad41e1ef-c12d-539c-936a-66be05ef82b6	FALSE	NA	NA	NA	617	TF-Tumor Free	NA	f6e0fb2a-3f0b-4a13-a018-1aed398f3d94	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	e7d8d45d-2ffa-44f4-a2ee-4de1de3b8a08;f920c410-cea7-5309-970b-8bc5adb439a5	Radiation, Implants;Radiation, External Beam	NA	yes	NA	NA	NA	114;92	NA	108;58	1	500;4500	2;25	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-BG-A0MU
TCGA-UCEC	TCGA-A5-A0GV	Stage IA	No	0	NA	1988	NA	Endometrium	24540	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	e71ae858-ef0c-5ca2-a931-dbf8abbb0e7b	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	67	-24540	NA	42b773b4-de7e-563d-b394-022955a80a1b	FALSE	NA	NA	NA	1643	TF-Tumor Free	NA;Adjuvant	796fc980-51a3-43cb-8cef-44d16f086c79;e3400b32-0368-41c9-81aa-ccb4d437d7d1	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	78552533-8f32-492c-9d3a-1fc2dbe9ab28;a20ab2ad-87d8-51ff-948f-ca3415f53cd6	Radiation, Implants;Radiation, External Beam	NA	yes	Recurrent Disease	NA	NA	461;426	NA	448;390	2;1	1500;5040	3;6	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-A5-A0GV
TCGA-UCEC	TCGA-EO-A22U	Stage IB	No	0	NA	2009	NA	Endometrium	30557	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	36f0913f-9b70-5403-9b6d-d8e3cced5f58	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	83	-30557	NA	e8d75a74-9bea-5427-ac4c-e20566531835	FALSE	NA	Canada	NA	1407	TF-Tumor Free	NA;Adjuvant	b508ccfc-6714-4c7a-ab2e-570c55a3db18;b880aa71-4a76-43a7-a9f0-08722b088f27	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	782a304e-53c4-5a39-b015-8b7f6eaf353b	Radiation, External Beam	NA	yes	NA	NA	NA	84	NA	49	NA	45	25	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-EO-A22U
TCGA-UCEC	TCGA-AP-A1DV	Stage II	No	0	NA	2009	NA	Endometrium	21901	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	516469f0-fecc-5018-8591-11518519030a	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	59	-21901	NA	48e7f835-6a07-549a-8f3e-d1ccdfb2ae3a	FALSE	NA	NA	NA	204	TF-Tumor Free	NA;Adjuvant	b4dfab73-b9f2-4657-9f3e-e07fda295b5a;dbfb9b0d-15c3-4755-bc76-f2f10c3ab316	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	5006618c-9c08-561a-b3b6-e5ae6d803668	Radiation Therapy, NOS	NA	yes	NA	NA	NA	NA	NA	NA	1	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AP-A1DV
TCGA-UCEC	TCGA-SJ-A6ZI	Stage IB	No	0	NA	2009	NA	Endometrium	23653	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2013	released	No	TRUE	NA	Surgical Resection	NA	8380/3	R0	primary	fc4ddf2e-0c66-5936-8e76-4dd8e54823a2	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	64	-23653	NA	9414ed5c-c3bf-5195-b220-09297a960ba8	FALSE	NA	United States	NA	631	TF-Tumor Free	Adjuvant;NA	31ef1b1b-664d-4a3d-ad2b-4ee889888192;85df961c-cbf8-4bca-92ca-914f3ade34d1	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	cb2eb786-9ad0-5af7-8361-153e87ed660d	Radiation, Internal	NA	yes	NA	NA	Complete Response	86	NA	86	NA	21	3	Primary Tumor Field	Gy	NA	NULL	NA	NA	NA	TCGA-SJ-A6ZI
TCGA-UCEC	TCGA-K6-A3WQ	Stage IVB	No	0	NA	2009	NA	Endometrium	22092	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2012	released	No	TRUE	NA	Biopsy	NA	8441/3	NA	primary	9542a14c-2521-575a-8430-31ef6aa00d50	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	60	-22092	NA	66209a4f-b667-5200-a6b9-4b39cfdb6f72	FALSE	NA	United States	427	427	WT-With Tumor	NA	7f5fac6b-fd0a-4a1d-808b-f013ec72e9a7	Pharmaceutical Therapy, NOS	Tamoxifen	unknown	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	97826b3a-bd76-5325-8bf3-1c89eaf34e26	Radiation, Internal	NA	yes	NA	NA	Unknown	258	NA	246	NA	2100	3	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-K6-A3WQ
TCGA-UCEC	TCGA-AJ-A3NH	Stage IB	No	0	NA	2009	NA	Endometrium	32871	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2011	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8441/3	R0	primary	05fae6e0-105f-517a-8fc6-bcc404aeb97a	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	89	-32871	NA	5260b2a3-c911-50eb-a9f3-7ab433a02860	TRUE	NA	United States	1	1	TF-Tumor Free	NA	146bdfb4-dd7c-4e76-a88c-a9bd6d9f0513	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	99ecb593-a180-4bf7-8d3a-be52e3e007e3	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AJ-A3NH
TCGA-UCEC	TCGA-QS-A744	Stage IIIB	No	0	NA	2009	NA	Isthmus uteri	31520	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2013	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	6da0b164-4420-596e-8f3f-26edad13cbba	C54.0	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	86	-31520	NA	4bb8f00c-d398-5777-8070-31fa84085acd	FALSE	NA	United States	NA	451	Unknown	NA	bddc9e54-7fa2-4375-870a-be66251ec680	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	80c2cf6a-e9d5-42e2-ade2-0d7af4d2037c	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-QS-A744
TCGA-UCEC	TCGA-B5-A11O	Stage IA	No	0	NA	1988	NA	Endometrium	22720	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	4528c73f-e558-5634-8ad1-76154e43a209	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	62	-22720	NA	b0e6de39-ab28-5b60-90a2-2ae8485c99d9	FALSE	NA	United States	NA	2609	TF-Tumor Free	NA;Adjuvant	5672259a-9992-4d19-976f-44518b511054;c230fb55-4bc2-4209-8995-5eae8474b62b;f166c518-fa80-528e-9ad3-a9bb7367e827	Pharmaceutical Therapy, NOS	NA;Tamoxifen	yes;not reported	Initial Diagnosis;NA	NA;Prior to Diagnosis	NA;Complete Response	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA;Adjuvant	3f355c8c-ebca-4c1f-af68-cbd39560ab22;89185395-597a-4c46-acec-0ee771cd8faf	Radiation Therapy, NOS	NA	yes	Initial Diagnosis;NA	NA	NA;Complete Response	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A11O
TCGA-UCEC	TCGA-D1-A2G0	Stage IB	No	0	NA	1995	NA	Endometrium	25573	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2007	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8441/3	R0	primary	3b9ea115-6fd4-5ead-91ad-38a0290e8a50	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	70	-25573	NA	d45a801b-a1cd-51a8-abd6-5b5f4ad4f091	FALSE	NA	United States	NA	1484	Unknown	Adjuvant;NA	02674f23-c7f6-5daf-818a-f167d8575e44;b15e5e6e-772f-479e-93ee-a4738e516cd9	Pharmaceutical Therapy, NOS	NA;Tamoxifen	unknown	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	1979678a-a1db-4e37-8b7d-f4dda7553f7d	Radiation Therapy, NOS	NA	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A2G0
TCGA-UCEC	TCGA-EY-A2OM	Stage IA	No	0	NA	2009	NA	Endometrium	20398	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	3b3e60e4-d5c1-5cf1-9ead-8a675165db70	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	55	-20398	NA	913d2af6-77a5-5410-a188-fe74d2567774	FALSE	NA	United States	NA	694	TF-Tumor Free	NA	0791d651-c970-495e-b031-b7cc3e1f47ef	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	1f4cc020-97aa-5d2d-b98f-66837d8741e8	Radiation, Implants	NA	yes	NA	NA	NA	116	NA	106	1	2100	3	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-EY-A2OM
TCGA-UCEC	TCGA-EC-A1NJ	Stage IA	No	0	NA	2009	NA	Endometrium	27002	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Surgical Resection	NA	8380/3	R0	primary	b4211663-bd7a-593e-8805-1813d9dee70c	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	73	-27002	NA	83619ed1-a7ed-5029-ae2d-608ce3dcbf3f	FALSE	NA	Russia	NA	488	TF-Tumor Free	Adjuvant;NA	583f8f48-82b6-5360-93af-73f4090473f6;8cbfbd68-fb22-4f67-9034-b4f9a7b66078	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	f3708ac1-b85f-4930-aed3-cbd4e4ccc2ea	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-EC-A1NJ
TCGA-UCEC	TCGA-AP-A0LM	Stage IIIC2	No	0	NA	NA	NA	Endometrium	12309	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2004	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	9fb6fe5c-fc24-57b1-90fb-68128caf82bc	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not reported	Alive	33	-12309	NA	be5b9e06-57b9-58e8-b0f2-c984c40219a7	FALSE	NA	NA	NA	825	TF-Tumor Free	NA	83f31676-3c83-4acd-aed3-a231c731a1dc	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	fbc51e68-0315-5a79-9663-7e6c6be0dabd	Radiation, External Beam	NA	yes	NA	NA	NA	149	NA	114	1	4140	23	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-AP-A0LM
TCGA-UCEC	TCGA-B5-A3S1	Stage IIIC1	No	0	NA	2009	NA	Endometrium	26031	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8441/3	NA	primary	0abb0115-7e82-55e9-8956-7920cf4aa855	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	71	-26031	NA	f8e5ff46-e164-5917-9a43-dcb119802be6	FALSE	NA	United States	NA	902	NA	NA	5402cac7-100f-4dc3-8774-d90a7b6257a4	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	a2b38aaa-1518-523c-890a-af4332701700	Radiation, External Beam	NA	yes	NA	NA	NA	153	NA	120	1	4500	NA	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-B5-A3S1
TCGA-UCEC	TCGA-B5-A0JN	Stage IVB	No	0	NA	1988	NA	Endometrium	30933	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2004	released	Yes	TRUE	NA	Surgical Resection	NA	8441/3	NA	primary	4c735ac3-31b0-59a6-9214-c58a003e4c8f	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not reported	Alive	84	-30933	NA	803b97ad-544f-5652-a79b-7dc4f1df6e1c	TRUE	NA	United States	NA	1939	TF-Tumor Free	NA	ba13c595-3aca-47ab-a009-bdd0f2bf4a01	Pharmaceutical Therapy, NOS	Tamoxifen	yes	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	b1026254-2b91-44c3-89b3-c00be631432f	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A0JN
TCGA-UCEC	TCGA-D1-A1NU	Stage IA	No	0	NA	2009	NA	Endometrium	27272	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8441/3	R0	primary	95c39d78-414a-58f7-ba98-0b27c5bbe04c	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	74	-27272	NA	0309ac57-a9e4-5985-afaa-1c22c3de13d7	FALSE	NA	United States	NA	402	TF-Tumor Free	NA	7794ee4d-db1f-4781-bec8-fde2b3acdbfe	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	d7507d19-229a-5024-a6ac-8829617c5e74	Radiation, Implants	NA	yes	NA	NA	NA	50	NA	35	1	2100	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-D1-A1NU
TCGA-UCEC	TCGA-PG-A7D5	Stage IA	No	0	NA	2009	NA	Endometrium	23006	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	eee42fb5-89c1-530d-952e-d9c333442c28	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	62	-23006	NA	b18085fa-a9fc-591d-97c2-4ca241b9bc92	FALSE	NA	United States	NA	1177	TF-Tumor Free	NA	aff4a519-3b41-4c96-8a43-2b1d907ab36b	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	556eafb4-eeb5-5301-bed7-28236be7be40;9d4bbaaa-0360-4208-af1b-cb3d1dffde80	Radiation, Internal;Radiation, External Beam	NA	yes	NA	NA	Complete Response	108;162	NA	108	NA	NA	5;1.8	Regional Site	NA	NA	NULL	NA	NA	NA	TCGA-PG-A7D5
TCGA-UCEC	TCGA-D1-A1NX	Stage IIIC	No	0	NA	2009	NA	Endometrium	24441	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8441/3	R0	primary	62fa317d-6ed7-5f82-8fd3-64caab7df675	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	66	-24441	NA	f0d1ed71-a6fc-526b-9a5a-8183ccd0229d	FALSE	NA	United States	NA	555	WT-With Tumor	NA	93966607-7ff5-46d4-bead-99017fe5de13	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant;NA	52290854-c07c-4c43-83d6-188026b104e9;5aa27f3f-511e-411f-8845-94f7f0ff5d29;88869daa-0ef2-51f5-8ee6-4a5ac4435d10	Radiation, External Beam;Radiation, Implants	NA	yes	NA;Recurrent Disease	NA	NA	216;209;534	NA	180;195;519	1;2	4500;1000;8400	25;2;12	Locoregional Site;Primary Tumor Field;Distant Site	cGy	NA	NULL	NA	NA	NA	TCGA-D1-A1NX
TCGA-UCEC	TCGA-AJ-A3EM	Stage IB	No	0	NA	2009	NA	Endometrium	25557	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	701ef023-6d22-59d1-8dd7-d94dc341ee5a	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	69	-25557	NA	93778d19-dd7a-5e27-8b67-4fba294de047	FALSE	NA	United States	NA	677	TF-Tumor Free	Adjuvant;NA	4ad72b2f-f4ce-537b-a4fa-23b78f5f0992;d4190539-e33e-4daa-a3e3-16eaa7081d7b	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	6cc5e41e-861a-49d6-ab95-f21c9b532ab3	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AJ-A3EM
TCGA-UCEC	TCGA-AX-A2IO	Stage IIA	No	0	NA	1988	NA	Endometrium	30539	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8441/3	R1	primary	f9192a59-62b1-59d0-8feb-bf2e9ec37371	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	83	-30539	NA	a3d8b15e-c949-5b84-8dfa-e04e6ef92814	FALSE	NA	United States	NA	1975	NA	NA	5c987848-170c-4259-8ec9-bf091d98ef36;8d7aaef7-0750-4a8c-9e00-d4e06c891a31;9e1bd472-8f4a-4019-931b-5c4b7b6a81c6	Pharmaceutical Therapy, NOS	Tamoxifen;Carboplatin;Paclitaxel	not reported;yes	NA	Prior to Diagnosis;NA	NA	NA;107	NA;No	NA;84	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	bced907c-b54c-570b-9717-e6de5a6a3360	Radiation, Internal	NA	yes	NA	NA	NA	120	NA	84	NA	NA	NA	Primary Tumor Field	NA	NA	NULL	NA	NA	NA	TCGA-AX-A2IO
TCGA-UCEC	TCGA-DF-A2KY	Stage IVA	No	0	NA	2009	NA	Endometrium	18086	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	NA	released	No	TRUE	NA	Other	NA	8380/3	R1	primary	f5b6b0dd-46c1-5d14-bd23-e714eefaf0d4	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	not reported	female	not reported	Alive	49	-18086	NA	176c0a99-0302-5a6a-b9ad-30ff04e3360c	FALSE	NA	Canada	NA	332	WT-With Tumor	NA	41b667f3-d19d-4c7f-946b-ea80f005f9a1	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	5c3c1f4f-7108-4bdb-a57e-b778f7d86d2b	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-DF-A2KY
TCGA-UCEC	TCGA-AP-A0LS	Stage IA	No	0	NA	2009	NA	Endometrium	23126	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2006	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	19e6b67b-cc43-5b42-9709-aa36599dc30b	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	63	-23126	NA	ce0d78ee-e0db-55d8-88b5-227de3fbf4d2	FALSE	NA	NA	NA	2904	TF-Tumor Free	NA;Adjuvant	3515f4c0-386f-4bf1-88bd-a5f59413aff9;71c44717-d8db-4cff-98c8-6c6ce66d5f62	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	1c5375dd-4ad4-5ae0-9598-b653026cff01	Radiation, Implants	NA	yes	NA	NA	NA	98	NA	78	1	2100	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-AP-A0LS
TCGA-UCEC	TCGA-AP-A0LP	Stage IA	No	0	NA	NA	NA	Endometrium	27898	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2005	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	36b996a5-e6ab-5daf-9006-2bde00cf0a69	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	76	-27898	NA	23aad101-4296-5c7d-9bd5-05f34d2cba6f	FALSE	NA	NA	NA	1875	TF-Tumor Free	NA	1ea736b7-2b17-4464-a83b-ac25a9e23cbe	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	298eb25e-d4f8-5e8e-b2f6-827091de3b50;bd1d6bc3-cc18-4e42-aa0b-76ba1740ad05	Radiation, External Beam	NA	yes	NA	NA	NA	118;113	NA	114;79	1	540;4500	3;25	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-AP-A0LP
TCGA-UCEC	TCGA-AX-A1C9	Stage IB	No	0	NA	1988	NA	Endometrium	26903	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	22b7a7e7-adde-5ac9-9f96-19c6f2c6128a	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	73	-26903	NA	97f38906-f4fd-584b-9a15-679d55409e68	FALSE	NA	NA	NA	802	TF-Tumor Free	Adjuvant;NA	0a758b1f-d674-525d-a6ce-421ae5ed0567;aa3379e8-84f9-427d-85b9-a304efa54df9	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	4258319d-ea02-4383-837f-4d7b8edafb88	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A1C9
TCGA-UCEC	TCGA-D1-A17H	Stage IB	No	0	NA	2009	NA	Endometrium	22389	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	b69f14a4-a7d5-5835-9968-652acdce5769	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	61	-22389	NA	d6a3f6e0-9fcc-5add-a7b0-77050a978c56	FALSE	NA	NA	NA	852	TF-Tumor Free	NA;Adjuvant	469d362f-943a-4a32-a794-0e17d08e3d5f;cc6b1ba9-a429-537b-ac64-afef83990274	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	696b429c-5fa9-4212-8e21-827253895a28	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A17H
TCGA-UCEC	TCGA-BS-A0TG	Stage IIIA	No	0	NA	1988	NA	Endometrium	22043	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2005	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	6473de9e-e3af-5f99-975c-a8373c55a391	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	60	-22043	NA	a761f58b-17f5-5a95-9d10-299a4fbf98e7	FALSE	NA	NA	NA	2371	WT-With Tumor	NA;Adjuvant	b8d7c6b9-634c-4ad9-9f96-f400695bd548;ffd4b2dd-893a-4b60-b959-371e66c42a8c	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	a0fd16e3-f175-5918-9b7f-dca383e84e83	Radiation, External Beam	NA	yes	NA	NA	NA	93	NA	61	1	4500	25	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-BS-A0TG
TCGA-UCEC	TCGA-AX-A3GI	Stage IIIC	No	0	NA	1988	NA	Endometrium	24388	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Laparotomy	NA	8441/3	NA	primary	4a075418-2792-5db0-9e64-396cb2c93fd8	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	66	-24388	NA	2d2bd541-cbc4-5496-ae3e-ce02fb8ca17d	FALSE	NA	United States	NA	12	NA	NA;Adjuvant	2ffcb1b9-fd86-4e76-8a0d-d9b0272da7e3;d8556c08-7ea4-54c6-88c7-b65f9a87e923	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;unknown	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	966b6ad3-1d18-4aac-b758-37948b0fd6ce	Radiation Therapy, NOS	NA	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A3GI
TCGA-UCEC	TCGA-AP-A1E3	Stage IIIC1	No	0	NA	2009	NA	Endometrium	16544	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	b00b4a47-9cfe-5954-8223-f8df456bc8ea	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	45	-16544	NA	036e7831-79a7-520f-9b55-d3fa32a88c71	FALSE	NA	NA	NA	847	WT-With Tumor	NA	d89041db-a0a5-4394-9e07-b733c5678c91	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	e43b0a77-d691-4bdb-87e2-005308d0ed9f	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AP-A1E3
TCGA-UCEC	TCGA-B5-A11J	Stage IA	No	0	NA	1988	NA	Endometrium	23485	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2006	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	e611e793-17c5-5251-ac80-d2947a148d81	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	64	-23485	NA	95491576-be63-50fd-a69a-453ec41714bb	FALSE	NA	United States	NA	1656	TF-Tumor Free	Adjuvant;NA	171dd5bf-4e87-53f0-a4ce-adbe5478f20d;a998b3ff-b5ce-42ca-9214-ab1ca462d65e	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	2986cd42-1489-420c-8f87-2c2570271101	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A11J
TCGA-UCEC	TCGA-B5-A1MR	Stage IIIA	No	0	NA	1988	NA	Endometrium	24017	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	1995	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	a21fbabe-e875-5677-9e68-6b37282186d6	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	65	-24017	NA	f3f20b72-0419-5862-a8ab-db01ed67c608	FALSE	NA	United States	NA	6859	TF-Tumor Free	Adjuvant;NA	70c0427a-fc77-4e93-8128-e4df1096c8b0;86b38fed-781e-4769-a1d1-2f2bf853a8e1	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	332578c7-1409-5142-8456-ef31512df5d6	Radiation, External Beam	NA	yes	NA	NA	NA	NA	NA	NA	1	NA	NA	Primary Tumor Field	NA	NA	NULL	NA	NA	NA	TCGA-B5-A1MR
TCGA-UCEC	TCGA-D1-A161	Stage IC	No	0	NA	1995	NA	Endometrium	28695	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	e0980a3b-3670-52a5-ad47-b6f1b4467acc	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	78	-28695	NA	3c625a1d-559a-5c1f-a2ac-a798cda8da14	FALSE	NA	NA	NA	892	TF-Tumor Free	Adjuvant;NA	2b6b0ec2-b4fd-5d34-b117-87d3a3ac016d;5da4498d-f69d-4c60-acce-dfe476844431	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	03f87353-16b0-42c2-88c7-256bac6d6386	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A161
TCGA-UCEC	TCGA-QS-A5YQ	Stage IIIA	No	0	NA	2009	NA	Endometrium	20425	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2013	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	c086b653-e209-5155-bd29-8da62fd7ec9a	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	55	-20425	NA	e2e24506-9147-5af7-abf8-8e974293db26	FALSE	NA	United States	NA	759	TF-Tumor Free	NA	3db0177a-1e72-426a-bb9e-4d25ba3f0440	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	0fb5dc43-a72f-5993-929a-3ef1486249cb	Radiation, External Beam	NA	yes	NA	NA	Unknown	99	NA	65	NA	45	25	Primary Tumor Field	Gy	NA	NULL	NA	NA	NA	TCGA-QS-A5YQ
TCGA-UCEC	TCGA-EY-A3L3	Stage IA	No	0	NA	2009	NA	Endometrium	30138	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	03da229e-75bb-588f-90bf-84d998331fe1	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	82	-30138	NA	cc57dcd7-5e85-5e52-b35b-4adf130b31d7	FALSE	NA	United States	NA	832	NA	NA	330000e7-658b-4599-810a-1fd3addfd50e	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	cad43da4-7e03-5555-87a4-121b24947e13	Radiation, Internal	NA	yes	NA	NA	Complete Response	198	NA	198	NA	1500	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-EY-A3L3
TCGA-UCEC	TCGA-EY-A2OO	Stage IB	No	0	NA	2009	NA	Endometrium	20797	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	baa98524-f76b-54a8-8de1-9c3ee7b39b65	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	56	-20797	NA	c37ab2c0-3978-59ee-a387-6e4a98de35ec	FALSE	NA	United States	NA	1392	TF-Tumor Free	NA	d6450bf3-8559-4cb3-9879-8e61ddd13525	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	e01f2849-0f29-5eff-a940-5422e4c675b5	Radiation, Implants	NA	yes	NA	NA	NA	116	NA	96	1	2100	3	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-EY-A2OO
TCGA-UCEC	TCGA-B5-A11L	Stage IC	Not Reported	0	NA	1988	NA	Endometrium	26120	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	not reported	2007	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	NA	primary	708bf6ee-ba97-507f-b1b3-3b4a66d91444	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Dead	71	-26120	NA	1ed66275-6c77-5a3c-9c2f-beae4c94d66f	FALSE	NA	NA	2240	2240	NA	NA;Adjuvant	47b599f5-e2d4-4de4-ad3a-028fc87e8f1c;c3af28e8-c846-42d4-a5fe-5066db2f5dc8	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	fdc31081-01fe-5709-a770-61d7a84f6f05	Radiation, Combination	NA	yes	Recurrent Disease	NA	NA	248	NA	NA	1	6900	NA	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-B5-A11L
TCGA-UCEC	TCGA-BS-A0TE	Stage IVB	No	0	NA	1988	NA	Corpus uteri	12983	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2005	released	No	TRUE	NA	Biopsy	NA	8380/3	R2	primary	d5fa3d4b-bfb9-5720-8ce5-6dfeab7ef6a1	C54.9	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	asian	female	not hispanic or latino	Dead	35	-12983	NA	23a46023-c970-5abe-aaaf-3bdc2e5b5cdb	FALSE	NA	NA	146	146	WT-With Tumor	NA	e74e472f-41f5-4cdb-b7b1-5b17fc5c780b	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Palliative	603f066d-4e7e-52c4-a1f1-2fbe9a5366d7	Radiation, External Beam	NA	yes	NA	NA	NA	127	NA	111	1	2600	13	Distant Site	cGy	NA	NULL	NA	NA	NA	TCGA-BS-A0TE
TCGA-UCEC	TCGA-D1-A1NY	Stage IB	No	0	NA	2009	NA	Endometrium	24683	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	bd8b549a-18d5-511c-bb8b-1dfc8cf0b32a	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	67	-24683	NA	1d5ce98d-18ee-5c7e-8b0e-2fe2da9bb1e9	FALSE	NA	United States	NA	513	TF-Tumor Free	NA	8c47a5b7-7a6f-466a-96f8-e9fb7dd658c6	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	7881606d-f7c3-5b9b-b820-3215466d5aac	Radiation, Implants	NA	yes	NA	NA	NA	60	NA	52	1	2100	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-D1-A1NY
TCGA-UCEC	TCGA-D1-A16S	Stage IIIC	No	0	NA	2009	NA	Endometrium	25690	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	5d61a85d-1db9-5712-834f-4150227d8901	C54.1	Endometrium	High Grade	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	70	-25690	NA	267743ea-2830-5b40-b683-f5e00d34c6c2	FALSE	NA	NA	NA	568	TF-Tumor Free	Adjuvant;NA	80f40263-8080-5cae-a72a-bd0022c8a164;a8bf1a95-a681-432a-8b4b-73cfe91e1a1d	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	e17f11cc-93e5-4a5a-81b7-8768657dea23	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A16S
TCGA-UCEC	TCGA-B5-A11U	Stage IVB	No	0	NA	2009	NA	Endometrium	27160	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	NA	primary	99639fd2-381e-57f3-8de0-6e9f3dd7f6fc	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not reported	Alive	74	-27160	NA	c0fa632c-0f09-59bd-9e43-fb1211bd54cb	FALSE	NA	United States	NA	509	TF-Tumor Free	NA;Adjuvant	38d5d81d-c208-45d6-90a7-9b40fc273271;683c42bf-e0a1-4d95-ad92-5d7221b1d3f5	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	a9964f6a-2edd-5200-9d60-f08d94beb79a	Radiation, External Beam	NA	yes	NA	NA	NA	137	NA	NA	1	NA	NA	Primary Tumor Field	NA	NA	NULL	NA	NA	NA	TCGA-B5-A11U
TCGA-UCEC	TCGA-EO-A2CH	Stage IVB	No	0	NA	2009	NA	Endometrium	26966	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8441/3	R2	primary	70b51cda-35f6-5d26-b3cf-78d6593f9bca	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	not reported	female	not reported	Dead	73	-26966	NA	0941ebb2-1a6b-5219-84c0-ff018fe2668f	FALSE	NA	Canada	590	590	NA	NA	d0c8410c-002c-4e2b-83ed-630519fefeb6	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	9f59d7e7-2c25-5d39-95c9-ebebeb98ee6b	Radiation, External Beam	NA	yes	NA	NA	Progressive Disease	NA	NA	578	NA	800	1	Distant Site	cGy	NA	NULL	NA	NA	NA	TCGA-EO-A2CH
TCGA-UCEC	TCGA-D1-A0ZR	Stage IB	No	0	NA	NA	NA	Endometrium	21157	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	dd662e50-f856-549e-b8c3-3d974418f62a	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	57	-21157	NA	7013e283-d503-51f1-b15e-14770b692036	FALSE	NA	NA	NA	17	TF-Tumor Free	Adjuvant;NA	1c79c103-84a2-5df3-a04c-23e6078fe081;58921918-14d9-492b-a304-a7d2c83b833e	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	bef2325e-cd8d-43c7-8427-f518e838702e	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A0ZR
TCGA-UCEC	TCGA-D1-A16Y	Stage IB	No	0	NA	2009	NA	Endometrium	20455	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	RX	primary	8bc6d042-8041-55ba-93f4-86fc56b8bcf6	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	56	-20455	NA	8802988a-0d68-5a09-bdc4-3b21e28f31f8	FALSE	NA	NA	NA	532	TF-Tumor Free	NA;Adjuvant	0ab4b6a1-94a8-443c-b0c0-c4472e4ab9c1;82762a59-3efa-5b1f-8d1f-3bf5927c05dd	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	2242f3e5-0a20-456a-93cd-ca4985eeb727	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A16Y
TCGA-UCEC	TCGA-B5-A1MV	Stage IA	No	0	NA	2009	NA	Endometrium	30926	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	NA	primary	1dfe36df-e4de-5a59-83e4-d4b83ab864b4	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	84	-30926	NA	62e5753a-c900-5b22-b3ab-7d11afe47bdf	FALSE	NA	United States	NA	1565	TF-Tumor Free	NA;Adjuvant	6757409f-8bae-43e5-b495-4d62b20b53b1;81ad654f-04f2-5ca0-91c3-65fe8350599d	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	dfe18218-29d2-48e4-b6e1-b157abe87a7d	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A1MV
TCGA-UCEC	TCGA-BG-A187	Stage IB	No	0	NA	2009	NA	Endometrium	24099	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	e8487744-febb-5b64-a59f-86367bf55cd4	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	65	-24099	NA	0f4a1aa0-c451-5604-8efd-ca457cdff74c	FALSE	NA	NA	NA	448	TF-Tumor Free	Adjuvant;NA	d3514da6-ca59-52b6-91c3-6d8386390293;fa97eed9-3d11-4bd4-94bc-301b196c95d3	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	5458c033-ab54-4923-bebc-4952863cccdc	Radiation Therapy, NOS	NA	yes	NA	NA	Complete Response	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BG-A187
TCGA-UCEC	TCGA-EO-A22X	Stage IIIA	No	0	NA	2009	NA	Endometrium	13245	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	ba89b860-0f53-5836-9e61-24f89de6f90c	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	not reported	female	not reported	Alive	36	-13245	NA	692609e2-c553-550a-ac55-c875089ec9f1	FALSE	NA	Canada	NA	1752	TF-Tumor Free	NA	5dd2dc28-1d81-4b83-8c79-bd9d2a24ef73	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	df1c8f09-e88d-4c52-aff4-9bce62164807	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-EO-A22X
TCGA-UCEC	TCGA-AX-A0IZ	Stage IB	No	0	NA	1988	NA	Endometrium	19364	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2007	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	fa08e52e-a08c-5dff-992d-48d8f2399ce4	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	53	-19364	NA	400b2e1e-7ebf-56da-a404-7bc683ec14ce	FALSE	NA	United States	NA	1333	NA	NA;Adjuvant	53b6a265-ca06-46fa-b3ea-2c22cd64db28;81d10302-589d-5a62-be62-0151793a6cea	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;unknown	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	79114de4-531e-49cc-bc58-c00863612a94	Radiation Therapy, NOS	NA	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A0IZ
TCGA-UCEC	TCGA-BK-A6W3	Stage II	No	0	NA	2009	NA	Endometrium	12590	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2013	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	5971e3ee-854f-5eef-a4bb-26c6b52d6ab7	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	34	-12590	NA	50b47db9-0041-58d4-b3a7-b028b78418ec	FALSE	NA	United States	NA	305	TF-Tumor Free	Adjuvant;NA	424728c5-477a-57f2-82b8-6b6bd092f1b1;dff6aac1-e58f-4c25-8e1b-b83ddc7f2528	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	7c2f57b5-b78e-44e4-8465-6836bbd8f9d9	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BK-A6W3
TCGA-UCEC	TCGA-D1-A17F	Stage IA	No	0	NA	2009	NA	Endometrium	25116	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	56b0f462-b736-5a75-9c4d-a1fe4352c8fd	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	68	-25116	NA	484728d0-24db-5eb6-af3c-0702a2907055	FALSE	NA	NA	NA	39	TF-Tumor Free	Adjuvant;NA	b5f7e265-6cd5-5b61-9322-faa8e910a3c6;bd21896e-2ecb-4543-9157-709a4c0609e7	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	47166f8c-bed0-471c-882f-7541d9128af7	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A17F
TCGA-UCEC	TCGA-A5-A0GD	Stage IA	No	0	NA	NA	NA	Endometrium	27399	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	1999	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	90623af9-2c1f-599e-9e2c-f2079e4715d6	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Dead	75	-27399	NA	46557fd9-7911-588f-a680-4f45ad150016	FALSE	NA	NA	3423	3423	TF-Tumor Free	NA;Adjuvant	a800f86e-1a44-4743-a6f1-e3e3ed751ea6;dffa6065-3577-52b2-90a9-5d28505c6d5e	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	f9a31d53-c0a5-4cd9-bafa-72eacc55ce01	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-A5-A0GD
TCGA-UCEC	TCGA-EY-A5W2	Stage IB	No	0	NA	2009	NA	Endometrium	26498	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2012	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	c192dd75-28e1-5ce0-9b66-234a0ad768d9	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	72	-26498	NA	e7a98c2c-539d-501e-8a18-f269636399ec	FALSE	NA	United States	NA	516	TF-Tumor Free	NA;Adjuvant	3cfe6798-146a-4f09-a5a3-c1acc45ed1ad;71aa8a4a-92ae-45f2-a1ec-369eff694e7f	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	355c8539-8e1b-5d0d-abdf-69bea260650a	Radiation, Internal	NA	yes	NA	NA	Complete Response	77	NA	70	NA	2100	3	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-EY-A5W2
TCGA-UCEC	TCGA-AX-A1CF	Stage IVB	No	0	NA	1988	NA	Endometrium	25300	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2004	released	No	TRUE	NA	Biopsy	NA	8380/3	R2	primary	151e2065-1540-58b5-b88a-fb97d6841ad8	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	69	-25300	NA	349f3d0a-a11d-5b87-9dd2-13ac1f4b68c2	FALSE	NA	NA	NA	2337	WT-With Tumor	NA	7281d767-b32d-4058-94fc-d0218c6199d7	Pharmaceutical Therapy, NOS	Tamoxifen	yes	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	c2f051d1-56b2-5b7d-8906-c5c26e591706	Radiation Therapy, NOS	NA	yes	Progressive Disease	NA	NA	NA	NA	1588	1	NA	NA	Distant Site	NA	NA	NULL	NA	NA	NA	TCGA-AX-A1CF
TCGA-UCEC	TCGA-BG-A2L7	Stage IA	No	0	NA	2009	NA	Endometrium	25091	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	RX	primary	b17bbee7-7e2f-56ad-8810-13b9ea30fe3a	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	68	-25091	NA	608b1f93-afe7-5b95-bf1c-dfd43e6e96ae	FALSE	NA	United States	NA	612	TF-Tumor Free	NA	444bb8e7-37c5-4d3f-a13e-b13947f5a420	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	9102dc7e-d93d-5801-a075-5306c4b9b07d	Radiation, Internal	NA	yes	NA	NA	Complete Response	202	NA	189	NA	21	3	Primary Tumor Field	Gy	NA	NULL	NA	NA	NA	TCGA-BG-A2L7
TCGA-UCEC	TCGA-A5-A0VQ	Stage IA	No	0	NA	NA	NA	Endometrium	22995	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	ba1222b9-d518-5a52-8a8e-a57934b985f1	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	not reported	female	hispanic or latino	Alive	62	-22995	NA	a1684e59-c0e1-56da-b466-e8365faf08b9	FALSE	NA	NA	NA	485	TF-Tumor Free	NA	f26a16fc-ee6f-4671-8ce7-24206703f1f5	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	6ff4b65e-578e-5226-8c6a-276afbfda6ec	Radiation, External Beam	NA	yes	NA	NA	NA	155	NA	141	1	2100	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-A5-A0VQ
TCGA-UCEC	TCGA-AJ-A3EL	Stage IA	No	0	NA	2009	NA	Endometrium	17442	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	99f23a7d-b458-552a-b214-67ede6224c8f	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	native hawaiian or other pacific islander	female	not reported	Alive	47	-17442	NA	0427721e-1969-585e-96ef-584f2d46f0fc	FALSE	NA	United States	NA	684	TF-Tumor Free	NA;Adjuvant	cac1d073-3250-4b6d-8cc9-51bae9c09eb5;e805f4ce-753c-5b66-9c83-4f12fba5debc	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	aae7216f-98c0-42bb-8f4a-65b954596fec	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AJ-A3EL
TCGA-UCEC	TCGA-FI-A2F9	Stage IA	No	0	NA	2009	NA	Endometrium	28886	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	ff559877-2c95-5ed7-822e-73243281e99f	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	79	-28886	NA	b66db2b7-1f4f-5998-bc30-50af2b0a5309	FALSE	NA	United States	NA	1803	TF-Tumor Free	NA;Adjuvant	35b7d0f8-df62-4259-b25b-f2b3d8895b17;90c5ae22-2477-464f-a831-328552838f8f	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	5403b64c-e62d-582b-be76-64325085a36d	Radiation, Implants	NA	yes	NA	NA	NA	116	NA	85	1	2500	5	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-FI-A2F9
TCGA-UCEC	TCGA-BS-A0U7	Stage IC	No	0	NA	1988	NA	Endometrium	23166	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2003	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	fb3b9f51-ed44-507f-b588-e6080170cedf	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	63	-23166	NA	4a0c54c1-ff0b-5393-b614-c022bb0a0ace	FALSE	NA	NA	935	935	TF-Tumor Free	NA;Adjuvant	59d41ea4-d3a6-4b4d-8d1a-879a1b7df4b5;b9e5f331-24ec-5b4d-87ea-640d24b17ef0	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	b8b15dbe-412a-4a44-8b9c-cd9ed543d30d	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BS-A0U7
TCGA-UCEC	TCGA-A5-A0R9	Stage IA	No	0	NA	1995	NA	Endometrium	18982	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	c1a50eaf-8bbe-5be7-b81e-efb5e1921af2	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	51	-18982	NA	e1dc80db-4a53-5b1c-9d21-5577d2a116db	FALSE	NA	NA	NA	749	TF-Tumor Free	NA;Adjuvant	5c741b9b-7239-41cf-ba7b-f3c0bab381ad;b255f29d-6902-424f-af38-147316c189f1	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	339de67c-c87f-5567-8418-61f2d754ece7	Radiation, Implants	NA	yes	NA	NA	NA	136	NA	124	1	2000	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-A5-A0R9
TCGA-UCEC	TCGA-A5-A1OF	Stage IA	No	0	NA	2009	NA	Endometrium	17308	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	650ef48f-88b9-5e34-a7e6-b86c220ce3d0	C54.1	Endometrium	High Grade	NA	NA	NA	NA	NA	NA	NA	NA	NA	not reported	female	hispanic or latino	Alive	47	-17308	NA	914f33d3-f471-5217-ab80-a340b1a61a93	FALSE	NA	United States	NA	973	TF-Tumor Free	NA;Adjuvant	3b648041-ddf6-4cfb-ac63-50191a8bd2b2;65a5e3ca-8091-47bf-b3a2-f609cc11a2c9	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	5c56574b-b9b5-5411-9463-bd91887e65d0	Radiation, External Beam	NA	yes	NA	NA	NA	107	NA	70	1	5040	8	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-A5-A1OF
TCGA-UCEC	TCGA-SL-A6JA	Stage IB	No	0	NA	2009	NA	Endometrium	28401	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2013	released	No	TRUE	NA	Surgical Resection	NA	8380/3	Unknown	primary	e78ab9fc-8c16-5b13-a3a6-592314fe0141	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	77	-28401	NA	ab0425be-3d1c-5564-b557-614a4080be6a	FALSE	NA	United States	NA	7	TF-Tumor Free	NA;Adjuvant	222d700a-26f4-4dc5-b532-83b45333bc33;fff63bc4-5160-5d59-b261-a47fba285a1c	Pharmaceutical Therapy, NOS	Tamoxifen;NA	unknown;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	d28c71ce-6bd7-4b6c-8890-898752967c59	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-SL-A6JA
TCGA-UCEC	TCGA-A5-A3LO	Stage IB	No	0	NA	2009	NA	Endometrium	23401	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	2baac3d4-74dd-5577-af66-fc9044528a99	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	64	-23401	NA	a86dfa2e-5d13-51d3-bf8e-cad075653a3d	FALSE	NA	United States	NA	776	TF-Tumor Free	NA	32ad3fdc-1f3d-4534-a048-dbcb24a5964f	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	033a2cd6-0b64-5a43-ad81-91b705778d83	Radiation, Implants	NA	yes	NA	NA	NA	125	NA	111	1	2100	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-A5-A3LO
TCGA-UCEC	TCGA-BS-A0V8	Stage IIB	No	0	NA	1988	NA	Endometrium	24981	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2006	released	No	TRUE	NA	Biopsy	NA	8380/3	R1	primary	c46365fa-932f-5775-863a-dd410c14bb57	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	native hawaiian or other pacific islander	female	not hispanic or latino	Alive	68	-24981	NA	3fecafa2-72e6-51c6-83b4-ad54786e9d2b	FALSE	NA	NA	NA	2544	TF-Tumor Free	Adjuvant;NA	4ae250ef-1fe7-516e-82e8-af91b922d990;5fc8bf4a-40a4-48d5-9137-e5b209e07684	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	49d8c00c-0a89-4ca9-a0d8-82261ea6ce40	Radiation Therapy, NOS	NA	yes	NA	NA	Complete Response	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BS-A0V8
TCGA-UCEC	TCGA-BK-A0CC	Stage IIIC	No	0	NA	NA	NA	Endometrium	25479	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Incisional Biopsy	NA	8441/3	RX	primary	7924d7fd-572e-5f05-920f-de2bc56e759f	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	hispanic or latino	Alive	69	-25479	NA	f3903f35-c35d-54f4-be3d-4c655da416f4	FALSE	NA	NA	NA	1067	WT-With Tumor	NA	009c113d-d981-4e1e-b219-9efeffc770fc;07cff2d7-ed0c-499d-9743-1820fa097e92	Pharmaceutical Therapy, NOS	NA;Tamoxifen	yes;no	Recurrent Disease;NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA;Adjuvant	500a1497-9f30-41a9-a14a-48934d222c0d;af85e4ac-f4ce-532c-ad60-f6c582a60a9e	Radiation Therapy, NOS;Radiation, External Beam	NA	no;yes	Recurrent Disease;NA	NA	NA	NA;179	NA	NA;147	NA;1	NA;4500	NA;25	NULL;Primary Tumor Field	NA;cGy	NA	NULL	NA	NA	NA	TCGA-BK-A0CC
TCGA-UCEC	TCGA-EO-A3AS	Stage IA	No	0	NA	2009	NA	Endometrium	31450	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	8f40046d-b2de-5d19-a62d-566622b93e6c	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	not reported	female	not reported	Alive	86	-31450	NA	15d4e11d-5881-5dc0-b3ab-6deca92452a2	FALSE	NA	Canada	NA	1046	TF-Tumor Free	Adjuvant;NA	4896604c-0cf5-5425-93af-bc80f526a66c;dbd8e306-76ab-4ef1-9cbd-a6e42c60d352	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	ba4ee500-cc4c-44f1-be48-8a8c6de81df4	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-EO-A3AS
TCGA-UCEC	TCGA-BG-A0W1	Stage II	No	0	NA	1988	NA	Endometrium	32750	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2007	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	2f57195e-be66-5f99-a9cf-800a9d022168	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	89	-32750	NA	2b410e4c-7ff6-5e08-9cd0-f4797aa28dc8	TRUE	NA	NA	NA	122	TF-Tumor Free	Adjuvant;NA	a93e2a76-3c1c-5b5e-86dc-a889d27ac599;b85070b7-b4a2-48db-9231-2f289d698140	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;unknown	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	c5604aa3-d3fb-43bb-ab3d-da4c234f0ff9	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BG-A0W1
TCGA-UCEC	TCGA-AX-A0IS	Stage IC	No	0	NA	1988	NA	Endometrium	19173	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	R1	primary	50933fe1-0bd4-5217-b7aa-17045b465258	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	52	-19173	NA	811f735d-e0fb-5847-abb3-90d83e5f56da	FALSE	NA	NA	1858	1858	WT-With Tumor	NA	03318658-e277-49f3-8ba8-f2bca5ae1dcd;38718c3c-f993-4936-9b81-d7fa836faf4f;8eccf49d-8f39-4ac7-96a6-af446186feae	Pharmaceutical Therapy, NOS	Gemcitabine Hydrochloride;Tivozanib;Tamoxifen	yes;not reported	Recurrent Disease;Progressive Disease;NA	NA;Prior to Diagnosis	NA	NA	NA	NA;1065	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	efbb1729-fa6d-42d4-a538-c91eb7aa136a	Radiation Therapy, NOS	NA	yes	NA	NA	Complete Response	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A0IS
TCGA-UCEC	TCGA-B5-A0K7	Stage IA	No	0	NA	2009	NA	Endometrium	23429	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	2db53c86-27d4-5a81-a2a0-6ac0e682102b	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	64	-23429	NA	a7d688f5-0410-5408-8e94-f4d5621df1df	FALSE	NA	United States	NA	1933	TF-Tumor Free	Adjuvant;NA	315d3d0f-e435-4cec-909b-c8cbc1e16168;950c2c60-a5b1-4744-a279-e7db251dffd8	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	3e5c4e8d-5a8a-55ea-bd1b-7b7f72c11076	Radiation, External Beam	NA	yes	Recurrent Disease	NA	NA	407	NA	393	1	7500	25	Locoregional Site	cGy	NA	NULL	NA	NA	NA	TCGA-B5-A0K7
TCGA-UCEC	TCGA-A5-A0GB	Stage IB	No	0	NA	1995	NA	Endometrium	23883	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	aafd3d0a-9b88-5dbe-8e83-18aaccc30289	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	65	-23883	NA	b6988514-2f1c-5264-b604-412054c5d4ec	FALSE	NA	NA	NA	997	TF-Tumor Free	Adjuvant;NA	5170468b-d90c-405a-8e0c-d068c5f2a7f1;565759d0-5ba2-4089-ba5f-c04547e2d042	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	7197d523-7793-5e75-9fc6-af3694d40210	Radiation, External Beam	NA	yes	NA	NA	NA	106	NA	101	1	1500	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-A5-A0GB
TCGA-UCEC	TCGA-AX-A3FW	Stage IB	No	0	NA	1988	NA	Endometrium	24419	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Surgical Resection	NA	8380/3	NA	primary	6c0615cd-0061-5fca-8bef-3ca10ce6383a	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	66	-24419	NA	7150706f-be8d-5f53-8882-93c479869817	FALSE	NA	United States	NA	17	NA	NA;Adjuvant	188aeee5-a2d9-4e04-b50d-0f24bdb76b28;fbbc28cf-2e15-50bb-8b1e-a9ee98107e79	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;unknown	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	4a2df453-5c70-498f-a090-422149992b8d	Radiation Therapy, NOS	NA	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A3FW
TCGA-UCEC	TCGA-DF-A2KR	Stage IIIC	No	NA	NA	NA	NA	Endometrium	NA	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	NA	released	No	TRUE	NA	Biopsy	NA	8380/3	RX	primary	483b7756-5065-5f57-adc2-4cb2e906d3f9	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	not reported	female	not reported	Alive	84	-31007	NA	1db96901-2fe2-55cd-84fa-dc1d0da97ede	TRUE	NA	Canada	NA	1865	TF-Tumor Free	Adjuvant;NA	c4466c27-5ca1-41a8-983e-3457e51334f3;e117642c-3809-4b67-890f-7dc176d3b9d5	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	155a92d0-f44a-58c0-9d49-33190002e34c;99024a77-cfb0-4670-8e7d-4d54cf64cb28	Radiation, External Beam	NA	yes	NA	NA	NA	NA;133	NA	NA;98	NA	NA	25;NA	Regional Site	NA	NA	NULL	NA	NA	NA	TCGA-DF-A2KR
TCGA-UCEC	TCGA-AX-A2HJ	Stage IC	No	0	NA	1988	NA	Endometrium	13112	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	4af5b840-400a-5d19-820c-3b9fd60ba6e3	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	asian	female	not hispanic or latino	Alive	35	-13112	NA	5a34c9fd-6e43-566b-8e12-af41e66ca002	FALSE	NA	United States	NA	935	TF-Tumor Free	Adjuvant;NA	54cacc4d-d511-43c9-9802-e6fa2bb220c4;d41c4ef8-9e6e-4ca2-b7f0-fbf9c025513b	Pharmaceutical Therapy, NOS	NA;Tamoxifen	yes;not reported	NA	NA;Prior to Diagnosis	Complete Response;NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	4ec967a9-ecd8-5df2-a50d-46f9f46f0731	Radiation, External Beam	NA	yes	NA	NA	NA	330	NA	274	1	NA	NA	Locoregional Site	NA	NA	NULL	NA	NA	NA	TCGA-AX-A2HJ
TCGA-UCEC	TCGA-A5-A0GH	Stage IA	No	0	NA	NA	NA	Endometrium	21090	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2004	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	e572117a-2fb1-5066-8813-9a18c7f4fe90	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	57	-21090	NA	d5ecc0c8-b648-567c-bef5-093fbf06a6cf	FALSE	NA	NA	NA	2254	TF-Tumor Free	NA;Adjuvant	b5d55cb6-d56c-4887-86bc-27f0e4839de2;c86ccec8-f08c-5efd-8ccd-c80ec68500b4	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	b4fbaf18-0ca8-4ad3-b09b-67f8d25c6778	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-A5-A0GH
TCGA-UCEC	TCGA-EY-A547	Stage IA	No	0	NA	NA	NA	Endometrium	27686	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2011	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	af37ed24-16f1-5b06-b606-2fd25594ecdc	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	75	-27686	NA	399576fd-07c2-54de-bfad-53f280417976	FALSE	NA	United States	NA	545	TF-Tumor Free	NA;Adjuvant	5c203a5b-9622-4252-b004-9b1132693331;b3d04230-9bbb-47b2-9e32-1a78788e17a3	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	83f289c0-5cd8-5688-9db9-efa2c7902a10	Radiation, Internal	NA	yes	NA	NA	Complete Response	185	NA	171	NA	2100	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-EY-A547
TCGA-UCEC	TCGA-D1-A179	Stage IIIC	No	0	NA	2009	NA	Endometrium	28037	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	09cbb646-8d49-589d-8ef2-f934f3dfd0be	C54.1	Endometrium	High Grade	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	hispanic or latino	Dead	76	-28037	NA	81cd252c-e9e4-51f3-8c0f-6b4b20f25bf4	FALSE	NA	NA	448	448	WT-With Tumor	NA	25ed7704-98cd-4ae6-b163-5ad7e3d3852f	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	9d859ce2-40b3-46b8-bde7-bd4a443b6ae7	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A179
TCGA-UCEC	TCGA-B5-A11E	Stage IB	No	0	NA	2009	NA	Endometrium	19458	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	1b2d6833-a1ee-5d20-9567-173f86e5af4d	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	53	-19458	NA	bac1495d-3338-556a-b9d6-93239b967de8	FALSE	NA	United States	NA	1820	TF-Tumor Free	Adjuvant;NA	9a3d0025-acb8-59da-bf52-9c4bccdfcc24;ed8d79de-7b70-45be-ab9f-d24510ac7854	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	bc34bc25-5454-44d3-b676-91414cd91151	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A11E
TCGA-UCEC	TCGA-EO-A3AZ	Stage IB	No	0	NA	2009	NA	Endometrium	29234	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8441/3	R0	primary	6a15561f-5eee-51c1-81ef-a8c63d313591	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	not reported	female	not reported	Alive	80	-29234	NA	4d5a76c9-3887-5675-bb43-b0fb50bc0d49	FALSE	NA	Canada	NA	826	TF-Tumor Free	Adjuvant;NA	6f41146a-6ec2-5aca-b679-e2554e0fea90;9f411943-4ec3-41ea-869a-a62d09ba4297	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	96032b64-71c7-4d3e-8368-c2536bd7aadc	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-EO-A3AZ
TCGA-UCEC	TCGA-BG-A222	Stage IA	No	0	NA	2009	NA	Endometrium	18220	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	0e900d10-ce62-519e-aa93-27cd4b5ab78c	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	49	-18220	NA	7fa24ac1-267b-525f-8deb-3a2b9b0e64a9	FALSE	NA	United States	NA	291	TF-Tumor Free	Adjuvant;NA	05449b6f-5ed0-5476-9414-33013a97f947;29dacd08-ab9a-4f3c-a710-e4ee4d988130	Pharmaceutical Therapy, NOS	NA;Tamoxifen	yes;no	NA	NA;Prior to Diagnosis	Complete Response;NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	f125f7d9-1c4a-4e65-af8b-7a09036d4ee0	Radiation Therapy, NOS	NA	yes	NA	NA	Complete Response	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BG-A222
TCGA-UCEC	TCGA-DF-A2KZ	Stage IB	No	0	NA	2009	NA	Endometrium	31973	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	NA	released	No	TRUE	NA	Surgical Resection	NA	8380/3	RX	primary	3d756b40-2ccd-55bc-bef9-5e5e5c2cd5c3	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	not reported	female	not reported	Alive	87	-31973	NA	1b0c592e-7c31-555e-bf54-a9b7dc83eaa5	FALSE	NA	Canada	NA	826	TF-Tumor Free	Adjuvant;NA	36b28f02-115f-5576-a922-2e892bd9708a;491e747c-0574-490f-b642-f2252104d80b	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	ad39fb04-52f3-4aed-8d1e-a3134baf6614	Radiation Therapy, NOS	NA	yes	NA	NA	Not Reported	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-DF-A2KZ
TCGA-UCEC	TCGA-D1-A167	Stage IC	No	0	NA	1995	NA	Endometrium	25575	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	65b84fd5-a017-5f29-b0be-353641c5d933	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	70	-25575	NA	a968b7ee-1a75-5678-b036-8721f572b4d3	FALSE	NA	NA	NA	478	TF-Tumor Free	NA;Adjuvant	21911aa8-83ab-4cb3-8133-4628ba1224cf;263b8b80-c79d-4110-9217-6cb8b01d1ac3	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	faedf77f-c33d-582f-9d6c-7b8f4969d379	Radiation, Implants	NA	yes	NA	NA	NA	146	NA	138	1	2100	3	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-D1-A167
TCGA-UCEC	TCGA-JU-AAVI	Stage IIIC1	No	0	NA	1988	NA	Endometrium	22289	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2013	released	No	TRUE	NA	Incisional Biopsy	NA	8441/3	R0	primary	f3001592-e8ec-56a5-8d72-3d58846fe180	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Dead	61	-22289	NA	f907a2a5-22a2-58dd-866e-d9feb0d7969f	FALSE	NA	United States	540	540	WT-With Tumor	NA	a260bcd5-d287-485c-823d-115a83f6dc82	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	747c73f7-9a94-44fb-aa8e-26d6c437704e;b3f73560-67d6-545c-9828-aa622d764e30	Radiation, Internal;Radiation, External Beam	NA	yes	NA	NA	Partial Response	137;123	NA	130;82	NA	1800;4860	3;27	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-JU-AAVI
TCGA-UCEC	TCGA-AX-A1CA	Stage IB	No	0	NA	1988	NA	Endometrium	25817	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8441/3	R1	primary	c05fa32f-6e1d-5526-ab18-4df2d3d31107	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	70	-25817	NA	ce12f12d-6909-5e15-b949-98cea3d19440	FALSE	NA	NA	NA	974	Unknown	NA	7f4dfce4-cf8f-49e4-bb81-6ee5d3b37da9	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	2e944883-aaa8-4230-a91b-3b1e5455eb1d	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A1CA
TCGA-UCEC	TCGA-DI-A1C3	Stage IB	No	0	NA	2009	NA	Endometrium	13885	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Other	NA	8380/3	R0	primary	fc1a25b2-20be-5150-bc58-c647c3513ace	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	38	-13885	NA	2861a82d-0e91-541e-b77d-c4585dc408e9	FALSE	NA	United States	NA	739	TF-Tumor Free	NA;Adjuvant	47d8d255-bab9-4764-bbe1-09aee19ffe39;a87dd9ac-58c0-5fc7-aba9-3fa3e6f9f6d0	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	d7c74242-9e5e-4364-8a70-7dce9845101f	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-DI-A1C3
TCGA-UCEC	TCGA-AJ-A3BF	Stage IIIC2	No	0	NA	2009	NA	Endometrium	23906	Papillary serous cystadenocarcinoma	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8460/3	R0	primary	4919e8d0-23a1-55d8-a0b0-5e138272b8e3	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	65	-23906	NA	ffc30aed-dee2-51e6-b47a-6040fd685f9e	FALSE	NA	United States	NA	551	Unknown	NA	cefd8a90-d8ab-43a0-965f-25d545efab76	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	266f55ee-b5db-46d3-ae64-c35c8158c001;444dfdac-c3b7-523a-9fb6-4326cef8fdd0;d9cf9adf-3fb2-4864-8725-a6a3c6209a98	Radiation, External Beam	NA	yes	NA	NA	Unknown;Progressive Disease;Complete Response	551;457;176	NA	517;411;136	NA	5500;5940;4500	NA	Distant Site;Regional Site;Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-AJ-A3BF
TCGA-UCEC	TCGA-AX-A1C4	Stage IB	No	0	NA	1988	NA	Endometrium	19209	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R1	primary	d13c3b46-984f-5d2f-b490-90fc9053caea	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	52	-19209	NA	f5abb0b7-7d51-5bf3-87e8-b27e9cba66c3	FALSE	NA	NA	NA	404	TF-Tumor Free	NA;Adjuvant	038a062a-d0cb-4c93-aed2-de127998a7a8;87dd191a-8d35-4c42-ac61-2a35b1c9e743	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	71b7f65b-6e7b-5617-811c-65652dccc1b8	Radiation, Combination	NA	yes	NA	NA	NA	NA	NA	203	1	NA	NA	Primary Tumor Field	NA	NA	NULL	NA	NA	NA	TCGA-AX-A1C4
TCGA-UCEC	TCGA-AJ-A6NU	Stage II	No	0	NA	2009	NA	Endometrium	23498	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2012	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	ec644a47-fd68-5f24-817a-9757acec06d4	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	64	-23498	NA	2f20b9e2-817b-5e08-a486-b2009adaea1f	FALSE	NA	United States	NA	632	TF-Tumor Free	Adjuvant;NA	6ce3636b-6379-5e1e-b73c-59210b7bf1d4;c143d9b9-0f60-4c62-ac7d-79a0c41ec9d4	Pharmaceutical Therapy, NOS	NA;Tamoxifen	unknown;no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	551fe405-206e-4562-a20a-d614b8f0ef1e	Radiation Therapy, NOS	NA	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AJ-A6NU
TCGA-UCEC	TCGA-AJ-A8CW	Stage IA	No	0	NA	2009	NA	Endometrium	23554	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Surgical Resection	NA	8380/3	R0	primary	65763f7d-c3f8-5db5-a71e-f921edcc96e4	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	64	-23554	NA	6890a0be-464d-57fe-a1e4-40299008de2c	FALSE	NA	United States	NA	4	TF-Tumor Free	NA;Adjuvant	617e472f-f585-4d04-8292-7c7ec7044604;8621a323-0eec-5454-be3a-119e8eabd5a3	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no;unknown	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	36716cf4-5533-4415-807c-836f5739a41a	Radiation Therapy, NOS	NA	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AJ-A8CW
TCGA-UCEC	TCGA-AP-A059	Stage IA	No	0	NA	2009	NA	Endometrium	25311	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2006	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	465fd288-52d6-53c1-a237-9e067167a270	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	69	-25311	NA	18454974-897b-5a0c-8f4e-a15d6a2da0f9	FALSE	NA	NA	NA	1461	TF-Tumor Free	NA;Adjuvant	171e9bc2-1254-4325-86aa-af04c8e1bcb2;4570218a-f738-4666-b2ad-dfe9bd41f656	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	acb7d17f-61c2-5616-a447-397eb297b65c	Radiation, Implants	NA	yes	NA	NA	NA	106	NA	78	1	2100	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-AP-A059
TCGA-UCEC	TCGA-AJ-A8CV	Stage IB	No	0	NA	2009	NA	Endometrium	21336	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	de2aacc8-38c0-5d11-ba43-f8971d5d018b	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not reported	Alive	58	-21336	NA	2a8d54bd-2634-51fc-86cf-c8e882f98f3b	FALSE	NA	United States	NA	1068	TF-Tumor Free	Adjuvant;NA	75d14244-c9f0-56cf-9117-9e956bab128c;ed3a6703-18a5-43bc-a49c-261261aab4ec	Pharmaceutical Therapy, NOS	NA;Tamoxifen	unknown;no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	a0ce8179-9158-4f9d-a1e0-dca7bb381d0a	Radiation Therapy, NOS	NA	yes	NA	NA	Complete Response	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AJ-A8CV
TCGA-UCEC	TCGA-FI-A2D2	Stage IB	No	0	NA	1988	NA	Endometrium	24260	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	d4f21a6a-c973-5e3b-8577-7ae13dc8940b	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	66	-24260	NA	eba1519c-68e7-55ca-b7cb-8d2133a25108	FALSE	NA	United States	2352	2352	WT-With Tumor	NA	39944ad0-e23b-4113-9194-8269f55378f7;43481f59-62eb-4fa9-901b-e0acac22efa1	Pharmaceutical Therapy, NOS	NA;Tamoxifen	yes;no	Recurrent Disease;NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	a47f2396-a881-492d-891a-9a89fce0d2ae	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-FI-A2D2
TCGA-UCEC	TCGA-A5-A0G5	Stage IB	No	0	NA	NA	NA	Endometrium	26827	Clear cell adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8310/3	R0	primary	441b699d-7cc8-5b83-b985-f773df3101d5	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not reported	Alive	73	-26827	NA	8de932fa-c5e3-5a52-b36c-7989aee3737b	FALSE	NA	NA	NA	1126	TF-Tumor Free	Adjuvant;NA	0f56d4f4-ebdd-4b41-b4f3-3e25a1195451;120be95c-8fcf-46aa-8ed9-f487e05d590c	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	ecfdbad7-38fe-5b2b-bf45-864601a0f756;f9c1a492-b49a-4617-aca1-1b8062e885cd	Radiation, External Beam;Radiation, Implants	NA	yes	NA	NA	NA	882;898	NA	115;889	1;2	4500;1260	25;10	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-A5-A0G5
TCGA-UCEC	TCGA-FI-A2D4	Stage IIIC	No	0	NA	1988	NA	Endometrium	16163	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R2	primary	5c53c6e5-1b23-58c4-bfaa-18a833c3d53e	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Dead	44	-16163	NA	f8b39abc-ffd6-56f1-8b85-2075bcb14cf2	FALSE	NA	United States	243	243	WT-With Tumor	NA	2077592d-c630-4a9a-a8b8-500de5d23f15	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	da3c6caa-84ad-49bf-82f2-2adb38598e5a	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-FI-A2D4
TCGA-UCEC	TCGA-AP-A05O	Stage IB	No	0	NA	2009	NA	Endometrium	24978	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	2efa2af1-2122-5915-b315-b04d67565aad	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	68	-24978	NA	a7d5fa96-a744-5b60-90ae-aecdafa90d04	FALSE	NA	NA	NA	384	TF-Tumor Free	NA	773b79eb-5bdd-4352-b29c-b62d6b0a2d7f	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	23d756a9-9cf5-55b0-91f0-13288b48e198	Radiation, Implants	NA	yes	NA	NA	NA	132	NA	104	1	2100	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-AP-A05O
TCGA-UCEC	TCGA-EO-A3B0	Stage IIIC2	No	0	NA	2009	NA	Endometrium	15954	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	RX	primary	3381b937-de4b-527c-ad36-5984ddcc6bb2	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	asian	female	not reported	Alive	43	-15954	NA	3b813f30-d519-5c0e-9aa7-ce07c2780822	FALSE	NA	Canada	NA	1412	TF-Tumor Free	Adjuvant;NA	3871232a-c174-5f4d-9cbd-9d74d3cc9124;49741fe9-ffa6-4db0-8358-f759adfe019e	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	f8e1b147-fc46-49c6-8d65-c021a5f62690	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-EO-A3B0
TCGA-UCEC	TCGA-BG-A0M9	Stage IB	No	0	NA	1988	NA	Endometrium	26708	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	9f5c213e-be1c-526f-9212-a644cca7a5f4	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	73	-26708	NA	d762555b-0370-5081-905f-16fa84728790	FALSE	NA	NA	NA	2270	TF-Tumor Free	Adjuvant;NA	032c27f3-c02c-5276-9bba-8ef0c0c4b394;abd690e4-0c7b-4976-aa03-52d9bef6d39b	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	62ed7155-1420-4be5-a0b7-a9f31c67319b	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BG-A0M9
TCGA-UCEC	TCGA-AJ-A3BK	Stage IC	No	0	NA	2009	NA	Endometrium	24943	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	e8ed2352-d01d-524f-ada4-cff9500d186c	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	68	-24943	NA	0926f2b4-a18a-531b-82a7-f798da65b318	FALSE	NA	United States	NA	1031	TF-Tumor Free	Adjuvant;NA	79555916-fec2-4d71-866b-511d6373c572;8725ff5c-5406-4803-b3e2-7f53149f6271	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	38667152-25fb-562a-84b4-3db79cc955e2	Radiation, External Beam	NA	yes	NA	NA	Complete Response	168	NA	137	NA	4500	25	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-AJ-A3BK
TCGA-UCEC	TCGA-AJ-A3BI	Stage IA	No	0	NA	2009	NA	Endometrium	24623	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	76791262-f3b4-5bfc-85aa-0244e4b2ac0f	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	67	-24623	NA	c5e55511-7437-599c-9032-552b66dedc28	FALSE	NA	United States	NA	575	TF-Tumor Free	NA	7a5f0fbd-cc15-441a-b816-d8d0258939b8	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	65320371-656f-4517-8587-a007c61f4a98	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AJ-A3BI
TCGA-UCEC	TCGA-AX-A3FZ	Stage IIIB	No	0	NA	1988	NA	Endometrium	12331	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Laparotomy	NA	8380/3	NA	primary	327da626-cc15-56c4-8c4d-aefe97dee801	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	33	-12331	NA	22d6ec5d-0d1f-56e3-babd-8ee6d909622c	FALSE	NA	United States	NA	6	NA	NA;Adjuvant	3729fc3a-1486-4731-a053-832b4276013f;b393e885-8aa9-5599-9315-f9c680b86c57	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;unknown	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	6a693d06-0175-4ee3-9d8a-8fabcd5cdcfa	Radiation Therapy, NOS	NA	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A3FZ
TCGA-UCEC	TCGA-AX-A2HC	Stage IIIC	No	0	NA	1988	NA	Endometrium	19485	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2006	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	338fe46f-b6a4-50ed-8fc2-2ff30bca40e1	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	53	-19485	NA	baa2500b-d4c9-5e0f-bc4a-41390e221f01	FALSE	NA	United States	NA	1044	WT-With Tumor	NA	ee70f138-39e9-4938-ba36-1245dc179282	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Palliative	e28a8158-7cf7-535b-86c4-451eaa12d50a	Radiation Therapy, NOS	NA	yes	NA	NA	NA	955	NA	924	1	NA	NA	Distant Site	NA	NA	NULL	NA	NA	NA	TCGA-AX-A2HC
TCGA-UCEC	TCGA-D1-A16I	Stage IC	No	0	NA	1995	NA	Endometrium	22836	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	1e7f4048-0130-582a-9efb-c35579987389	C54.1	Endometrium	High Grade	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	62	-22836	NA	83564807-d14e-5322-865d-4869b93fc86d	FALSE	NA	NA	350	350	TF-Tumor Free	NA;Adjuvant	863b07da-71a1-47c2-9b31-37642207f114;e182c9ba-43a1-4b73-98c2-1d14332605f1	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no;yes	NA	Prior to Diagnosis;NA	NA;Complete Response	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	ae66f263-4856-52b2-bc3d-702c88df34b3	Radiation, Implants	NA	yes	NA	NA	NA	95	NA	88	1	2100	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-D1-A16I
TCGA-UCEC	TCGA-QS-A8F1	Stage IIIA	No	0	NA	2009	NA	Fundus uteri	31386	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2013	released	No	TRUE	NA	Surgical Resection	NA	8441/3	Unknown	primary	cf4f8fc1-67e6-5fac-a933-4266cfd81299	C54.3	Fundus uteri	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Dead	85	-31386	NA	289d909f-5255-5016-8ff0-00454a0ca55a	FALSE	NA	United States	135	135	WT-With Tumor	NA	2171cf87-d50b-4ef7-ba7c-b9e56d795df8	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	f2450315-5c81-4204-a1f1-1e9610c137ee	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-QS-A8F1
TCGA-UCEC	TCGA-BK-A0CB	Stage IIIC	No	0	NA	NA	NA	Endometrium	21930	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Incisional Biopsy	NA	8380/3	R0	primary	5a486ede-eca5-51a6-bbec-2e5edf372fae	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	60	-21930	NA	1f26523e-25cd-56bb-9040-3a6c41c9990a	FALSE	NA	NA	NA	1092	TF-Tumor Free	NA	7a3081b2-0ef6-4f86-961c-d6d21833c5f9	Pharmaceutical Therapy, NOS	Tamoxifen	unknown	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	6d9bb9fe-b29f-479b-8591-00bd52bdf40a	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BK-A0CB
TCGA-UCEC	TCGA-D1-A17K	Stage IA	No	0	NA	2009	NA	Endometrium	27283	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	8924b9e4-ba8b-5514-ae8f-634829d050f5	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	74	-27283	NA	68902cda-85a5-5b5d-8aa5-69a8fc3b7da5	FALSE	NA	NA	NA	854	TF-Tumor Free	NA;Adjuvant	88e5b893-6b29-499d-9cce-f012ad259069;e478cef9-e92d-5b9b-a744-f744825d6cff	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	24e7ef81-a696-4dfb-b724-c1a6aba42185	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A17K
TCGA-UCEC	TCGA-A5-A1OG	Stage IIIC2	No	0	NA	2009	NA	Endometrium	23956	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8441/3	R0	primary	f853a784-588f-507c-9f83-400ecd132330	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	asian	female	not hispanic or latino	Dead	65	-23956	NA	0083a218-06f6-5278-ac8e-1bc4f0cf5124	FALSE	NA	United States	973	973	WT-With Tumor	NA	d45a1eca-995e-4359-b64e-a3509c93f793	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	c9205b54-6bd3-4402-81d8-8df967c76ac4;d835223b-c175-5c78-bffa-0d96ffdc85a7	Radiation, Implants;Radiation, External Beam	NA	yes	NA	NA	NA	238;216	NA	223;179	1	1500;5050	3;28	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-A5-A1OG
TCGA-UCEC	TCGA-B5-A1MY	Stage IIIC2	No	0	NA	2009	NA	Endometrium	22805	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8441/3	NA	primary	fe06b940-4e3d-5573-a605-d51e85687e05	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not reported	Dead	62	-22805	NA	f29ecfc9-9382-5135-8dc7-46978064f64e	FALSE	NA	United States	361	361	WT-With Tumor	NA	36aa8b80-6692-41de-8f9e-afa1da3df2b5	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	5a8c6402-cd3b-59a8-962e-68bae816ecb6;821f14fe-1812-44a6-8f44-482670f07ab8	Radiation, Radioisotope;Radiation, External Beam	NA	yes	NA	NA	NA	228;164	NA	214;133	1	1200;4500	3;32	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-B5-A1MY
TCGA-UCEC	TCGA-AJ-A23N	Stage IIIA	No	0	NA	2009	NA	Endometrium	25772	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Cytology	NA	8441/3	R2	primary	6c98a7d8-ead1-5662-9673-613cbaa8c99b	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Dead	70	-25772	NA	22f3b2a8-466f-59e5-a3f7-03c1a8beee4b	FALSE	NA	United States	439	439	WT-With Tumor	NA	b0790518-d654-4690-8d0b-4d0e91679416	Pharmaceutical Therapy, NOS	Tamoxifen	unknown	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	172b4f09-46e1-5474-89df-c355b61adacf	Radiation, External Beam	NA	yes	NA	NA	Progressive Disease	206	NA	165	NA	6200	31	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-AJ-A23N
TCGA-UCEC	TCGA-AP-A0LV	Stage IA	No	0	NA	NA	NA	Endometrium	14556	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	3d9dedea-6420-562b-96e0-30befcd1d44f	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	39	-14556	NA	5b89e6af-bc94-5d29-9aae-508edc9f7ae2	FALSE	NA	NA	NA	763	TF-Tumor Free	Adjuvant;NA	3344f8fb-070c-5e93-baaf-dd4901d6976d;b114b047-1d09-4cfc-a214-140ee3e387e7	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	e0777327-5267-490c-8fc3-6ecb3fa03256	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AP-A0LV
TCGA-UCEC	TCGA-EO-A1Y5	Stage IIIC2	No	0	NA	2009	NA	Endometrium	23251	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8441/3	R0	primary	a52f4e96-efca-5354-ac1f-d5e4600af48f	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	not reported	female	not reported	Alive	63	-23251	NA	fd594d66-0c40-5b02-9262-afbc6549a207	FALSE	NA	Canada	NA	332	TF-Tumor Free	NA	d305cea4-51fa-4945-b4db-b9d9f9a7f420	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	e7870fa8-d744-59c3-97d4-6ea0b3f51420	Radiation, Internal	NA	yes	NA	NA	Complete Response	283	NA	280	NA	NA	5.5	Regional Site	NA	NA	NULL	NA	NA	NA	TCGA-EO-A1Y5
TCGA-UCEC	TCGA-BS-A0U9	Stage IIA	No	0	NA	1988	NA	Endometrium	21580	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2006	released	No	TRUE	NA	Cytology	NA	8380/3	RX	primary	97a94aa4-98f6-51d5-8f84-f33325cc9d45	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	native hawaiian or other pacific islander	female	not hispanic or latino	Alive	59	-21580	NA	adc48981-fe38-5f10-b8d5-97a058523a5c	FALSE	NA	NA	NA	2825	TF-Tumor Free	NA;Adjuvant	b7c402c2-17e6-4502-8586-ca2a2ccdac8b;c983df28-1815-5382-8e67-b3967b6032c3	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	d882ea79-baa8-4711-859f-77e0d187a591	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BS-A0U9
TCGA-UCEC	TCGA-FI-A2F8	Stage II	No	0	NA	2009	NA	Endometrium	23649	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	8e61edf0-cbe0-5a74-8ae9-1082dff20b6e	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	64	-23649	NA	a4323184-d6f7-50dc-85ae-1b9adbf70349	FALSE	NA	United States	NA	933	WT-With Tumor	NA	f1012374-f1a1-4021-8b24-291a051557bc	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	d6868356-de07-4ccf-a240-262c84887ea6	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-FI-A2F8
TCGA-UCEC	TCGA-BG-A0VV	Stage IA	No	0	NA	2009	NA	Endometrium	19581	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	753cacfd-1655-5069-814e-8960f01f0aca	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	53	-19581	NA	92763274-a8e2-5612-a776-b334b6ae5dbe	FALSE	NA	NA	NA	1553	TF-Tumor Free	Adjuvant;NA	2105efad-c535-50fc-9b6c-1abc93a65c97;f6d313e3-391d-47ed-aae2-74909eda4a8d	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;unknown	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	a8044688-dfd6-46ba-8cef-e26fc74aa83f	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BG-A0VV
TCGA-UCEC	TCGA-BG-A18B	Stage I	No	0	NA	2009	NA	Endometrium	19550	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	RX	primary	4cb8a266-6605-5f34-95c2-b3dcee52e93e	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	53	-19550	NA	5c40ea92-1293-5e14-96bf-5e39c5875c25	FALSE	NA	NA	NA	470	TF-Tumor Free	NA;Adjuvant	20041fa0-946f-4268-84dc-1bf866227d30;a8f65561-fd60-50f9-876f-40b137c56808	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	925ea9e0-4e43-4724-a776-0436aaaa66f1	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BG-A18B
TCGA-UCEC	TCGA-AX-A064	Stage IIA	No	0	NA	1988	NA	Endometrium	29625	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2007	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	8d97aefb-5fe0-5a3b-a87e-d9d0f992ceab	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	81	-29625	NA	7a2e57b2-e19b-5407-967c-2f076d5ee7fc	FALSE	NA	NA	NA	1517	TF-Tumor Free	Adjuvant;NA	14fae94d-544a-58d6-8461-1f3aaf95ce41;bd26aa4e-7d2e-43d0-9d31-3a23c049df70	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	ecd16019-ba52-40e7-b5ae-b87618bb91bf	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A064
TCGA-UCEC	TCGA-QS-A5YR	Stage IIIB	No	0	NA	2009	NA	Endometrium	22372	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2012	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	RX	primary	933be2c9-e498-54b3-97d2-99f70124dba0	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	61	-22372	NA	32525c21-d012-5d48-add2-322fb2132125	FALSE	NA	United States	NA	719	WT-With Tumor	NA;Adjuvant	15d6af97-49a7-4749-bbf4-64d6ff0be21b;73d3ee91-14e0-51ca-b7f3-fb82fb08309c	Pharmaceutical Therapy, NOS	Tamoxifen;NA	unknown;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	af2fef63-5680-4157-bc55-fffef6565f07	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-QS-A5YR
TCGA-UCEC	TCGA-BG-A18C	Stage IA	No	0	NA	2009	NA	Endometrium	26602	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	RX	primary	8337ee7b-e16c-5f14-93f5-f8730b9788c5	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	72	-26602	NA	06e72bfd-79e9-5aa2-a14c-1c4bb7c4bd57	FALSE	NA	NA	NA	470	TF-Tumor Free	NA;Adjuvant	20a147cc-9a77-463d-9734-2cef73cbe689;5b32ad9a-4607-583b-b0ae-f7534c108f8f	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	26ef6d90-5005-4309-a50c-a61db4eb4550	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BG-A18C
TCGA-UCEC	TCGA-BG-A0LW	Stage IA	No	0	NA	2009	NA	Endometrium	17369	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	565c2697-e6db-5c22-be88-bbc3f88f1424	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	47	-17369	NA	d8c4248b-3e80-5a02-bf28-aff20c54f0dc	FALSE	NA	NA	NA	566	TF-Tumor Free	NA;Adjuvant	33315f08-0d56-408a-a2c9-6dc3014ff339;4278df68-abfe-558c-9aea-4848666f3327	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	afc8af37-8d2b-48db-8371-7ace8db9278b	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BG-A0LW
TCGA-UCEC	TCGA-AJ-A3QS	Stage IIIA	No	0	NA	2009	NA	Endometrium	21162	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	9e06c1b9-f53c-574c-bcaf-9f3d6b0d778d	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	57	-21162	NA	4b4e030a-6c7f-5469-9180-3d974b5900d2	FALSE	NA	United States	NA	513	TF-Tumor Free	NA	a86de5fe-4182-41c3-9bdd-7cce6b6ffbfa	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	81ea6788-6a4d-594c-b016-93bb00b4cb44;baf334b3-bda9-4a9c-a586-e4a5101a09d9	Radiation, External Beam;Radiation, Internal	NA	yes	NA	NA	Complete Response	143;162	NA	114;148	NA	NA;1500	NA;3	Primary Tumor Field	NA;cGy	NA	NULL	NA	NA	NA	TCGA-AJ-A3QS
TCGA-UCEC	TCGA-AJ-A8CT	Stage IA	No	0	NA	2009	NA	Endometrium	21515	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2012	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	2e7d9194-0cb7-5ba2-912c-90ac968c8b4d	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not reported	Alive	58	-21515	NA	dac92b16-78e8-5599-94e2-bf73feae8378	FALSE	NA	United States	NA	82	TF-Tumor Free	NA;Adjuvant	477bd6c0-f977-4fb4-a837-d92a0bd02dcf;b0ad9250-bf04-544e-9cd7-b662617d7bc3	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no;unknown	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	c86c4741-2e7e-405e-a35b-e1c8a0f0389c	Radiation Therapy, NOS	NA	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AJ-A8CT
TCGA-UCEC	TCGA-BG-A0VX	Stage IB	No	0	NA	1988	NA	Endometrium	21425	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Excisional Biopsy	NA	8380/3	RX	primary	d48fb6b3-bc0c-54d1-8b6b-ddcf57e9798e	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	58	-21425	NA	3eafb5fd-b307-50ba-838d-d8a4921cce6d	FALSE	NA	NA	NA	1043	TF-Tumor Free	NA;Adjuvant	113f6308-f23a-4b3f-848e-b1127003a7d1;1db4ad1f-8856-4795-90a8-c3eda6c12238	Pharmaceutical Therapy, NOS	Tamoxifen;NA	unknown;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	647fc589-2820-52fb-a2d1-f38ccc26aa32	Radiation, External Beam	NA	yes	NA	NA	Complete Response	104	NA	77	NA	2350	NA	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-BG-A0VX
TCGA-UCEC	TCGA-AX-A2HK	Stage IIIC	No	0	NA	1988	NA	Endometrium	28316	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2005	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	50428742-f7c1-581f-85b2-57306292200f	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Dead	77	-28316	NA	2966ded1-5d55-55d5-a8b6-385a79d36fba	FALSE	NA	United States	90	90	WT-With Tumor	NA;Adjuvant	5f1e7d07-94ba-4224-afe9-cd514eb09ef2;dd94fa65-56d6-572e-9e15-35e4d93507d3	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	f7bbcbe5-659c-4440-8819-fb795cdcf6f5	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A2HK
TCGA-UCEC	TCGA-A5-A0GA	Stage IIIC2	No	0	NA	NA	NA	Endometrium	24659	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2006	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	7f059916-7f28-518d-b3d2-39ba89ce94e7	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	67	-24659	NA	e2c8cc50-bd74-513f-b812-c01b1b9600c2	FALSE	NA	NA	543	543	WT-With Tumor	NA	1caf931f-2534-4f45-9421-76df26b5177a	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	cc0c20a7-c83a-4723-b13f-31a14da89457	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-A5-A0GA
TCGA-UCEC	TCGA-BG-A0MO	Stage IA	No	0	NA	1988	NA	Endometrium	23287	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	b05be386-4150-55a8-870e-6501f1517364	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	63	-23287	NA	ca39bf6f-6549-5d17-ae60-15dde3f5a32d	FALSE	NA	NA	NA	1309	TF-Tumor Free	Adjuvant;NA	6b604897-b730-440c-8b4a-560fad3934fa;9509c21f-dd0a-4285-9a65-bb4ecd629af2	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	1b233bee-34f2-552a-b0e1-5eb8ce1e039f	Radiation, Implants	NA	yes	NA	NA	NA	89	NA	77	1	1000	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-BG-A0MO
TCGA-UCEC	TCGA-D1-A17R	Stage IA	No	0	NA	2009	NA	Endometrium	21382	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	38409ad3-77ba-53f6-951c-92fc23d78067	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	58	-21382	NA	19d4a3c9-de61-5c42-b9fa-c1f83f34a08c	FALSE	NA	NA	339	339	TF-Tumor Free	Adjuvant;NA	5c57bd8f-8573-569b-81a6-b92af2efa9b8;78c44be8-27fa-4205-9c42-6235fdfb142e	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	d87b18c0-4958-46aa-af92-9995701a0353	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A17R
TCGA-UCEC	TCGA-EY-A54A	Stage IIIC2	No	0	NA	2009	NA	Corpus uteri	24822	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2012	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	b0351059-8e11-5467-97c2-a451c3438893	C54.9	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	67	-24822	NA	be31e54c-a3d3-5eb6-8d3f-25c7b2e63f8c	FALSE	NA	United States	NA	447	NA	NA	fe374df0-7a9e-4135-8ade-d61a1fa4e91f	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	71705968-3a24-5db0-8a48-2f04c84bc90c	Radiation, External Beam	NA	yes	NA	NA	Complete Response	176	NA	140	NA	4500	25	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-EY-A54A
TCGA-UCEC	TCGA-FI-A2D6	Stage IB	No	0	NA	2009	NA	Endometrium	27060	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	a5b33358-e477-5003-a61b-918ef585c326	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	74	-27060	NA	64644953-9847-5512-ab46-7325c89519b5	FALSE	NA	United States	767	767	Unknown	Adjuvant;NA	032537d8-6aed-5929-a8c7-0d4baaf8e538;d0253a69-200d-4d6b-92cf-2b93c1986613	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	dd109267-0f48-41d3-a246-25fa443e821a	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-FI-A2D6
TCGA-UCEC	TCGA-AX-A2HG	Stage IC	No	0	NA	1988	NA	Endometrium	20771	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R1	primary	cb06baac-9e6b-5d41-984c-1ccfebb0f5b5	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	hispanic or latino	Alive	56	-20771	NA	3505f603-e5fb-5a9e-8824-99e97c974956	FALSE	NA	United States	NA	1163	TF-Tumor Free	Adjuvant;NA	7b073811-74e0-457b-bbbc-5cfd8e7b5a3a;f685d423-922c-4034-a547-fa1e8ed7e46e	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	52852649-d3fd-4ec5-857d-864c54df6f93;be30cb19-8b77-5966-9d16-2acff402db61	Radiation, Implants;Radiation, External Beam	NA	yes	NA	NA	NA	122;105	NA	NA	2;1	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A2HG
TCGA-UCEC	TCGA-BS-A0TC	Stage IB	No	0	NA	1988	NA	Fundus uteri	25560	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2004	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	6fb8ef5d-caed-5f93-8238-73f5291b6370	C54.3	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	asian	female	not hispanic or latino	Alive	69	-25560	NA	9d386311-6715-5417-a3fb-06d248c6e813	FALSE	NA	NA	NA	2602	TF-Tumor Free	Adjuvant;NA	94cbf165-19f0-56fc-908b-7050937cb943;af6dd9a2-fde7-4539-b26f-5deab1972af5	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	134d186b-e14e-4936-9784-12127d7a61b8	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BS-A0TC
TCGA-UCEC	TCGA-D1-A3DH	Stage IA	No	0	NA	2009	NA	Endometrium	25935	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Excisional Biopsy	NA	8380/3	R0	primary	4016a029-9a7a-5557-9078-8876bf570a60	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	71	-25935	NA	0b11fb4d-52a2-56e1-9cef-35568e1a2c19	FALSE	NA	United States	NA	573	TF-Tumor Free	NA;Adjuvant	55deb919-9027-4f6e-b503-7fba51b09c27;86380b6d-39e8-4d77-adac-3edbcc0ca29f	Pharmaceutical Therapy, NOS	Tamoxifen;NA	unknown;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	2275e016-0860-5fd9-a236-4fe8d14ed7ea	Radiation, Internal	NA	yes	NA	NA	Complete Response	50	NA	46	NA	21	3	Primary Tumor Field	Gy	NA	NULL	NA	NA	NA	TCGA-D1-A3DH
TCGA-UCEC	TCGA-D1-A17D	Stage IB	No	0	NA	2009	NA	Endometrium	21441	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	ada11ac6-b450-5feb-ad99-5631e0845094	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	58	-21441	NA	b13e3c60-a675-5a8c-a335-12e65a23a310	FALSE	NA	NA	NA	926	TF-Tumor Free	NA	7cbc2c41-941b-4620-bd25-75df90450f10	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	8935759e-cc41-5b31-8138-5db438299830	Radiation, Implants	NA	yes	NA	NA	NA	66	NA	57	1	2100	3	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-D1-A17D
TCGA-UCEC	TCGA-D1-A16Q	Stage II	No	0	NA	2009	NA	Endometrium	19873	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	52a2d92b-2ab7-5fcd-b853-58703bf7770b	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	54	-19873	NA	fe1bd1e0-1b8f-5c74-bb5d-f068ea6327ed	FALSE	NA	NA	NA	324	TF-Tumor Free	NA;Adjuvant	112ed5b5-3be3-46c6-ad9d-17c54fe9cd71;98a34762-ec10-51e9-b12b-489454074c15	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no;yes	NA	Prior to Diagnosis;NA	NA;Complete Response	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	f86542c3-95dc-4900-8a5a-a4ab82fa330c	Radiation Therapy, NOS	NA	yes	NA	NA	Complete Response	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A16Q
TCGA-UCEC	TCGA-B5-A1MZ	Stage IA	No	0	NA	2009	NA	Endometrium	19955	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	NA	primary	474dca13-43a1-5c7a-8fa9-21dfd1a79d7b	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	54	-19955	NA	d0725cda-50ff-56dc-a9bd-64f4ae186931	FALSE	NA	United States	NA	1598	TF-Tumor Free	Adjuvant;NA	b187910f-eff1-59c2-ad9a-0b9551241194;bfa544ae-63e1-4621-8fa6-e6e80f67c8db;f273f959-be88-4e0e-8837-8b137abab910	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;not reported	NA;Recurrent Disease	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA;Adjuvant	0be50b58-a549-4e57-bad4-a25554a6756f;452493b5-408f-47ae-a686-856c7462be07	Radiation Therapy, NOS	NA	yes	Recurrent Disease;NA	NA	NA;Complete Response	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A1MZ
TCGA-UCEC	TCGA-A5-A2K2	Stage IA	No	0	NA	2009	NA	Endometrium	28456	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2003	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	ca7e77ce-472f-5fe6-9e5a-50bf9e5b3fca	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	77	-28456	NA	d090c047-cf0d-569c-beb8-c5a933d12d42	FALSE	NA	United States	NA	3595	TF-Tumor Free	NA	b1451696-4206-4d30-98a6-8f5843ba11d0	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	58c8402f-918a-45aa-a3a5-45336fc0ba35	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-A5-A2K2
TCGA-UCEC	TCGA-5S-A9Q8	Stage IIIA	No	0	NA	2009	NA	Endometrium	18785	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2013	released	No	TRUE	NA	Excisional Biopsy	NA	8380/3	R0	primary	d3102afa-c8e9-5eae-997f-1bf246a5b819	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	51	-18785	NA	9bc7569c-897a-5443-a8f7-f160ecba3605	FALSE	NA	United States	NA	313	Unknown	NA	cd66db84-6b98-418a-ad01-5ef7ef33c32e	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	610bbc3f-3888-5d71-b2ed-29af76ac3d7b	Radiation, Internal	NA	yes	NA	NA	Complete Response	202	NA	186	NA	2100	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-5S-A9Q8
TCGA-UCEC	TCGA-AX-A05W	Stage IIB	No	0	NA	1988	NA	Endometrium	22200	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2004	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	b7d4f74c-12af-5445-b73d-84769ca2e86c	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	60	-22200	NA	2a3c98a5-a5b9-56cc-9247-093e90862409	FALSE	NA	NA	NA	2450	TF-Tumor Free	NA;Adjuvant	7475e1ef-61a3-4506-a1db-dbe3062f5068;be3c981b-54f6-5287-9e05-aad09e92a735	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	f68ec458-5da0-4404-9abb-e19812f66b68	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A05W
TCGA-UCEC	TCGA-AJ-A3IA	Stage IB	No	0	NA	2009	NA	Endometrium	28470	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2011	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	15536478-e5fd-539a-9ce0-3beb75abd69f	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	77	-28470	NA	7d424c52-15ea-5d54-9fc8-3bdfb035d686	FALSE	NA	United States	NA	633	TF-Tumor Free	NA;Adjuvant	a16ab985-16c0-4fa6-ae64-f27c61103b66;b774bff9-6bb0-5134-8bbe-161997a63981	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	55b43254-670e-499f-a1d0-2d9ef7948016	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AJ-A3IA
TCGA-UCEC	TCGA-D1-A16V	Stage IIIC	No	0	NA	2009	NA	Endometrium	28635	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Surgical Resection	NA	8380/3	R0	primary	6f7e7f7a-d0fd-52fb-b263-c8678cbdfcbe	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	78	-28635	NA	c70e4bfa-e599-54ca-91a6-d9088fab9f05	FALSE	NA	NA	120	120	NA	Adjuvant;NA	0b5906f7-d802-5f84-813c-0e371f8ace82;c6ce7b32-a2a5-4f19-919b-24f25b70f3b4	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	225979cf-f34c-45ab-8947-a41ba9782338	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A16V
TCGA-UCEC	TCGA-AX-A3FT	Stage IB	No	0	NA	1988	NA	Endometrium	23543	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Laparotomy	NA	8380/3	NA	primary	87f6a4eb-1096-5d7a-8994-9394e567c502	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	64	-23543	NA	a0b12635-e4b8-5c98-8598-5d12f61f0f2a	FALSE	NA	United States	NA	6	NA	NA;Adjuvant	1ca3a908-87d1-46d5-b9ee-ef6274d1162b;a813bcfb-5f99-5ff2-8f53-8f6842292720	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;unknown	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	82f9659a-e39f-43c4-91b2-76955faee6c0	Radiation Therapy, NOS	NA	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A3FT
TCGA-UCEC	TCGA-BG-A0M0	Stage IA	No	0	NA	2009	NA	Endometrium	24427	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	3232eb69-feda-59db-907e-136c7f3f6721	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	66	-24427	NA	253415bb-94cc-5a4a-8235-d20cb0ee900e	FALSE	NA	NA	NA	588	TF-Tumor Free	Adjuvant;NA	001809bd-11a9-5bdc-8abd-682e42f4297a;26de354b-4998-4833-9271-3bc130491410	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	c6368ec9-4dd6-4bc4-94f1-538e679f9649	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BG-A0M0
TCGA-UCEC	TCGA-AX-A3FS	Stage IA	No	0	NA	1988	NA	Endometrium	30102	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Laparoscopy	NA	8380/3	NA	primary	aab6e5c3-dc5a-5f48-9bc6-9ab2ea1b7235	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	82	-30102	NA	75c88efc-df2b-5dc9-8f26-0a8826fc80c5	FALSE	NA	United States	NA	7	NA	Adjuvant;NA	0bbc2e25-f483-5390-9aec-edd9531f8305;a506a4c0-b264-40ea-aea6-339a33ebe494	Pharmaceutical Therapy, NOS	NA;Tamoxifen	unknown;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	62891cde-95e9-4b77-8430-377c02b761f9	Radiation Therapy, NOS	NA	unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A3FS
TCGA-UCEC	TCGA-EO-A3AU	Stage II	No	0	NA	2009	NA	Endometrium	26406	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	NA	primary	742571f6-a445-57d3-bf47-4142abe4f1bf	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	not reported	female	not reported	Alive	72	-26406	NA	71e171de-4fbc-5396-8a52-e362331a8fd9	FALSE	NA	Canada	NA	1543	TF-Tumor Free	NA;Adjuvant	184f0b43-686f-4aea-a1b5-30f8c0062623;a93700a8-f34c-5c2d-88c8-7920e2cf7d45;be0ddb40-dd2c-4c46-a31e-a979bad66495	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;yes	Initial Diagnosis;NA	NA;Prior to Diagnosis	NA;Complete Response	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA;Adjuvant	3d4079f2-0075-4bf0-9caf-a8fa0ef7eb50;51b50b3d-cce7-4d48-b444-5b16e7ba9f59	Radiation Therapy, NOS	NA	no;yes	Initial Diagnosis;NA	NA	NA;Complete Response	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-EO-A3AU
TCGA-UCEC	TCGA-EO-A22S	Stage IB	No	0	NA	2009	NA	Endometrium	21328	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	dde5c9f9-6cd7-5b32-b160-a711fc93b1f7	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	not reported	female	not reported	Alive	58	-21328	NA	3d97f2b9-778a-5826-8aa7-ddc7402c36c2	FALSE	NA	Canada	NA	1872	TF-Tumor Free	Adjuvant;NA	01c90d3a-c926-480d-ae3a-cd03bd32cae5;269c86a6-e13a-4ee6-8e20-397f21f1adac	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	6c44fbd4-5976-5484-9e81-2817197df8de	Radiation, External Beam	NA	yes	NA	NA	NA	107	NA	NA	NA	4500	25	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-EO-A22S
TCGA-UCEC	TCGA-AJ-A2QL	Stage IIIC1	No	0	NA	2009	NA	Endometrium	22057	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	7b4cfed7-6fbc-51b1-8b33-e05317244f31	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	60	-22057	NA	ea1129e7-d64f-5806-8611-03a0818e92fc	FALSE	NA	United States	NA	602	TF-Tumor Free	NA	d887233c-17c2-482c-8f35-d8737391a18c	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	d4039093-cb8f-462a-9216-a13be2c95dc5	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AJ-A2QL
TCGA-UCEC	TCGA-DF-A2KU	Stage IB	No	NA	NA	NA	NA	Endometrium	NA	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	NA	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	RX	primary	d8d39996-51aa-594d-a4df-fbeebce320eb	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	not reported	female	not reported	Alive	NA	NA	NA	a1f289cf-dd76-53da-85d7-8289e9f6d3fa	FALSE	NA	Canada	NA	3067	TF-Tumor Free	Adjuvant;NA	65f6d420-d04b-4882-86d0-df415dd1e6f6;b8c3f5bf-29c3-467f-8f2c-7fb5f5d4f179	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	e4f76860-c1f8-5f10-b979-503d75caba06	Radiation, External Beam	NA	yes	NA	NA	Unknown	251	NA	212	NA	4500	25	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-DF-A2KU
TCGA-UCEC	TCGA-D1-A169	Stage IV	No	0	NA	1995	NA	Endometrium	23238	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	6475596b-d57b-55b5-add0-768e2e451294	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	63	-23238	NA	32f9bc7f-6bbe-55fb-8c70-28e7cd114d27	FALSE	NA	NA	NA	1135	WT-With Tumor	NA	0491c2f1-61ee-4eef-956f-eef44faade8b	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	a14a70bc-c373-429c-9352-ce7dda0dc9c0	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A169
TCGA-UCEC	TCGA-AP-A0L8	Stage IIIC2	No	0	NA	NA	NA	Endometrium	25733	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2000	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	45d8de3a-d52a-5566-8697-68775330fbba	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not reported	Dead	70	-25733	NA	dc7a4a86-4e5d-5763-939f-1ef9f9df5bf5	FALSE	NA	NA	1484	1484	WT-With Tumor	NA;Adjuvant	85ff7f53-656d-46a4-bfa5-63e85331ca3d;875c0ba5-c41b-4ea1-86e9-ae8f31b02b7b	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant;Palliative	39922249-e7fb-41d4-955f-984a09b9d604;b53427c6-ff21-4431-b52c-e1e9775fe08f;d602a5df-060d-5d39-b2af-cd35f774b133	Radiation, External Beam	NA	yes	NA	NA	NA	130;1467;142	NA	102;1456;131	1;2	3000;2693;1440	20;9;8	Regional Site;Distant Site	cGy	NA	NULL	NA	NA	NA	TCGA-AP-A0L8
TCGA-UCEC	TCGA-A5-A3LP	Stage IB	No	0	NA	2009	NA	Endometrium	27131	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	64e2a390-b639-56d8-89e6-dd4dadc1c92f	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	74	-27131	NA	ce8a91da-f81d-51b6-a2e5-82541798e6b9	FALSE	NA	United States	NA	455	TF-Tumor Free	NA	e105d865-29d6-4e35-a5b7-4afb6f3b5091	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	6749bd9a-e18e-4735-8084-c9ecea278b73	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-A5-A3LP
TCGA-UCEC	TCGA-BG-A0MG	Stage IA	Not Reported	0	NA	1988	NA	Endometrium	26957	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	not reported	2007	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	c8e5a50b-7533-55fc-b7f9-c9d246d65b2a	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	73	-26957	NA	d8ac2c9f-ad6c-5280-8b9b-2851dbd4af1c	FALSE	NA	NA	NA	1477	TF-Tumor Free	Adjuvant;NA	72656f0e-d49d-5f08-82b1-99989496ddbe;fc6a38b1-3b8c-4fcf-97c6-41e60738df18	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	cd5aa596-e907-41f0-983a-9d87896ea359	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BG-A0MG
TCGA-UCEC	TCGA-D1-A101	Stage IB	No	0	NA	NA	NA	Endometrium	22078	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	RX	primary	af7710fa-9154-5b82-bcfb-9c50c2290f88	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	60	-22078	NA	c049a25f-94b1-5f01-a13c-0ec35b371750	FALSE	NA	NA	NA	53	TF-Tumor Free	Adjuvant;NA	1a69ff9e-1d7b-5c93-9646-47a367eb1a29;70d8b6cc-b12d-4e79-b00d-cb669aacf4b3	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	b65e7e17-0fc2-469b-9e71-4d1694c28eb8	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A101
TCGA-UCEC	TCGA-BG-A3PP	Stage II	No	0	NA	2009	NA	Endometrium	30227	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	0facab6a-307d-5b57-af33-9afebf96a986	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	82	-30227	NA	190653c3-b629-5caf-8cad-8a6dfc4b62f9	FALSE	NA	United States	NA	681	WT-With Tumor	NA	f1e8bf95-6abd-45da-9951-eab0dbaaa787	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	b7e48094-6fa6-509e-b289-82ec1f865547	Radiation, External Beam	NA	yes	NA	NA	Complete Response	253	NA	238	NA	20	11	Primary Tumor Field	Gy	NA	NULL	NA	NA	NA	TCGA-BG-A3PP
TCGA-UCEC	TCGA-AP-A0LO	Stage IA	No	0	NA	NA	NA	Endometrium	16493	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2005	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	91213600-3f58-58a5-a12c-e90f4f1c9f90	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	45	-16493	NA	d07b1e85-ccc7-5cd4-9a87-b38f8ae021bb	FALSE	NA	NA	1016	1016	WT-With Tumor	NA;Adjuvant	dce1dab5-70ee-44ca-b343-dcbe839085b0;f56a9d4b-57e7-480a-91e1-d96c0b486d48	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	5443e55e-9317-4656-8ef4-07a34ba43bd4;55c9dfc2-0933-5e78-9e9d-e719a12cafb9	Radiation, Implants;Radiation, External Beam	NA	yes	Recurrent Disease	NA	NA	684;671	NA	682;639	1	1800;4500	4;25	Locoregional Site	cGy	NA	NULL	NA	NA	NA	TCGA-AP-A0LO
TCGA-UCEC	TCGA-EY-A72D	Stage II	Yes	0	NA	2009	NA	Endometrium	31818	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2013	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	c584ec2e-e218-50e5-845f-eb874468128a	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	87	-31818	NA	c8b4918b-961a-55ee-930c-51304d95033f	FALSE	NA	United States	NA	179	NA	NA;Adjuvant	36c8fa74-f49d-411c-8ffe-57879a056491;49732276-e5ab-5fea-98fe-dfc0c5f4d4cc	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	f9913f38-8148-4a75-b785-db29d6d0c270	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-EY-A72D
TCGA-UCEC	TCGA-AX-A2H7	Stage IC	No	0	NA	1988	NA	Endometrium	32100	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	bebfb9f5-f3ef-5aa7-a11f-2616dfdee4a0	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	87	-32100	NA	c44cf1de-5a77-5fad-b61a-6878e3bdb55c	TRUE	NA	United States	772	772	WT-With Tumor	NA;Adjuvant	2bc519bd-af0d-4bb5-9d46-94a40364e7d7;c3d672a1-f9bb-4bb2-a0bf-63de1aac3bb5	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	315b14aa-f4e7-5df3-9968-9be063f71479	Radiation, Implants	NA	yes	NA	NA	NA	NA	NA	NA	1	NA	NA	Regional Site	NA	NA	NULL	NA	NA	NA	TCGA-AX-A2H7
TCGA-UCEC	TCGA-EY-A1GE	Stage IA	No	0	NA	2009	NA	Endometrium	24667	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	d67270f5-331a-59d8-bb5d-52d08dd818b2	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	67	-24667	NA	06154713-6fc5-589b-8799-e904a7d3ebd6	FALSE	NA	United States	NA	741	TF-Tumor Free	NA;Adjuvant	12439a9d-b85f-4b86-98b7-832030b58ea0;db85fdb2-ef42-5d45-9d98-f3bb3ffccbb5	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	f940f5ae-7872-424a-9525-e2081a81b07b	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-EY-A1GE
TCGA-UCEC	TCGA-A5-A0GN	Stage IB	No	0	NA	NA	NA	Endometrium	24020	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2006	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	03e39652-cda1-5257-a00c-b2959370daf1	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	65	-24020	NA	8dc88809-3a23-5cdf-8f5a-97e7747200b9	FALSE	NA	NA	NA	1841	TF-Tumor Free	Adjuvant;NA	40a4b64a-3636-4b09-ba9b-8728139d2739;eecf74c4-9c32-4147-b374-c7940fde3a27	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	ca7cd085-c216-51aa-b48b-5ade175dccfa	Radiation, External Beam	NA	yes	NA	NA	NA	112	NA	71	1	5040	28	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-A5-A0GN
TCGA-UCEC	TCGA-AP-A5FX	Stage IIIC1	No	0	NA	2009	NA	Endometrium	25063	Adenocarcinoma with mixed subtypes	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8255/3	RX	primary	0dcdbef2-95f1-5dbe-b7ed-98f7bacfe3e8	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not reported	Dead	68	-25063	NA	c54df739-8b8f-53d4-be3f-4bb048131e5d	FALSE	NA	United States	1099	1099	WT-With Tumor	NA	bdcc57b2-b8fe-4423-b889-61b7938d08f2	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	59d9ccb0-1130-5204-8080-95ad631ca47a	Radiation, External Beam	NA	yes	NA	NA	Complete Response	305	NA	273	NA	4500	25	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-AP-A5FX
TCGA-UCEC	TCGA-B5-A0JR	Stage IB	No	0	NA	1988	NA	Endometrium	26814	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2006	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	NA	primary	938f9cea-823b-5d31-be57-89661c35ca40	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	73	-26814	NA	ac45a829-3a9a-5711-953f-829b2fec2583	FALSE	NA	United States	NA	1731	TF-Tumor Free	NA;Adjuvant	1cd374f8-1011-41a7-a078-0574b81c8e04;d525ff07-ba20-515e-a548-eba05bd605cc	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	61f6474d-d979-4b39-a642-27f0e7541a7d	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A0JR
TCGA-UCEC	TCGA-BS-A0UM	Stage IB	No	0	NA	1988	NA	Endometrium	23400	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2005	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	46329a92-6677-51db-ab6e-891dca8b0683	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	64	-23400	NA	ee82158d-3054-55ab-a9f7-25cc3d32151e	FALSE	NA	NA	NA	2644	WT-With Tumor	NA	44984d3e-343f-4678-84b7-d57fb194061a	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	4acb371c-e20d-4a55-8855-9caf8e70eff7;f86d765a-e914-554f-8902-7c44d38b72c0	Radiation, Stereotactic/Gamma Knife/SRS	NA	yes	Progressive Disease	NA	NA	1743;1870	NA	1743;1870	1;2	NA;2400	1	Distant Site	NA;cGy	NA	NULL	NA	NA	NA	TCGA-BS-A0UM
TCGA-UCEC	TCGA-EY-A1GX	Stage IIIA	No	0	NA	2009	NA	Endometrium	27962	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	51442c7f-83e1-5dee-b60b-d7393a63ebf6	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	76	-27962	NA	f1aab7a0-5038-57c0-bbcd-a20644b292c6	FALSE	NA	United States	1127	1127	NA	NA;Adjuvant	00a76477-c462-4f7b-86ec-44ab1eb9d451;19b24758-fc6d-49cd-85b5-3db687c79d1a;2e803209-934e-5057-ac22-b2e4f59b52c9	Pharmaceutical Therapy, NOS	NA;Tamoxifen	unknown;not reported;no	Recurrent Disease;NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA;Adjuvant	c38c662c-8252-4b0b-a88c-d66f57312ba1;f10eefe9-a714-4e44-9129-6c55bad31598	Radiation Therapy, NOS	NA	yes;no	Recurrent Disease;NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-EY-A1GX
TCGA-UCEC	TCGA-AX-A3GB	Stage IB	No	0	NA	1988	NA	Endometrium	26724	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Surgical Resection	NA	8380/3	R0	primary	a3becdfe-4514-5c7a-9363-0d079ffb5f25	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	73	-26724	NA	c24bb733-c129-5932-bba5-c197ac5b1bef	FALSE	NA	United States	NA	440	NA	NA	c8e65620-3cfe-4f10-aa88-6051c2c2c921	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	8708cb98-29f0-45c8-8b53-d21a8fa41157	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A3GB
TCGA-UCEC	TCGA-BG-A0LX	Stage IB	No	0	NA	2009	NA	Endometrium	20928	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	64f9d868-5fb4-5a05-b777-196a4c569488	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	57	-20928	NA	1bcc5a0d-6671-5861-b26d-b67afa80d667	FALSE	NA	NA	NA	614	TF-Tumor Free	NA;Adjuvant	6446f36a-7804-4abc-909f-de084fc8d6a0;a5357c61-393a-4c24-bc56-0c7575c883d3	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	29470147-1ea9-5cf9-b1d5-a422a62d321c	Radiation, Implants	NA	yes	NA	NA	NA	96	NA	82	1	2100	3	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-BG-A0LX
TCGA-UCEC	TCGA-B5-A3FA	Stage IC	No	0	NA	1988	NA	Endometrium	26850	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2004	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	c99b7ccb-7e94-5dc8-9192-5d3d7a6f8708	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	73	-26850	NA	03dbbfce-a850-50b1-a52b-10a4bda28aaa	FALSE	NA	United States	NA	2929	TF-Tumor Free	Adjuvant;NA	8352456b-9961-58af-a2df-092254af1008;9b46ab39-61e1-4203-b865-220948398389	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	182f690c-8eab-4238-963b-af2b5141acc1	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-B5-A3FA
TCGA-UCEC	TCGA-AP-A1DQ	Stage IIIC1	No	0	NA	2009	NA	Endometrium	27815	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	42051a2d-4aa0-53ce-b7ec-e9dc8ba5aab3	C54.1	Endometrium	High Grade	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Dead	76	-27815	NA	306dab98-cd1e-50f5-989a-70e8f5e5da76	FALSE	NA	NA	1423	1423	WT-With Tumor	NA	71852ec9-c2de-47d4-981f-9c8d5fdc8fe5	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Palliative	bc799570-1022-5ad9-9c7d-96f05e735efe	Radiation, External Beam	NA	yes	NA	NA	NA	961	NA	941	1	3500	14	Distant Site	cGy	NA	NULL	NA	NA	NA	TCGA-AP-A1DQ
TCGA-UCEC	TCGA-B5-A5OC	Stage IIIB	No	0	NA	2009	NA	Endometrium	26109	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	NA	NA	8380/3	R2	primary	d0efbe59-a540-5d2d-83db-f1e2c8d18b8e	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not reported	Alive	71	-26109	NA	7d93421a-71dc-502a-9c1a-8d3d30104edf	FALSE	NA	United States	NA	1249	TF-Tumor Free	NA	40481b68-1b52-46b1-b7e1-f3363f3b55bc;60567454-4dfb-4242-90e5-56623d5ba4e8	Pharmaceutical Therapy, NOS	Tamoxifen;Cisplatin	no;yes	NA	Prior to Diagnosis;NA	NA	NA;111	NA;No	NA;111	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	480b91ab-910b-5bac-ad43-dca37c364126	Radiation, External Beam	NA	yes	NA	NA	NA	115	NA	105	NA	45	NA	Primary Tumor Field	Gy	NA	NULL	NA	NA	NA	TCGA-B5-A5OC
TCGA-UCEC	TCGA-B5-A11Q	Stage IIIA	No	0	NA	1988	NA	Endometrium	23538	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	4dd34623-3977-5703-a403-b19e465e46ab	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	64	-23538	NA	78723c73-98b3-5130-8a7b-d983311f213b	FALSE	NA	United States	NA	976	TF-Tumor Free	NA	95b4127c-f81c-42e4-b12c-f5152bcb3f7f	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	9bc0ffaa-75f6-5a59-9284-3fb18baee886	Radiation, External Beam	NA	yes	NA	NA	NA	843	NA	76	1	4500	NA	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-B5-A11Q
TCGA-UCEC	TCGA-AX-A2H4	Stage IIIA	No	0	NA	1988	NA	Endometrium	24234	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2006	released	No	TRUE	NA	Biopsy	NA	8441/3	R2	primary	e1162466-e10b-58a1-96ac-2399188c61ef	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	66	-24234	NA	aa0c0ecd-e82a-5798-b1a4-a40911eaf464	FALSE	NA	United States	916	916	WT-With Tumor	Adjuvant;NA	034af59b-5a06-55d2-b842-413567ec649a;1280d1e0-042c-4379-abfe-409c8db14abf	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no;not reported	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	68b1d164-432b-4aa9-8001-a244f3f9ce78	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A2H4
TCGA-UCEC	TCGA-A5-A0RA	Stage IB	No	0	NA	NA	NA	Endometrium	25060	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	b4cac064-3445-58c8-8349-dbf25cf9fe3d	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	68	-25060	NA	0c86e026-26be-5c46-b41c-fa8aaaf5668b	FALSE	NA	NA	NA	884	TF-Tumor Free	NA;Adjuvant	eb6ceb2a-52ad-4385-9971-a20081025951;f7d88262-4ffc-45af-9ecf-7c2313733727	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	778d9f52-fdff-5736-b77a-bd0338744023	Radiation, External Beam	NA	yes	NA	NA	NA	151	NA	99	1	5040	28	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-A5-A0RA
TCGA-UCEC	TCGA-BS-A0UV	Stage IIIC	No	0	NA	1988	NA	Endometrium	20266	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2005	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	299e7afb-cff2-535a-ad6f-7a13d7a1bd44	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	native hawaiian or other pacific islander	female	not hispanic or latino	Alive	55	-20266	NA	04f8eb46-e4c3-5074-ae25-c74e2facb1df	FALSE	NA	NA	NA	2228	TF-Tumor Free	Adjuvant;NA	9cb639e3-877c-5a07-a5a9-95b265b15172;c4fad535-3869-4e47-9da3-f47dd8c1fa5c	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	87c9a093-87c1-465c-9a63-c3e8e1ef528c	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BS-A0UV
TCGA-UCEC	TCGA-PG-A917	Stage IA	No	0	NA	2009	NA	Endometrium	27104	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2012	released	No	TRUE	NA	Cytology	NA	8380/3	R0	primary	b57f13c5-0feb-5c26-b363-ea4811c9f398	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	74	-27104	NA	6a5c27c8-b7e0-5ef7-8113-fd24e5e1a494	FALSE	NA	United States	NA	212	TF-Tumor Free	Adjuvant;NA	1a4bcd82-3c46-554a-a446-15b5ff91cec3;bf1d4ce5-5e3c-4d1b-9e2a-8fe2e00d2c7a	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	8d1c5370-60ce-455d-809f-b087764e6958	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-PG-A917
TCGA-UCEC	TCGA-AP-A0LJ	Stage IA	No	0	NA	2009	NA	Endometrium	15577	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2004	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	4b5538b8-395b-5c6f-aad4-0cca187eccf8	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	42	-15577	NA	f8f23111-a666-52f4-aab4-9640dcf8e425	FALSE	NA	NA	NA	1421	TF-Tumor Free	Adjuvant;NA	0aedb67e-1ddf-58bf-9679-462d6162fcf9;f5e99150-2327-4e17-a96d-9842c9ca3265	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	95fcf0b0-a5a8-4d3f-9dba-1d79f253783d	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AP-A0LJ
TCGA-UCEC	TCGA-AX-A06J	Stage IB	No	0	NA	1988	NA	Endometrium	26000	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	86f02a51-8598-52f5-9385-2039491b5c30	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	71	-26000	NA	96e572fd-b222-549c-969e-fd4cc8e894d3	FALSE	NA	NA	NA	913	TF-Tumor Free	NA	822ac3c3-d086-4632-8ba5-4b254876fd0b	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	3d47647b-b5ab-5673-832f-36582f08741d	Radiation, Implants	NA	yes	NA	NA	NA	87	NA	73	1	NA	NA	Primary Tumor Field	NA	NA	NULL	NA	NA	NA	TCGA-AX-A06J
TCGA-UCEC	TCGA-BG-A0MI	Stage IA	No	0	NA	1988	NA	Endometrium	30334	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2007	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	0269ec13-6288-5b21-91f1-82f13a57ecd0	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	83	-30334	NA	0fb4bc67-19f3-5554-b4f5-9cdc29776597	FALSE	NA	NA	714	714	TF-Tumor Free	NA;Adjuvant	5b7e7c6e-8f76-437b-85fd-c69d344e896c;6122e669-a6d0-5f9b-89ab-8a52e1128891	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	f92ad0fa-3771-4aea-b1f3-edfda97c92c2	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-BG-A0MI
TCGA-UCEC	TCGA-AX-A1C8	Stage IIIC	No	0	NA	1988	NA	Endometrium	28452	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8441/3	R1	primary	2409cab7-cad6-57d6-8b56-732c17c0e990	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	77	-28452	NA	46ee949e-91ac-585a-b287-023dda00ab3d	FALSE	NA	NA	NA	776	Unknown	NA	e6ca90f3-a838-4476-bbd2-0fda08d555bb	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	6ec3e13b-84e5-4257-be05-f991f30c2f26	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-AX-A1C8
TCGA-UCEC	TCGA-A5-A2K4	Stage IIIA	No	0	NA	2009	NA	Endometrium	25270	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Surgical Resection	NA	8441/3	R1	primary	2b092884-4975-5b4f-a839-d6fe0ff71e1f	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Dead	69	-25270	NA	50869b7a-55b7-59d1-913e-a177d11580ff	FALSE	NA	United States	871	871	WT-With Tumor	NA	12989db1-68ff-436b-b6be-5b3b70f879f2	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	f22ca4de-f185-4ff8-ad11-a564df307ca6	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-A5-A2K4
TCGA-UCEC	TCGA-D1-A15Z	Stage IB	No	0	NA	1995	NA	Endometrium	26638	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	66e7281a-e104-5a39-9ca1-9645b46f893c	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	72	-26638	NA	69387b62-2c68-5b85-a959-7200561ef196	FALSE	NA	NA	58	58	TF-Tumor Free	Adjuvant;NA	4022dab4-2357-5bbd-a965-817f18876ff1;8edbf3cf-7b84-4ece-81ac-2052aefdd3a3	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	730343c8-ff85-445f-8c75-30f6b1b5c173	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-D1-A15Z
TCGA-UCEC	TCGA-AX-A2H5	Stage IIIC	No	0	NA	1988	NA	Endometrium	24757	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2005	released	No	TRUE	NA	Biopsy	NA	8441/3	R1	primary	a2c8a8c5-431a-528b-b5d2-e077796b783d	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	67	-24757	NA	e0765893-2c2e-50ce-a4c7-ac3526a8746e	FALSE	NA	United States	NA	2167	NA	NA	4670cc2b-df9c-4fb2-b3b0-60955c16c24a	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	95a7a730-476b-5069-9f63-3652c25c345f	Radiation Therapy, NOS	NA	yes	NA	NA	NA	NA	NA	NA	1	NA	NA	Primary Tumor Field	NA	NA	NULL	NA	NA	NA	TCGA-AX-A2H5
TCGA-UCEC	TCGA-A5-A0GQ	Stage IB	No	0	NA	1988	NA	Endometrium	28078	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2007	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	eb9b510d-cb05-581d-a51b-fc771c65913e	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	76	-28078	NA	7847ae82-f710-579e-a09d-765bec5e27a0	FALSE	NA	NA	NA	2247	TF-Tumor Free	NA;Adjuvant	42fe040f-e70c-4bb2-aaf4-04064d9e3fa5;c687623c-9fb3-5af2-9b9c-2efcfab2413f	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	8910f56f-a903-471b-a438-86bf873c129a	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-A5-A0GQ
TCGA-UCEC	TCGA-FI-A2F4	Stage IC	No	0	NA	1988	NA	Endometrium	23621	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2009	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	e001828e-632e-5044-993e-67f821ca7c0f	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	64	-23621	NA	c7999b4d-27ca-56c5-bf89-79ad97db1621	FALSE	NA	United States	NA	2230	TF-Tumor Free	Adjuvant;NA	3c12b331-e51a-529c-87e6-dce892fc320e;9c63c748-48ef-4714-9334-b57e88bdcb0b	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	53a3ba9a-aa73-410a-8510-e981106c4226	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-FI-A2F4
TCGA-UCEC	TCGA-EO-A3KU	Stage II	No	0	NA	2009	NA	Endometrium	25116	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2011	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	4075524a-4217-50e3-b313-06ebf63c29c8	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	not reported	female	not reported	Alive	68	-25116	NA	97fe2fbf-2085-5ffe-a6f9-5133af42f12d	FALSE	NA	Canada	NA	677	TF-Tumor Free	NA	3e50dd2c-8009-4f9f-aad9-3f905601712a;7721754b-d506-4b45-9866-311afc65af90;cccbe2ae-1186-468e-92af-86482700a01c;e339186b-4f1f-45b7-b343-57c92ce01fc8	Pharmaceutical Therapy, NOS	Carboplatin;Tamoxifen;Paclitaxel	yes;no	NA	NA;Prior to Diagnosis	Complete Response;NA	276;265;NA	No;NA	2;72;NA;63	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	1f18a7e3-3945-5bf9-8943-3437b951df50;f039b72a-f992-4f4f-a4e4-e242a6637e8c	Radiation, External Beam	NA	yes	NA	NA	NA;Complete Response	167	NA	132	NA	NA;4500	25	Primary Tumor Field	NA;Gy	NA	NULL	NA	NA	NA	TCGA-EO-A3KU
TCGA-UCEC	TCGA-A5-A0GM	Stage IA	No	0	NA	NA	NA	Endometrium	19452	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2006	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	582dc06e-79d4-52fb-b0a2-11597a992790	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	53	-19452	NA	2bb9d677-ca90-5a3c-a8d6-6962e1ecaa7e	FALSE	NA	NA	NA	1841	TF-Tumor Free	NA;Adjuvant	238f3d63-a9c7-4a23-801a-fa2cdc83c190;84cd1149-7f47-5e2c-a7b9-0d3946c006e8	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	3490d87a-caad-4aeb-98fa-fe7145400e50	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-A5-A0GM
TCGA-UCEC	TCGA-B5-A0KB	Stage IB	Not Reported	0	NA	2009	NA	Endometrium	22669	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	not reported	2010	released	Yes	TRUE	NA	Biopsy	NA	8380/3	NA	primary	04bd0019-9fba-559e-8549-f05d73de63db	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not reported	Alive	62	-22669	NA	2c9e2f40-5433-5194-ab7d-730d982de2f5	FALSE	NA	NA	NA	824	WT-With Tumor	NA	64df7e51-dd97-4346-a601-6af65a4b7ed4	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	Adjuvant	a4dbf4c9-f936-5397-b5bc-a8ce8ada2980	Radiation, Radioisotope	NA	yes	NA	NA	NA	55	NA	41	1	3000	5	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-B5-A0KB
TCGA-UCEC	TCGA-KJ-A3U4	Stage IA	No	0	NA	2009	NA	Endometrium	20392	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2012	released	No	TRUE	NA	Surgical Resection	NA	8441/3	R0	primary	9f60a2c7-9963-59e1-8563-8e4da64db571	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	hispanic or latino	Alive	55	-20392	NA	fdbce5bb-88bb-572b-8b58-e3f94a340c33	FALSE	NA	United States	NA	1095	TF-Tumor Free	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Adjuvant	28e2ea07-2a69-447c-b0b5-57357f9a2dc8	Radiation Therapy, NOS	NA	no	NA	NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	TCGA-KJ-A3U4
TCGA-UCEC	TCGA-D1-A16G	Stage IV	No	0	NA	1995	NA	Endometrium	27065	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8441/3	RX	primary	e5f2e1a4-d619-5852-88a9-7951d63188d1	C54.1	Endometrium	High Grade	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	74	-27065	NA	3078ca72-dee9-5c7d-8a6a-a75206adc1bd	FALSE	NA	NA	834	834	WT-With Tumor	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Adjuvant	2ce1e51d-937d-5861-81d1-3df10bf5369a;6a7c54df-815a-417d-9a51-5daa89430740	Radiation, Implants;Radiation, External Beam	NA	yes	NA	NA	NA	250;257	NA	243;220	1	1100;4500	2;25	Regional Site;Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-D1-A16G
TCGA-UCEC	TCGA-AJ-A3BG	Stage IA	No	0	NA	2009	NA	Endometrium	23861	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2011	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	03aaa2cc-0cbd-5e47-b13d-c4fe8c4cb7b5	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	65	-23861	NA	5b4a1e6c-e831-5826-949b-e548534065f8	FALSE	NA	United States	NA	550	WT-With Tumor	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	195855e6-4a3c-5a3b-897a-3b8b5bae8ecf	Radiation, External Beam	NA	yes	NA	NA	Complete Response	184	NA	123	NA	6000	NA	Primary Tumor Field	cGy	NA	NULL	NA	NA	NA	TCGA-AJ-A3BG
TCGA-UCEC	TCGA-BS-A0T9	Stage IVB	No	0	NA	1988	NA	Endometrium	14253	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2005	released	No	TRUE	NA	Surgical Resection	NA	8380/3	R2	primary	09579d8d-9ca2-5ee9-a9bb-ee05496857cf	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	native hawaiian or other pacific islander	female	not hispanic or latino	Dead	39	-14253	NA	d78ace8f-6085-5241-8f2c-ca6c81a6e286	FALSE	NA	NA	1428	1428	WT-With Tumor	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	a22838a0-ead2-59c5-bf1d-975911f5ca40	Radiation, External Beam	NA	yes	Recurrent Disease	NA	NA	1055	NA	1013	2	5600	28	Regional Site	cGy	NA	NULL	NA	NA	NA	TCGA-BS-A0T9
TCGA-UCEC	TCGA-D1-A0ZS	Stage IB	No	0	NA	NA	NA	Endometrium	19821	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	61c62350-18f6-5bdd-9eb5-447cef6c4df1	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	54	-19821	NA	7e3c3954-9e54-5294-be2e-0761ef69da77	FALSE	NA	NA	NA	148	TF-Tumor Free	Adjuvant;NA	5e23eb9c-56ae-445a-abfd-1416703c268a;7a17414a-79bb-4cec-af88-2f5bb7d6c04e	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-D1-A0ZS
TCGA-UCEC	TCGA-EY-A1GK	Stage IB	No	0	NA	2009	NA	Endometrium	27127	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2009	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	4bcfe1ca-121f-5b5f-bfb9-4f8586ae8672	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	74	-27127	NA	524b3bcd-5407-5806-9e56-c91529f85f1e	FALSE	NA	United States	NA	693	TF-Tumor Free	Adjuvant;NA	007a5fe2-00d9-4440-9e64-2ee0ce831a74;f17285be-90ab-402b-8fdd-9fdfddcce692	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-EY-A1GK
TCGA-UCEC	TCGA-DI-A2QU	Stage IVB	No	0	NA	1988	NA	Endometrium	24488	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2005	released	No	TRUE	NA	Biopsy	NA	8441/3	RX	primary	e65420d0-c503-5f87-b36b-859e397daaf4	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	67	-24488	NA	74ad2067-0e7b-5ac0-8f46-6a3ca0f0e2c1	FALSE	NA	United States	946	946	WT-With Tumor	NA	9cafd343-2663-5552-9e0e-03ff493eb811	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-DI-A2QU
TCGA-UCEC	TCGA-FL-A1YF	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-FL-A1YF
TCGA-UCEC	TCGA-AP-A0LT	Stage II	No	0	NA	NA	NA	Endometrium	21107	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2006	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	7c15d92c-4f55-5d8d-9d22-73ed30c7c263	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	57	-21107	NA	dbfb019a-7f60-5b22-9d2f-87c1f3c2f6fd	FALSE	NA	NA	NA	1497	TF-Tumor Free	Adjuvant;NA	3018732b-d2e8-47ca-80a5-2c7a4a695cec;e786c80f-ade7-4600-8fdb-77950c198144	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-AP-A0LT
TCGA-UCEC	TCGA-EY-A1GJ	Stage IA	No	0	NA	2009	NA	Endometrium	26715	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	b75b9c27-b4aa-5797-a64e-053c8f838e5a	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Alive	73	-26715	NA	87e40b47-5597-599e-a9ae-34e77130cda2	FALSE	NA	United States	NA	727	TF-Tumor Free	NA;Adjuvant	43752c9a-00e1-4792-af0a-69804a5bbc51;eb7c069a-6bcb-446e-aebc-2d923973a661	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-EY-A1GJ
TCGA-UCEC	TCGA-AJ-A3BH	Stage IB	No	NA	NA	2009	NA	Endometrium	NA	Endometrioid adenocarcinoma, NOS	2025-01-08T13:25:23.427225-06:00	no	2011	released	No	TRUE	NA	NA	NA	8380/3	R0	primary	42feafc4-47c7-5f07-938b-cab59277e396	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	NA	NA	NA	1974fb64-2bf1-5ae4-a1d3-549373310899	FALSE	NA	United States	NA	NA	NA	NA	712d6c72-03e3-563c-a608-66fac6735f30	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-AJ-A3BH
TCGA-UCEC	TCGA-AP-A0LL	Stage IA	No	0	NA	NA	NA	Endometrium	20700	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2004	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	f06b7f7a-a842-5716-a603-cc32d3f20ba4	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	56	-20700	NA	08c435d5-dcc2-53eb-b1bc-64e9ff9fdb60	FALSE	NA	NA	NA	2554	TF-Tumor Free	NA	edfecaf1-0916-4c48-867c-0d6e52cbce0b	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-AP-A0LL
TCGA-UCEC	TCGA-DI-A1BU	Stage IIB	No	0	NA	2009	NA	Endometrium	20114	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	0322cb67-0295-5910-8351-7749a26fb857	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	55	-20114	NA	5e7522d0-0e5d-5ca7-84c7-e0ae4e82dfee	FALSE	NA	United States	NA	1195	TF-Tumor Free	NA	a3d5831e-5523-41e8-b91f-82c39d7dfe42	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-DI-A1BU
TCGA-UCEC	TCGA-FL-A3WE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-FL-A3WE
TCGA-UCEC	TCGA-FL-A1YT	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-FL-A1YT
TCGA-UCEC	TCGA-B5-A0JV	Stage IA	No	0	NA	1988	NA	Endometrium	23295	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2007	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	NA	primary	70a965e0-7f44-5ba2-9ae0-b5dbb74d7153	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not reported	Alive	63	-23295	NA	e88ad5a0-3e91-5f6f-a2b5-19a6bc04e25a	FALSE	NA	United States	NA	2616	TF-Tumor Free	NA;Adjuvant	10008bcf-8102-4769-92c5-ca727320354a;d834e477-e9dd-4848-b5c9-a43f3a285ef7	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-B5-A0JV
TCGA-UCEC	TCGA-B5-A0K9	Stage II	No	0	NA	2009	NA	Endometrium	32289	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	309688e1-4ee9-5fba-8b99-74fd8ef540df	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Dead	88	-32289	NA	7a511403-4d2c-5581-b0ba-8f177e17b6dc	FALSE	NA	United States	409	409	NA	NA;Adjuvant	98a1d287-b22e-43b3-8b20-515dfd952c82;d1d21abf-025b-4799-8060-240142431852	Pharmaceutical Therapy, NOS	Tamoxifen;NA	not reported;no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-B5-A0K9
TCGA-UCEC	TCGA-AP-A0LH	Stage IA	No	0	NA	NA	NA	Endometrium	22169	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2002	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8441/3	R0	primary	8061a94b-839c-5815-b4d5-18d8f4bf6ad1	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	60	-22169	NA	8bd4e246-74c0-5a87-a680-0a9764a0bde5	FALSE	NA	NA	1106	1106	WT-With Tumor	NA	5e3ac2b2-85b1-4789-8499-f9b831f9fff0	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-AP-A0LH
TCGA-UCEC	TCGA-B5-A11R	Stage II	No	0	NA	1988	NA	Endometrium	18878	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8380/3	NA	primary	f675bdd0-9c39-5e2b-8e82-80ff3efeaba3	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not reported	Alive	51	-18878	NA	e331981e-7b68-53b7-95c2-5cf15949c2ea	FALSE	NA	United States	NA	2349	TF-Tumor Free	NA	41a09716-e8fb-4c18-9512-1b1b2bf1646e	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-B5-A11R
TCGA-UCEC	TCGA-FL-A1YV	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-FL-A1YV
TCGA-UCEC	TCGA-AP-A05J	Stage II	No	0	NA	NA	NA	Endometrium	24119	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	ba11f1ed-4646-5adf-b91e-6b8562dbf59d	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	66	-24119	NA	ffb5b981-6cb5-5f4e-b50f-0fd3b4d6dcea	FALSE	NA	NA	NA	1122	TF-Tumor Free	NA	61bd1ec7-cc14-458c-aa58-f7c6a435617a	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-AP-A05J
TCGA-UCEC	TCGA-AP-A1DP	Stage IA	No	0	NA	2009	NA	Endometrium	25601	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8441/3	R0	primary	c96495d3-47a4-5cd1-8e8b-cc70f395057c	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Dead	70	-25601	NA	4a9cbf57-5459-5e8b-8fda-2a5dd5a9e2f5	FALSE	NA	NA	1081	1081	WT-With Tumor	NA	877d2a8e-c645-471d-80a1-b07e641df598	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-AP-A1DP
TCGA-UCEC	TCGA-D1-A2G6	Stage IIIC	No	0	NA	1995	NA	Endometrium	19547	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2007	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	8035dae0-412a-51c1-86a1-7a159431ace3	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Dead	53	-19547	NA	4c66146b-bcc2-5139-8bbc-91f38bf58f48	FALSE	NA	United States	258	258	WT-With Tumor	NA	6a8afad1-f9b7-5be2-9bee-ef63deb26c03	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-D1-A2G6
TCGA-UCEC	TCGA-FL-A1YI	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-FL-A1YI
TCGA-UCEC	TCGA-FL-A1YM	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-FL-A1YM
TCGA-UCEC	TCGA-B5-A0K4	Stage IB	No	0	NA	2009	NA	Endometrium	18631	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	NA	primary	d54c375d-f9ef-5698-8f4d-af8872247cee	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	not reported	female	not reported	Alive	51	-18631	NA	9234f877-58d0-540d-89b1-9666a42bbfc4	FALSE	NA	United States	NA	1757	TF-Tumor Free	NA	bfca5cdf-d7fb-4a96-9256-e4ae106a68f5	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-B5-A0K4
TCGA-UCEC	TCGA-DI-A0WH	Stage IB	No	0	NA	2009	NA	Endometrium	23692	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	da620a34-6f3c-58dc-afeb-42eb7cdbc88c	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	64	-23692	NA	d4e997f3-b77d-5c7b-8e71-f598cfd8f14a	FALSE	NA	United States	NA	496	TF-Tumor Free	Adjuvant;NA	3ee9b933-d803-486e-bd0d-e37ff0d27edd;7eba61ea-f363-42ae-8de4-78bc62c8f43e	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-DI-A0WH
TCGA-UCEC	TCGA-FL-A1YN	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-FL-A1YN
TCGA-UCEC	TCGA-AP-A0LE	Stage IA	No	0	NA	NA	NA	Endometrium	20967	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2002	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	32ccea2a-8907-5b3f-8c66-1b5b68ea35ad	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	57	-20967	NA	5ac7cfe5-25b4-5521-8ed4-023f2afa3d42	FALSE	NA	NA	NA	3357	TF-Tumor Free	NA;Adjuvant	4fede077-bffe-4f80-b2c5-8b9e39440182;6dc59343-2bae-4eb5-b3f0-b4a5609ebef8	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-AP-A0LE
TCGA-UCEC	TCGA-AP-A1DH	Stage IA	No	0	NA	2009	NA	Endometrium	22652	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2005	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	8cbd7dd9-f707-56af-ac1b-85833817d15f	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	62	-22652	NA	a0172345-d345-5bd2-b785-7f054781a0fe	FALSE	NA	NA	NA	2180	TF-Tumor Free	NA;Adjuvant	0618eb28-ce07-42cb-b87b-7473dea1e977;eb04c317-8668-4468-9b36-8764c6017313	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-AP-A1DH
TCGA-UCEC	TCGA-FL-A1YL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-FL-A1YL
TCGA-UCEC	TCGA-FL-A1YG	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-FL-A1YG
TCGA-UCEC	TCGA-D1-A0ZZ	Stage IB	No	0	NA	NA	NA	Endometrium	29420	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	9710210a-9824-50a8-9373-b37370b16b27	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	80	-29420	NA	f6beb124-7592-52b5-9440-69a20be0004e	FALSE	NA	NA	NA	686	TF-Tumor Free	NA	fad000d5-0c95-449c-a975-27486ec22dca	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-D1-A0ZZ
TCGA-UCEC	TCGA-EY-A1GH	Stage IA	No	0	NA	2009	NA	Endometrium	25802	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	989578c6-378e-573e-9073-63846c0150e4	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	70	-25802	NA	ea34983c-8abf-5e0e-b795-731c3baf565e	FALSE	NA	United States	NA	710	TF-Tumor Free	Adjuvant;NA	87e5f057-5136-4005-a096-54fa7b88f200;a42d4ca1-13f3-4ef7-b1af-fcde3fd324b6	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-EY-A1GH
TCGA-UCEC	TCGA-FL-A1YH	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-FL-A1YH
TCGA-UCEC	TCGA-AP-A05N	Stage IA	No	0	NA	NA	NA	Endometrium	21254	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	0d8675f4-8c52-557b-a5c1-7e8f13b5e3e1	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Dead	58	-21254	NA	04149f27-e7a1-546d-816b-906f65010536	FALSE	NA	NA	726	726	TF-Tumor Free	NA;Adjuvant	b8e056f0-2c5b-49e2-b9d4-83fe000a823f;be48ff3a-9e97-486f-9bb1-edd023b18c40	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-AP-A05N
TCGA-UCEC	TCGA-AP-A05H	Stage IB	No	0	NA	NA	NA	Endometrium	27744	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8441/3	R0	primary	5814746b-6afc-5eda-90ad-4e03e226a6dc	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	75	-27744	NA	73f1bca1-fc2b-5767-899a-8ff467a68d62	FALSE	NA	NA	NA	1385	TF-Tumor Free	NA	4cdd29e7-b57f-4dc3-99a7-aba6c03ce596	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-AP-A05H
TCGA-UCEC	TCGA-FL-A1YU	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-FL-A1YU
TCGA-UCEC	TCGA-AP-A1DM	Stage IA	No	0	NA	2009	NA	Endometrium	22239	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2007	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	313fd825-764e-5f76-a974-459faf3c2800	C54.1	Endometrium	G1	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	60	-22239	NA	eb14ffb2-f120-5873-8146-038dadc0fba8	FALSE	NA	NA	NA	1700	TF-Tumor Free	NA;Adjuvant	4acc7a7b-8661-4419-a715-28ee70ef6cec;ddb5a413-fac4-4b85-bddd-9d96c420c750	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-AP-A1DM
TCGA-UCEC	TCGA-DI-A1BY	Stage IIB	No	0	NA	2009	NA	Endometrium	23113	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Other	NA	8380/3	R0	primary	a439ad3c-44d7-5d10-ae48-718f94201a2b	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	63	-23113	NA	73986089-8e5f-5a89-8e84-674c67d66ce7	FALSE	NA	United States	NA	1114	TF-Tumor Free	NA;Adjuvant	581f4e82-3df2-4ebd-850c-c69a88ee7130;89881cf6-32d5-49ef-bbd6-fc8c09540563	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-DI-A1BY
TCGA-UCEC	TCGA-D1-A15X	Stage IA	No	0	NA	1995	NA	Endometrium	16532	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Biopsy	NA	8441/3	R0	primary	b4a0d69d-3c39-5956-b8c4-c05c4d083263	C54.1	Endometrium	High Grade	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	45	-16532	NA	94e5d21e-5343-553f-80b3-79fb4e38d0ba	FALSE	NA	NA	NA	909	TF-Tumor Free	Adjuvant;NA	110cfc08-d89a-4b7a-a22b-810f8010645c;312375ba-61f5-4073-8063-352ec5e69281	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-D1-A15X
TCGA-UCEC	TCGA-AP-A05A	Stage II	No	0	NA	NA	NA	Endometrium	29914	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2006	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8441/3	R0	primary	96c1048b-6aae-5406-9ec5-44b1e2b5807b	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Dead	81	-29914	NA	e2c969a6-33f1-5950-af29-6b93725ec9c0	FALSE	NA	NA	1944	1944	TF-Tumor Free	NA	99c5e6c5-3186-4919-bb7e-9836788e0dbb	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-AP-A05A
TCGA-UCEC	TCGA-EY-A1GI	Stage IB	No	0	NA	2009	NA	Endometrium	19117	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2009	released	No	TRUE	NA	Excisional Biopsy	NA	8380/3	R0	primary	a6b29f73-2887-5de1-88ea-25441a3379e9	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	52	-19117	NA	15b9957d-8c31-5525-b249-cb4e25a082fd	FALSE	NA	United States	NA	710	TF-Tumor Free	Adjuvant;NA	2a6f2a2c-7b21-4816-8ba9-824202fd0a0d;738bbf1f-07f9-4971-9ef5-a28d8f5021bd	Pharmaceutical Therapy, NOS	NA;Tamoxifen	no	NA	NA;Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-EY-A1GI
TCGA-UCEC	TCGA-DI-A2QT	Stage IIIC	No	0	NA	1988	NA	Endometrium	18835	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2008	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8441/3	R2	primary	06f7b4e5-837b-5466-9916-77470ee9e884	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	american indian or alaska native	female	hispanic or latino	Dead	51	-18835	NA	8ab85fd8-bf9d-5f86-942f-60383f958f5b	FALSE	NA	United States	377	377	WT-With Tumor	NA	d7bb4b46-3f72-5749-aef0-54d592a446e6	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-DI-A2QT
TCGA-UCEC	TCGA-EY-A1GU	Stage IB	No	0	NA	2009	NA	Endometrium	24304	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2010	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	b9931a2c-2e4f-5dc9-a4b5-6d30be3fd97d	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	black or african american	female	not hispanic or latino	Dead	66	-24304	NA	fc12f5c0-916b-58cd-adf6-ffd5a2316196	FALSE	NA	United States	997	997	TF-Tumor Free	NA;Adjuvant	087408da-7aa6-47a4-944f-b3397f9a9f21;21f9fe9c-c0c0-4a93-80a5-9b7f6e575bd0	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-EY-A1GU
TCGA-UCEC	TCGA-KP-A3VZ	Stage IV	No	0	NA	2009	NA	Endometrium	25366	Serous cystadenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2010	released	No	TRUE	NA	Biopsy	NA	8441/3	RX	primary	15ac85f0-1a5c-5f57-8c36-8d0d94fb9c8c	C54.1	Endometrium	High Grade	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	69	-25366	NA	847fa83d-736f-5a87-a0db-2dfbe7973176	FALSE	NA	Canada	NA	722	WT-With Tumor	NA	05716f00-af36-463d-b739-cdfc83f86d39	Pharmaceutical Therapy, NOS	Tamoxifen	not reported	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-KP-A3VZ
TCGA-UCEC	TCGA-FL-A1YQ	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-FL-A1YQ
TCGA-UCEC	TCGA-EY-A1GQ	Stage IB	No	0	NA	2009	NA	Endometrium	27905	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	yes	2010	released	No	TRUE	NA	Dilation and Curettage Procedure	NA	8380/3	R0	primary	26cd1b0f-a731-52ee-b6f8-1b4d226a267d	C54.1	Endometrium	G3	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not hispanic or latino	Alive	76	-27905	NA	823c38c3-da83-5448-a724-54b825439b21	FALSE	NA	United States	NA	544	WT-With Tumor	NA	0844c2ae-1411-4cdc-857f-aad5a0e37e0b	Pharmaceutical Therapy, NOS	Tamoxifen	no	NA	Prior to Diagnosis	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-EY-A1GQ
TCGA-UCEC	TCGA-AP-A0LQ	Stage IA	No	0	NA	NA	NA	Endometrium	21629	Endometrioid adenocarcinoma, NOS	2025-10-24T10:03:58.643295-05:00	no	2005	released	No	TRUE	NA	Biopsy	NA	8380/3	R0	primary	6be62a2d-e230-51da-8986-5b4bcfabc9d7	C54.1	Endometrium	G2	NA	NA	NA	NA	NA	NA	NA	NA	NA	white	female	not reported	Alive	59	-21629	NA	af758c42-36b7-5be1-b6ac-87916ca117fb	FALSE	NA	NA	NA	2457	TF-Tumor Free	NA;Adjuvant	a1d4f9c6-f378-4158-8d8b-2bf8707dc1d6;a6fb3a87-7d21-4b19-b63d-4f93dc7ce31b	Pharmaceutical Therapy, NOS	Tamoxifen;NA	no	NA	Prior to Diagnosis;NA	NA	NA	NA	NA	NA	NA	NA	NULL	NA	NA	NULL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-AP-A0LQ
